IDEX CORP /DE/, 10-K filed on 2/19/2026
Annual Report
v3.25.4
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2025
Feb. 13, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 1-10235    
Entity Registrant Name IDEX CORP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 36-3555336    
Entity Address, Address Line One 3100 Sanders Road,    
Entity Address, Address Line Two Suite 301,    
Entity Address, City or Town Northbrook,    
Entity Address, State or Province IL    
Entity Address, Postal Zip Code 60062    
City Area Code 847    
Local Phone Number 498-7070    
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol IEX    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 13,228,549,364
Entity Common Stock, Shares Outstanding   74,347,824  
Documents Incorporated by Reference
Portions of the proxy statement with respect to the IDEX Corporation 2026 annual meeting of stockholders (the “2026 Proxy Statement”) are incorporated by reference into Part III of this Form 10-K.
    
Amendment Flag false    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Entity Central Index Key 0000832101    
v3.25.4
Audit Information
 12 Months Ended
Dec. 31, 2025
Audit Information [Abstract]  
Auditor Name DELOITTE & TOUCHE LLP
Auditor Location Chicago, Illinois
Auditor Firm ID 34
v3.25.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands, shares in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 3,457,500 $ 3,268,800 $ 3,273,900
Cost of sales 1,918,700 1,823,600 1,827,000
Gross profit 1,538,800 1,445,200 1,446,900
Selling, general and administrative expenses 818,800 758,700 703,500
Restructuring expenses and asset impairments 20,700 9,300 10,900
Operating income 699,300 677,200 732,500
Gain on sale of businesses – net 0 (4,000) (84,700)
Other expense (income) – net 2,300 (2,600) 5,200
Interest expense - net 64,400 44,500 51,700
Income before income taxes 632,600 639,300 760,300
Provision for income taxes 150,100 134,700 164,700
Net income 482,500 504,600 595,600
Net loss attributable to noncontrolling interest 700 400 500
Net income attributable to IDEX $ 483,200 $ 505,000 $ 596,100
Earnings per common share:      
Basic earnings per common share attributable to IDEX (in dollar per share) $ 6.41 $ 6.66 $ 7.87
Diluted earnings per common share attributable to IDEX (in dollar per share) $ 6.41 $ 6.64 $ 7.85
Share data:      
Basic weighted average common shares outstanding (in shares) 75.3 75.7 75.6
Diluted weighted average common shares outstanding (in shares) 75.3 75.9 75.9
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 482.5 $ 504.6 $ 595.6
Other comprehensive income (loss):      
Pension and other postretirement adjustments, net of tax 2.2 3.1 (7.4)
Cumulative translation adjustment 186.3 (88.2) 87.8
Other comprehensive income (loss), net of tax 188.5 (85.1) 80.4
Comprehensive income 671.0 419.5 676.0
Comprehensive loss attributable to noncontrolling interest 0.7 0.4 0.5
Comprehensive income attributable to IDEX $ 671.7 $ 419.9 $ 676.5
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 580.0 $ 620.8
Receivables – net 521.7 465.9
Inventories – net 479.4 429.7
Other current assets 62.1 76.3
Total current assets 1,643.2 1,592.7
Property, plant and equipment – net 468.0 460.4
Goodwill 3,414.5 3,251.7
Intangible assets – net 1,247.4 1,284.8
Other noncurrent assets 153.9 155.7
Total assets 6,927.0 6,745.3
Current liabilities    
Trade accounts payable 224.7 197.8
Accrued expenses 297.0 278.7
Current portion of long-term borrowings 0.7 100.7
Dividends payable 53.0 52.5
Total current liabilities 575.4 629.7
Long-term borrowings – net 1,820.1 1,859.5
Deferred income taxes 303.0 267.2
Other noncurrent liabilities 202.3 194.8
Total liabilities 2,900.8 2,951.2
Commitments and contingencies (Note 10)
Preferred stock:    
Authorized: 5.0 million shares, $0.01 per share par value; Issued: None 0.0 0.0
Common stock:    
Authorized: 150.0 million shares, $0.01 per share par value Issued: 90.1 million shares at both December 31, 2025 and 2024 0.9 0.9
Treasury stock at cost: 15.5 million shares at December 31, 2025 and 14.2 million shares at December 31, 2024 (1,423.2) (1,170.3)
Additional paid-in capital 892.1 864.8
Retained earnings 4,500.1 4,230.2
Accumulated other comprehensive income (loss) 57.6 (130.9)
Total shareholders’ equity 4,027.5 3,794.7
Noncontrolling interest (1.3) (0.6)
Total equity 4,026.2 3,794.1
Total liabilities and equity $ 6,927.0 $ 6,745.3
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Preferred stock, shares authorized (in shares) 5,000,000.0 5,000,000.0
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares issued (in shares) 0 0
Common stock, shares authorized (in shares) 150,000,000.0 150,000,000.0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares issued (in shares) 90,100,000 90,100,000
Treasury stock, common (in shares) 15,500,000 14,200,000
v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
Total Shareholders’ Equity
Common Stock Shares
Common Stock and Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022     90,100,000          
Beginning balance at Dec. 31, 2022 $ 3,039.6 $ 3,039.3   $ 818.1 $ (1,184.3) $ (126.2) $ 3,531.7 $ 0.3
Beginning balance (in shares) at Dec. 31, 2022         14,500,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 595.6 596.1         596.1 (0.5)
Other comprehensive income (loss), net of tax 80.4 80.4       80.4    
Net issuance of shares of treasury stock (net of tax) (in shares)         (300,000)      
Net issuance of shares of treasury stock (net of tax) $ 21.5 21.5     $ 21.5      
Repurchases of common stock (in shares) 100,000       100,000      
Repurchases of common stock $ (24.2) (24.2)     $ (24.2)      
Share-based compensation 21.8 21.8   21.8        
Cash dividends declared (193.5) (193.5)         (193.5)  
Ending balance (in shares) at Dec. 31, 2023     90,100,000          
Ending balance at Dec. 31, 2023 3,541.2 3,541.4   839.9 $ (1,187.0) (45.8) 3,934.3 (0.2)
Ending balance (in shares) at Dec. 31, 2023         14,300,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 504.6 505.0         505.0 (0.4)
Other comprehensive income (loss), net of tax (85.1) (85.1)       (85.1)    
Net issuance of shares of treasury stock (net of tax) (in shares)         (100,000)      
Net issuance of shares of treasury stock (net of tax) $ 16.7 16.7     $ 16.7      
Repurchases of common stock (in shares) 0              
Share-based compensation $ 25.8 25.8   25.8        
Cash dividends declared (209.1) (209.1)         (209.1)  
Ending balance (in shares) at Dec. 31, 2024     90,100,000          
Ending balance at Dec. 31, 2024 $ 3,794.1 3,794.7   865.7 $ (1,170.3) (130.9) 4,230.2 (0.6)
Ending balance (in shares) at Dec. 31, 2024 14,200,000       14,200,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 482.5 483.2         483.2 (0.7)
Other comprehensive income (loss), net of tax 188.5 188.5       188.5    
Net issuance of shares of treasury stock (net of tax) (in shares)         (100,000)      
Net issuance of shares of treasury stock (net of tax) $ (0.5) (0.5)     $ (0.5)      
Repurchases of common stock (in shares) 1,400,000       1,400,000      
Repurchases of common stock $ (252.4) (252.4)     $ (252.4)      
Share-based compensation 27.3 27.3   27.3        
Cash dividends declared (213.3) (213.3)         (213.3)  
Ending balance (in shares) at Dec. 31, 2025     90,100,000          
Ending balance at Dec. 31, 2025 $ 4,026.2 $ 4,027.5   $ 893.0 $ (1,423.2) $ 57.6 $ 4,500.1 $ (1.3)
Ending balance (in shares) at Dec. 31, 2025 15,500,000       15,500,000      
v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]      
Total other comprehensive income (loss), Tax $ (1.2) $ (0.7) $ 2.3
Net issuance of shares of common stock, tax amount $ 4.2 $ 2.7 $ 2.8
Cash dividends declared, per common share outstanding (in dollars per share) $ 2.84 $ 2.76 $ 2.56
Excise tax $ 2.4    
Repurchases of common stock (in shares) 1,400,000 0 100,000
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net income $ 482.5 $ 504.6 $ 595.6
Adjustments to reconcile net income to net cash flows provided by operating activities:      
Gain on sale of businesses – net 0.0 (4.0) (84.7)
Asset Impairments 0.7 0.1 0.8
Credit loss on note receivable from collaborative partner 0.0 0.0 7.7
Depreciation 75.8 68.5 57.2
Amortization of intangible assets 130.7 107.1 94.9
Share-based compensation expense 27.3 25.8 21.8
Deferred income taxes 12.8 (19.4) (14.7)
Changes in (net of the effect from acquisitions/divestitures and foreign currency translation):      
Receivables – net (41.2) (16.9) 20.5
Inventories – net (34.2) 17.6 66.2
Other current assets 1.6 (0.1) (6.5)
Trade accounts payable 15.2 8.9 (25.3)
Deferred revenue 2.7 (17.9) 12.7
Accrued expenses 1.8 (8.6) (34.8)
Other – net 4.7 2.4 5.3
Net cash flows provided by operating activities 680.4 668.1 716.7
Cash flows from investing activities      
Capital expenditures (63.6) (65.1) (89.9)
Acquisition of businesses, net of cash acquired (76.2) (984.5) (311.8)
Proceeds from sale of businesses, net of cash remitted 0.0 45.1 118.6
Purchase of marketable securities 0.0 0.0 (29.0)
Proceeds from sale of marketable securities 0.0 4.5 24.8
Other – net 2.2 (6.5) 3.5
Net cash flows used in investing activities (137.6) (1,006.5) (283.8)
Cash flows from financing activities      
Borrowings under revolving credit facilities 252.0 279.3 0.0
Payments under revolving credit facilities (322.9) (69.1) 0.0
Proceeds from issuance of long-term borrowings 0.0 496.7 100.0
Payment of long-term borrowings (100.0) (50.0) (250.0)
Cash dividends paid to shareholders (212.6) (205.3) (190.7)
(Payments) proceeds from share issuances, net of shares withheld for taxes (0.5) 16.7 21.5
Repurchases of common stock (247.8) 0.0 (24.2)
Other – net (0.8) (2.4) (1.3)
Net cash flows (used in) provided by financing activities (632.6) 465.9 (344.7)
Effect of exchange rate changes on cash and cash equivalents 36.8 (22.9) 15.9
Net (decrease) increase in cash and cash equivalents and restricted cash (53.0) 104.6 104.1
Cash and cash equivalents and restricted cash at beginning of year [1] 638.9 534.3 430.2
Cash and cash equivalents and restricted cash at end of year [1] 585.9 638.9 534.3
Cash paid for:      
Interest 72.2 47.4 50.8
Income taxes - net $ 134.6 $ 171.4 $ 199.5
[1] Includes $5.9 million and $18.1 million of restricted cash at December 31, 2025 and December 31, 2024. respectively. At December 31, 2025, $3.0 million of the restricted cash has been included in Other current assets and $2.9 million has been included in Other noncurrent assets in the Consolidated Balance Sheets. At December 31, 2024, $18.1 million was included in Other current assets in the Consolidated Balance Sheets. There was no restricted cash as of December 31, 2023 or December 31, 2022.
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restricted cash $ 5.9 $ 18.1 $ 0.0 $ 0.0
Other Current Assets        
Restricted cash 3.0      
Other Noncurrent Assets        
Restricted cash $ 2.9      
v3.25.4
Significant Accounting Policies
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Significant Accounting Policies Significant Accounting Policies
Business

IDEX is an applied solutions provider specializing in the manufacturing of health and science technologies, fluid and metering technologies, and fire, safety and other diversified products built to customers’ specifications. IDEX’s products are sold in niche markets across a wide range of industries throughout the world. The Company operates through three reportable segments: Health & Science Technologies (“HST”), Fluid & Metering Technologies (“FMT”) and Fire & Safety/Diversified Products (“FSDP”).

Consolidation and Basis of Presentation

The accompanying Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for credit losses, inventory valuation, recoverability of long-lived assets, valuation of goodwill and intangible assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions.

Revenue Recognition

The Company accounts for a contract with a customer when it has approval from both parties, the rights and payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company determines the appropriate revenue recognition by analyzing the terms and conditions of the contract. Revenue, or Net sales, is recognized when control of the products or services is transferred to a customer at an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring the products or providing the services. Control is transferred to customers when performance obligations within a contract are satisfied. A performance obligation is a promise to transfer a distinct product or service to a customer.

The majority of the Company’s contracts have a single performance obligation which represents, in most cases, the product being sold to the customer. Some contracts include multiple performance obligations such as a product and related installation, extended warranty, engineering, software and/or maintenance services.

For contracts that require complex design, manufacturing and installation activities, certain performance obligations may not be separately identifiable and, therefore, not distinct. As a result, the entire contract is accounted for as a single performance obligation. For contracts that include distinct products or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct products or services. For product sales, each product sold to a customer generally represents a distinct performance obligation. For contracts with multiple performance obligations, the Company allocates the total transaction price to each performance obligation in an amount based on the relative standalone selling prices of the promised products or services underlying each performance obligation. When available, the observable standalone sales are used in the allocation of the total transaction price, but in certain cases, the Company may be required to estimate the standalone selling price using the expected cost plus margin approach, under which it forecasts the expected costs of satisfying a performance obligation and then adds an appropriate margin for the distinct product or service.

The Company’s performance obligations are satisfied at either a point in time or over time as work progresses. For performance obligations satisfied at a point in time, revenue is recognized when control transfers to the customer, typically upon shipment. For performance obligations in which the Company transfers control of a product or service over time, revenue
is recognized over time as work is performed. Typically, this results when the Company performs services over time or the Company creates a product with no alternative use and has an enforceable right to payment for its performance to date.

When accounting for over-time contracts, the Company generally uses a cost input measure to determine the extent of progress towards completion of the performance obligation. The Company believes this measure of progress best depicts the transfer of control to the customer which occurs as the Company incurs costs on its contracts. Incurred cost represents work performed, which corresponds with the transfer of control to the customer. Contract costs include labor, material and overhead. Revenue is recognized based on the relationship between actual costs incurred to date for each contract and the total estimated costs for such contract at completion of the performance obligation.

As a significant change in one or more of these estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its estimates regularly. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised. Such revisions to costs and income are recognized in the period in which the revisions are determined as a cumulative catch-up adjustment. The impact of the adjustment on profit recorded to date on a contract is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance are recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, the Company recognizes provisions for estimated losses on incomplete contracts in the period in which such losses are determined.

The Company records allowances for discounts and product returns at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties (primarily assurance-type) and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company.

Contract Assets and Liabilities

The timing of billings and cash collections can result in customer receivables, billings in excess of revenue recognized, advance payments or deposits. Customer receivables include both amounts billed and currently due from customers as well as unbilled amounts (contract assets) and are included in Receivables - net on the Consolidated Balance Sheets. Amounts are billed in accordance with contractual terms or as work progresses. Unbilled amounts arise when the timing of billing differs from the timing of revenue recognized, such as when contract provisions require specific milestones to be met before a customer can be billed. Unbilled amounts primarily relate to performance obligations satisfied over time when the cost-to-cost method is utilized and the revenue recognized exceeds the amount billed to the customer as there is not yet a right to invoice in accordance with contractual terms. Unbilled amounts are recorded as a contract asset when the revenue associated with the contract is recognized prior to billing and derecognized when billed in accordance with the terms of the contract.

Contract liabilities include advance payments, deposits and billings in excess of revenue recognized and are included in deferred revenue which is classified as current or noncurrent based on the timing of when the Company expects to recognize the revenue. The current portion is included in Accrued expenses and the noncurrent portion is included in Other noncurrent liabilities on the Consolidated Balance Sheets. Advance payments, deposits and billings in excess of revenue represent contract liabilities and are recorded when customers remit contractual cash payments in advance of satisfaction of performance obligations under contractual arrangements, including those with performance obligations satisfied over time. The Company generally receives advance payments from customers related to maintenance services which are recognized ratably over the service term. The Company also receives deposits from customers on certain orders which the Company recognizes as revenue at a point in time. Contract liabilities are derecognized when revenue is recognized.

Shipping and Handling Costs

Shipping and handling costs are included in Cost of sales and are recognized as a period expense during the period in which they are incurred.

Advertising Costs

Advertising costs of $16.3 million, $16.9 million and $15.9 million for 2025, 2024 and 2023, respectively, are expensed as incurred within Selling, general and administrative expenses.
Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with an original maturity of 3 months or less to be cash and cash equivalents.

Marketable Securities

From time to time, the Company may hold investments in marketable securities, which are recorded in Other current assets in the Consolidated Balance Sheets. These investments are recorded at fair value, with gains and losses, dividends and interest income included in Other expense (income) – net in the Consolidated Statements of Income.

Accounts Receivable and Allowance for Credit Losses

Accounts receivable are recorded at face amount less an allowance for credit losses including bad debts as well as other estimated returns and allowances. The allowance for bad debt is an estimate based on historical collection experience, current and future economic and market conditions and a review of the current status of each customer’s trade accounts receivable. Management evaluates the aging of the accounts receivable balances and the financial condition of its customers and all other forward-looking information that is reasonably available to estimate the amount of accounts receivable that may not be collected in the future and records the appropriate provision. Reserves for returns and other allowances and adjustments, which are provided for in the same period the related sales are recorded and reduce net sales, are estimated using historical experience as well as specific customer circumstances when known.

Inventories

The Company states inventories at the lower of cost or net realizable value. Cost, which includes material, labor and overhead, is determined on a first in, first out basis. The Company makes adjustments to reduce the cost of inventory to its net realizable value, if required, for estimated excess, obsolete, zero usage or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes.

Impairment of Long-Lived Assets

A long-lived asset is reviewed for impairment if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below its carrying value, as measured by comparing its net book value to the projected undiscounted future cash flows generated by its use. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. A long-lived asset impairment exists when the carrying value of the asset group exceeds its fair value. The amount and timing of the impairment charge for an asset group requires the estimation of future cash flows, which are then discounted to determine the fair value of the asset group. An impaired asset group is recorded at its estimated fair value. Refer to Note 14, “Restructuring Expenses and Asset Impairments,” for further discussion on impairment of long-lived assets.

Goodwill and Indefinite-Lived Intangible Assets

The Company reviews the carrying value of goodwill and indefinite-lived intangible assets annually, or more frequently if events occur or circumstances change that would indicate an asset may be impaired. The Company evaluates the recoverability of these assets as of October 31 based on the estimated fair value of each reporting unit and the indefinite-lived intangible assets. See Note 6, “Goodwill and Intangible Assets,” for further discussion on goodwill and indefinite-lived intangible assets.

Borrowing Expenses

Expenses incurred in securing and issuing debt are capitalized and amortized over the life of the related borrowing and the related amortization is included in Interest expense - net in the Consolidated Statements of Income. Debt issuance costs related to senior notes and term loans are included as a reduction of the carrying amount of the related borrowing. Debt issuance costs related to securing the Company’s Revolving Facility are included in Other noncurrent assets in the Consolidated Balance Sheets.
Earnings per Common Share

Diluted earnings per common share (“EPS”) attributable to IDEX is computed by dividing Net income attributable to IDEX by the weighted average number of common shares outstanding (basic) plus common stock equivalents outstanding (diluted) during the year. Common stock equivalents consist of restricted stock, performance share units and stock options, which have been included in the calculation of weighted average common shares outstanding using the treasury stock method.

Outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has both participating and non-participating securities. Dividend rights for restricted stock awards issued under the IDEX Corporation 2024 Incentive Award Plan (the “2024 Incentive Award Plan”) are subject to the same vesting requirements as the underlying restricted stock awards, and therefore these awards are considered non-participating securities. Dividend rights for restricted stock awards issued prior to the adoption of the 2024 Incentive Award Plan are non-forfeitable and are not subject to the same vesting requirements as the underlying restricted stock awards. As such, these awards have been determined to be participating securities. Accordingly, Diluted EPS attributable to IDEX was computed using the two-class method.

Basic weighted average common shares outstanding reconciles to diluted weighted average common shares outstanding as follows:
202520242023
Basic weighted average common shares outstanding75.3 75.7 75.6 
Dilutive effect of restricted stock, performance share units and stock options— 0.2 0.3 
Diluted weighted average common shares outstanding75.3 75.9 75.9 

Share-based payment awards that were not included in the computation of Diluted EPS attributable to IDEX because the effect of their inclusion would have been antidilutive were as follows:

202520242023
Antidilutive shares not included in Diluted EPS attributable to IDEX0.8 0.4 0.2 

Share-Based Compensation

The Company expenses the fair value of the awards granted under its share-based compensation plan. That cost is recognized in the Consolidated Financial Statements over the requisite service period of the grants. See Note 15, “Share-Based Compensation,” for further discussion on share-based compensation.

Depreciation and Amortization

Property and equipment are stated at historical cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over each asset’s estimated useful life. Property and equipment are generally depreciated over the following estimated useful lives:

Land improvements
8 to 12 years
Buildings and improvements
8 to 30 years
Machinery, equipment and other
3 to 12 years
Office and transportation equipment
2 to 10 years
Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are generally as follows:

Trade names
15 to 20 years
Customer relationships
5 to 20 years
Technology
5 to 20 years
Software5 years

Research and Development Expenditures

Costs associated with engineering activities, including research and development, are expensed in the period incurred and are included in Cost of sales.

Total engineering expenses, which include research and development as well as application and support engineering, were $122.3 million, $111.2 million and $107.5 million in 2025, 2024 and 2023, respectively. Research and development expenses, which include costs associated with developing new products and major improvements to existing products, were $70.0 million, $67.4 million and $68.4 million in 2025, 2024 and 2023, respectively.

Foreign Currency Translation and Transaction

The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date and the income statement amounts have been translated using the average monthly exchange rates for the year. Translation adjustments from year to year have been reported in Accumulated other comprehensive income (loss) in the Consolidated Balance Sheets. Foreign currency transaction gains and losses from transactions denominated in a currency other than the functional currency of the subsidiary involved are reported within Other expense (income) – net in the Consolidated Statements of Income. Net transaction loss (gain) for the years ended December 31, 2025, 2024 and 2023 was $5.6 million, $(1.0) million and $7.3 million, respectively.

Income Taxes

Income tax expense includes U.S., state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and tax bases of existing assets and liabilities and for loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company recognizes the tax benefit of uncertain income tax positions only if those positions are more likely than not to be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense. See Note 12, “Income Taxes,” for further discussion on income taxes.

Concentration of Credit Risk

The Company is not dependent on a single customer as its largest customer accounted for less than 3% of net sales for all years presented.

Recently Adopted Accounting Standards

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to disclose standard categories in the tax rate reconciliation, additional information for reconciling items that meet a quantitative threshold and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied prospectively, but may be applied retrospectively to all prior periods presented in the financial statements. The Company adopted this standard on a prospective basis during the year ended December 31, 2025. The adoption of this standard did not have a material impact on the Company’s Consolidated Financial Statements, but resulted in incremental income tax disclosures. See Note 12, “Income Taxes,” for further detail.
Recently Issued Accounting Standards

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires public entities to disclose, within the footnotes to the financial statements, disaggregated information about certain income statement expense captions, including disclosure of amounts for purchases of inventory, employee compensation, depreciation and intangible asset amortization, included in each relevant expense caption. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU should be applied prospectively, but may be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company’s financial statement disclosures and expects the standard will increase disclosures in the Company’s annual and interim reporting when adopted.

In December 2025, the FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities, which establishes authoritative guidance on the accounting for government grants to business entities. ASU 2025-10 is effective for annual and interim periods beginning after December 15, 2028. Adoption of this ASU may be applied using a modified prospective, modified retrospective or retrospective approach. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company’s financial statement disclosures, but does not expect the impact to be material.
v3.25.4
Acquisitions and Divestitures
 12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions and Divestitures Acquisitions and Divestitures
All of the Company’s acquisitions of businesses have been accounted for under ASC 805, Business Combinations. Accordingly, the assets and liabilities of the acquired companies, after adjustments to reflect the fair values assigned to the assets and liabilities, have been included in the Company’s Consolidated Balance Sheets from their respective dates of acquisition. The results of operations of businesses acquired have been included in the Company’s Consolidated Statements of Income since their respective dates of acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on the Company’s Consolidated Financial Statements individually or in the aggregate.

The Company makes a preliminary allocation of the purchase price for each acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets and assumed liabilities. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. As the Company continues to obtain additional information, primarily related to the valuations of these assets and liabilities, and continues to integrate the newly acquired business, the Company will refine the estimates of fair value and more accurately allocate the purchase price through the completion of the measurement period, which is not to exceed one year from the date of acquisition. Only items that existed as of the acquisition date are considered for subsequent adjustment to the purchase price allocation. Goodwill recognized reflects the strategic fit, revenue and earnings growth potential of the acquired business and its synergies with existing IDEX businesses.

2025 Acquisitions

Micro-LAM, Inc.

On July 29, 2025, the Company acquired Micro-LAM, Inc. (“Micro-LAM”) in a stock acquisition. Micro-LAM is an advanced optics manufacturer of laser-assisted machining, ultra-precision diamond tools and custom optics that is complementary to the Company’s Optics Technologies solutions. Headquartered in Portage, Michigan, Micro-LAM operates in the Company’s Scientific Fluidics & Optics reporting unit within the Company’s HST segment. Micro-LAM was acquired for cash consideration of $80.4 million, net of cash acquired of $0.3 million, plus a potential earnout of up to $12.0 million of additional cash consideration based upon the achievement of certain financial performance targets over a two-year period. Total consideration of $81.6 million includes the fair value of the potential earnout as of the acquisition date of $1.2 million. For additional discussion of the earnout valuation, refer to Note 8, “Fair Value Measurements.” The acquisition was funded using additional borrowings under the Company’s Revolving Facility (as defined in Note 7, “Borrowings”). Goodwill and intangible assets recognized as part of this transaction were $37.0 million and $44.8 million, respectively. The goodwill is not deductible for tax purposes.
As of December 31, 2025, the preliminary allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$7.5 
Property, plant and equipment8.1 
Goodwill37.0
Intangible assets44.8 
Other noncurrent assets2.9 
Total assets acquired100.3 
Current liabilities(6.2)
Deferred income taxes(9.9)
Other noncurrent liabilities(2.6)
Net assets acquired(1)
$81.6 

(1) During the fourth quarter of 2025, the Company finalized the purchase price of Micro-LAM, resulting in a reduction to the purchase price of $0.3 million.

The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$5.3 15
Customer relationships21.1 11
Technology18.4 12
Acquired intangible assets$44.8 

2024 Acquisitions

Mott Corporation

On September 5, 2024, the Company acquired Mott Corporation and its subsidiaries (“Mott”) in a stock acquisition. Mott is a leading microfiltration business specializing in the design, customization and manufacturing of sintered porous metal components and engineered solutions used in fluidic applications. Headquartered in Farmington, Connecticut, Mott operates in the Scientific Fluidics & Optics reporting unit within the Company’s HST segment. Mott was acquired for cash consideration of $982.0 million, net of cash acquired of $3.1 million. The purchase price was funded using a combination of cash on hand of $207.7 million, borrowings under the Company’s Revolving Facility of $279.3 million and net proceeds of $495.0 million from the issuance of the Company’s 4.950% Senior Notes (as defined in Note 7, “Borrowings”). Goodwill and intangible assets recognized as part of this transaction were $488.6 million and $412.8 million, respectively. Of the total goodwill balance recognized, $439.0 million is deductible for tax purposes.
The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$82.3 
Property, plant and equipment51.5 
Goodwill488.6
Intangible assets412.8
Other noncurrent assets15.0
Total assets acquired1,050.2 
Current liabilities(50.7)
Deferred income taxes(4.6)
Other noncurrent liabilities(12.9)
Net assets acquired(1)
$982.0 

(1) During the first quarter of 2025, the Company finalized the purchase price of Mott, resulting in a reduction to the purchase price of $4.2 million. Funds were received by the Company in the first quarter of 2025.

The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$42.0 15
Customer relationships269.0 14
Technology101.8 13
Acquired intangible assets$412.8 

2023 Acquisitions

Iridian Spectral Technologies

On May 19, 2023, the Company acquired Iridian Spectral Technologies (“Iridian”) in a stock acquisition. Iridian is a global leader in designing and manufacturing thin-film, multi-layer optical filters serving the laser communications, telecommunications and life sciences markets and expands the Company’s array of optical technology offerings. Headquartered in Ottawa, Canada, Iridian operates in the Company’s Scientific Fluidics & Optics reporting unit within the HST segment. Iridian was acquired for cash consideration of $109.8 million. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $54.2 million and $44.1 million, respectively. The goodwill is not deductible for tax purposes.
The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$10.6 
Property, plant and equipment19.4 
Goodwill54.2
Intangible assets44.1
Other noncurrent assets5.4
Total assets acquired133.7
Current liabilities(1.2)
Deferred income taxes(17.8)
Other noncurrent liabilities(4.9)
Net assets acquired
$109.8 

The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$5.2 15
Customer relationships27.8 12
Technology11.1 11
Acquired intangible assets$44.1 

STC Material Solutions

On December 14, 2023, the Company acquired STC Material Solutions (“STC”) in a stock acquisition. STC specializes in the design and manufacturing of technical ceramics and hermetic sealing products for critical applications in the semiconductor, space and defense, industrial technology, medical technology and energy markets. Headquartered in St. Albans, Vermont, with additional operations in Santa Ana, California, STC operates in the Company’s Scientific Fluidics & Optics reporting unit within the HST segment. STC was acquired for cash consideration of $200.4 million. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $104.3 million and $92.3 million, respectively. The goodwill is not deductible for tax purposes.

The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$16.7 
Property, plant and equipment12.1 
Goodwill104.3 
Intangible assets92.3 
Other noncurrent assets3.0 
Total assets acquired228.4 
Current liabilities(5.5)
Deferred income taxes(19.8)
Other noncurrent liabilities(2.7)
Net assets acquired(1)
$200.4 

(1) During the first quarter of 2024, the Company finalized the purchase price of STC, resulting in a reduction to the purchase price of $1.6 million.
The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$9.3 15
Customer relationships63.0 15
Technology20.0 11
Acquired intangible assets$92.3 

Acquisition-Related Costs

The Company incurred acquisition costs related to completed, pending and potential transactions, including those that ultimately were not completed. These costs were recorded in Selling, general and administrative expenses in the Company’s Consolidated Statements of Income. The Company also incurred fair value inventory step-up charges associated with completed acquisitions. These costs were recorded in Cost of sales in the Company’s Consolidated Statements of Income. A summary of the acquisition costs and the fair value inventory step-up charges recorded in the years ended December 31, 2025, 2024 and 2023 are presented in the following table:

202520242023
Acquisition costs$4.6 $10.4 $7.3 
Fair value inventory step-up charges0.6 9.6 1.6 

Divestitures

The Company periodically reviews its businesses relative to its core business. As such, from time to time, the Company may sell various businesses or assets for a variety of reasons. Any resulting gain or loss recognized due to divestitures is recorded within Gain on sale of businesses - net in the Consolidated Statements of Income. The divestitures did not represent a strategic shift that had a major effect on operations and financial results and, therefore, did not qualify for presentation as discontinued operations.

On June 3, 2024, the Company completed the sale of Alfa Valvole, Srl (“Alfa Valvole”) for proceeds of $45.1 million, net of cash remitted, resulting in a gain on the sale of $4.0 million, net of a release of cumulative foreign currency translation losses of $5.5 million. There was no income tax impact associated with this transaction in the Consolidated Statements of Income due to the participation exemption of its consolidated group. The results of Alfa Valvole were reported in the Valves reporting unit within the FMT segment through the date of disposition.

On December 29, 2023, the Company completed the sale of Novotema, SpA (“Novotema”) for proceeds of $8.3 million, net of cash remitted, resulting in a loss on the sale of $9.1 million. There was no income tax impact associated with this transaction in the Consolidated Statements of Income due to the participation exemption of its consolidated group. The results of Novotema were reported in the Sealing Solutions reporting unit within the HST segment through the date of disposition.
On August 3, 2023, the Company completed the sale of Micropump, Inc. (“Micropump”) for proceeds of $110.3 million, net of cash remitted, resulting in a pre-tax gain on the sale of $93.8 million. The divestiture resulted in $22.7 million of income tax expense in the Consolidated Statements of Income during the year ended December 31, 2023. Micropump was its own reporting unit and its results were reported within the HST segment through the date of disposition.
v3.25.4
Collaborative Investments
 12 Months Ended
Dec. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Collaborative Investments Collaborative Investments
On May 12, 2020, a subsidiary of IDEX entered into a joint venture agreement with a third party to form a limited liability company (the “Joint Venture”) that manufactures and sells high performance elastomer seals for the oil and gas industry to customers within the Kingdom of Saudi Arabia as well as exports these high performance elastomer seals outside of the Kingdom of Saudi Arabia. The Joint Venture maintains operations in Dammam, Saudi Arabia and operates in the Company’s Sealing Solutions reporting unit within the HST segment. The Company has contributed $0.7 million for 55% of the share capital while the third-party partner has contributed $0.6 million for 45% of the share capital. The Joint Venture has been selling since July 2022. Since IDEX controls the entity, IDEX has consolidated the Joint Venture and recorded a Noncontrolling interest in its Consolidated Financial Statements.

During 2021 and 2022, a subsidiary of IDEX funded a total of $7.2 million in promissory notes as an investment in a start-up company that provides communication technology to improve individual performance and team coordination for firefighters’ responses, which aligns with IDEX’s FSDP segment’s strategic plan. On a quarterly basis, the Company evaluated whether an allowance for credit losses was required for these promissory notes and measured the allowance using the current expected credit loss model. During the second quarter of 2023, IDEX determined that its investment may no longer be recoverable. As a result, IDEX recorded a credit loss of $7.7 million in Other expense (income) – net in the Consolidated Statements of Income and a reserve in Other noncurrent assets on the Consolidated Balance Sheets for the full amount of the principal and accrued interest outstanding. During the fourth quarter of 2023, IDEX converted the promissory notes to equity, resulting in a cost method investment with zero value.
v3.25.4
Balance Sheet Components
 12 Months Ended
Dec. 31, 2025
Additional Financial Information Disclosure [Abstract]  
Balance Sheet Components Balance Sheet Components
 December 31,
 20252024
RECEIVABLES - NET
Customers$511.9 $461.0 
Other19.2 14.7 
Total531.1 475.7 
Less: allowance for credit losses
9.4 9.8 
Receivables - net$521.7 $465.9 
INVENTORIES - NET
Raw materials and components parts$316.1 $285.5 
Work in process47.7 34.4 
Finished goods115.6 109.8 
Inventories - net$479.4 $429.7 
PROPERTY, PLANT AND EQUIPMENT - NET
Land and improvements$31.6 $30.0 
Buildings and improvements287.5 268.9 
Machinery, equipment and other657.3 607.9 
Office and transportation equipment107.9 108.6 
Construction in progress38.0 34.9 
Total1,122.3 1,050.3 
Less: accumulated depreciation and amortization
654.3 589.9 
Property, plant and equipment - net$468.0 $460.4 
ACCRUED EXPENSES
Payroll and related items$112.2 $105.0 
Management incentive compensation19.1 14.6 
Income taxes payable14.0 10.1 
Warranty14.4 13.6 
Deferred revenue45.8 50.7 
Lease liability27.8 26.1 
Restructuring3.0 0.9 
Accrued interest11.7 12.7 
Other49.0 45.0 
Accrued expenses$297.0 $278.7 
v3.25.4
Revenue
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of Revenue

The Company has a comprehensive offering of products, including technologies, built to customers’ specifications that are sold in niche markets throughout the world. The Company disaggregates revenue from contracts with customers by reporting unit and geographical region for each segment as the Company believes it best depicts how the amount, nature, timing and uncertainty of its revenue and cash flows are affected by economic factors. Revenue, presented as Net sales on the Consolidated Statements of Income, was attributed to geographical region based on the location of the customer. The following tables present revenue disaggregated by reporting unit and geographical region.
Revenue by reporting unit for the years ended December 31, 2025, 2024 and 2023 was as follows:
For the Year Ended December 31,
202520242023
Scientific Fluidics & Optics$859.3 $706.1 $681.5 
Performance Pneumatic Technologies259.2 237.4 250.0 
Sealing Solutions249.6 232.4 242.3 
Material Processing Technologies127.4 122.2 120.7 
Micropump(1)
— — 21.9 
Intersegment elimination(4.8)(4.1)(2.9)
Health & Science Technologies1,490.7 1,294.0 1,313.5 
Pumps426.6 408.3 402.9 
Water351.8 347.8 345.8 
Energy205.2 207.6 209.3 
Agriculture143.3 146.4 159.6 
Valves97.1 123.1 129.5 
Intersegment elimination(1.5)(1.4)(2.9)
Fluid & Metering Technologies1,222.5 1,231.8 1,244.2 
Fire & Safety478.4 467.2 431.9 
Dispensing147.2 161.3 167.5 
BAND-IT119.7 115.8 119.4 
Intersegment elimination(1.0)(1.3)(2.6)
Fire & Safety/Diversified Products744.3 743.0 716.2 
Net sales
$3,457.5 $3,268.8 $3,273.9 

(1) Revenue from Micropump (sold on August 3, 2023) has been included in the Company’s Consolidated Statements of Income through the date of disposition. See Note 2, “Acquisitions and Divestitures,” for further detail.
Revenue by geographical region for the years ended December 31, 2025, 2024 and 2023 was as follows:

For the Year Ended December 31, 2025
HSTFMTFSDPIDEX
U.S.$695.7 $693.3 $371.8 $1,760.8 
North America, excluding U.S.24.7 73.0 32.0 129.7 
Europe448.4 202.6 195.2 846.2 
Asia292.3 158.1 112.6 563.0 
Other(1)
34.4 97.0 33.7 165.1 
Intersegment elimination(4.8)(1.5)(1.0)(7.3)
Net sales
$1,490.7 $1,222.5 $744.3 $3,457.5 

For the Year Ended December 31, 2024
HSTFMTFSDPIDEX
U.S.$573.7 $693.1 $354.9 $1,621.7 
North America, excluding U.S.29.9 68.3 34.2 132.4 
Europe408.0 210.1 178.4 796.5 
Asia261.4 169.7 139.9 571.0 
Other(1)
25.1 92.0 36.9 154.0 
Intersegment elimination(4.1)(1.4)(1.3)(6.8)
Net sales
$1,294.0 $1,231.8 $743.0 $3,268.8 

For the Year Ended December 31, 2023
HSTFMTFSDPIDEX
U.S.$575.5 $695.7 $371.9 $1,643.1 
North America, excluding U.S.22.6 70.3 33.4 126.3 
Europe439.9 213.8 166.7 820.4 
Asia249.4 177.6 108.5 535.5 
Other(1)
29.0 89.7 38.3 157.0 
Intersegment elimination(2.9)(2.9)(2.6)(8.4)
Net sales
$1,313.5 $1,244.2 $716.2 $3,273.9 

(1) Other includes: South America, Middle East, Australia and Africa.

Performance Obligations

The Company’s performance obligations are satisfied either at a point in time or over time as work progresses. Revenue from products and services transferred to customers at a point in time comprised approximately 95% of the Company’s revenue and over time comprised approximately 5% of the Company’s revenue in all years presented.

Contract Assets and Liabilities

The timing of billings and cash collections can result in customer receivables, billings in excess of revenue recognized, advance payments or deposits. Customer receivables include both amounts billed and currently due from customers as well as unbilled amounts (contract assets) and are included in Receivables – net on the Consolidated Balance Sheets.
The composition of customer receivables was as follows:
December 31, 2025December 31, 2024
Billed receivables$477.1 $443.2 
Unbilled receivables34.8 17.8 
Total customer receivables$511.9 $461.0 

Billings in excess of revenue recognized, advance payments and deposits represent contract liabilities and are included in deferred revenue which is classified as current or noncurrent based on when the Company expects to recognize the revenue. The current portion is included in Accrued expenses and the noncurrent portion is included in Other noncurrent liabilities on the Consolidated Balance Sheets.

The composition of deferred revenue was as follows:

December 31, 2025December 31, 2024
Deferred revenue - current$45.8 $50.7 
Deferred revenue - noncurrent22.0 13.2 
Total deferred revenue$67.8 $63.9 
v3.25.4
Goodwill and Intangible Assets
 12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for 2025 and 2024, by reportable business segment, were as follows:

HSTFMTFSDPTotal
Goodwill$1,834.5 $805.7 $398.7 $3,038.9 
Accumulated goodwill impairment losses(149.8)(20.7)(30.1)(200.6)
Balance at January 1, 20241,684.7 785.0 368.6 2,838.3 
Foreign currency translation(43.4)(8.9)(8.1)(60.4)
Acquisitions483.6 — — 483.6 
Measurement period adjustments1.8 — — 1.8 
Divestitures— (11.6)— (11.6)
Balance at December 31, 20242,126.7 764.5 360.5 3,251.7 
Foreign currency translation88.0 16.5 16.3 120.8 
Acquisitions37.0 — — 37.0 
Measurement period adjustments5.0 — — 5.0 
Balance at December 31, 2025$2,256.7 $781.0 $376.8 $3,414.5 
 
Goodwill represents the purchase price in excess of the net amount assigned to the assets acquired and liabilities assumed and was tested for impairment at each of the Company’s reporting units as determined in accordance with ASC 350 as of October 31, 2025, the Company’s annual impairment test date, with no impairment noted. In assessing the fair value of the reporting units, the Company considers both the market approach and the income approach. Under the market approach, the fair value of the reporting unit is determined by the respective trailing 12 month earnings before interest, income taxes, depreciation and amortization (“EBITDA”) and the forward looking 2026 EBITDA (50% each), based on multiples of comparable public companies. The market approach is dependent on a number of significant management assumptions including forecasted EBITDA and selected market multiples. Under the income approach, the fair value of the reporting unit is determined based on the present value of estimated future cash flows. The income approach is dependent on a number of significant management assumptions including estimates of operating results, capital expenditures, net working capital requirements, long-term growth rates and discount rates. Weighting was equally attributed to both the market and the income approaches (50% each) in arriving at the fair value of the reporting units. In 2025 and 2024, there were no events or circumstances that would have required an interim impairment test.
The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2025 and 2024:

 At December 31, 2025At December 31, 2024
 Gross
Carrying
Amount		Accumulated
Amortization		NetGross
Carrying
Amount		Accumulated
Amortization		Net
Amortized intangible assets:
Trade names209.7 (71.4)138.3 201.4 (60.0)141.4 
Customer relationships1,148.4 (380.9)767.5 1,078.8 (278.7)800.1 
Technology(1)
344.3 (102.3)242.0 327.9 (87.1)240.8 
Software 16.0 (7.3)8.7 15.2 (3.6)11.6 
Total amortized intangible assets1,718.4 (561.9)1,156.5 1,623.3 (429.4)1,193.9 
Indefinite-lived intangible assets:
Banjo trade name62.1 — 62.1 62.1 — 62.1 
Akron Brass trade name28.8 — 28.8 28.8 — 28.8 
Total intangible assets$1,809.3 $(561.9)$1,247.4 $1,714.2 $(429.4)$1,284.8 

(1) In the third quarter of 2025, the Company revised its classification of intangible assets to combine patents and unpatented technology into a single category. This change was made to better reflect the integrated nature of the Company’s intellectual property portfolio. The gross carrying amount and accumulated amortization for patents as of December 31, 2024 of $2.5 million and $2.0 million, respectively, have been reclassified to conform to the current period presentation. The change had no impact on total intangible assets or amortization expense.

The Banjo and Akron Brass trade names are indefinite-lived intangible assets that were also tested for impairment as of October 31, 2025, with no impairments noted. These indefinite-lived intangible assets are tested for impairment on an annual basis in accordance with ASC 350 or more frequently if events or changes in circumstances indicate that the assets might be impaired. The Company uses the relief-from-royalty method, a form of the income approach, to determine the fair value of these trade names. The relief-from-royalty method is dependent on a number of significant management assumptions, including estimates of revenues, royalty rates and discount rates. In 2025 and 2024, there were no events or circumstances that would have required an interim impairment test.

Amortization of intangible assets was $130.7 million, $107.1 million and $94.9 million in 2025, 2024 and 2023, respectively. Based on the intangible asset balances as of December 31, 2025, expected amortization expense for the years 2026 through 2030 is as follows:

Estimated Amortization
2026$133.5 
2027128.7 
2028125.9 
2029115.7 
2030106.5 
v3.25.4
Borrowings
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Borrowings Borrowings
Borrowings at December 31, 2025 and 2024 consisted of the following:
December 31, 2025December 31, 2024
3.37% Senior Notes, due June 2025 (the “3.37% Senior Notes”)
$— $100.0 
5.13% Senior Notes, due June 2028 (the “5.13% Senior Notes”)
100.0 100.0 
4.950% Senior Notes, due September 2029 (the “4.950% Senior Notes”)
500.0 500.0 
3.00% Senior Notes, due May 2030 (the “3.00% Senior Notes”)
500.0 500.0 
2.625% Senior Notes, due June 2031 (the “2.625% Senior Notes”)
500.0 500.0 
$800.0 million Revolving Facility, due November 2027 (the “Revolving Facility”)
228.8 269.8 
Other borrowings1.0 1.5 
Total borrowings1,829.8 1,971.3 
Less: current portion0.7 100.7 
Less: unamortized debt issuance costs and discount on debt9.0 11.1 
Long-term borrowings$1,820.1 $1,859.5 

Revolving Facility and Term Facility

On November 1, 2022, the Company entered into an amended and restated credit agreement (as amended and restated, the “Credit Agreement”) along with certain of its subsidiaries, as borrowers (the “Borrowers”), Bank of America, N.A., as administrative agent, swing line lender and an issuer of letters of credit, and other agents party thereto. The Credit Agreement consists of a revolving credit facility in an aggregate principal amount of $800 million and a term credit facility available to the Company in an aggregate principal amount of $200 million (the “Term Facility”), both of which have a final maturity date of November 1, 2027. The maturity date of the Revolving Facility may be extended under certain conditions for an additional one-year term. Up to $100 million of the Revolving Facility is available for the issuance of letters of credit. Additionally, up to $50 million of the Revolving Facility is available to the Company for swing line loans, available on a same-day basis.

Proceeds of the Revolving Facility are available for use by the Borrowers for working capital and other general corporate purposes, including refinancing existing debt of the Company and its subsidiaries and financing of acquisitions. The Company may request increases in the lending commitments under the Credit Agreement, but the aggregate lending commitments pursuant to such increases may not exceed $400 million. The Company has the right, subject to certain conditions set forth in the Credit Agreement, to designate certain foreign subsidiaries of the Company as borrowers under the Credit Agreement. In connection with any such designation, the Company is required to guarantee the obligations of any such subsidiaries under the Credit Agreement. During 2025, the Company drew down an aggregate amount of $252.0 million under the Revolving Facility. A portion of these funds as well as cash on hand were used to repay the 3.37% Senior Notes upon their maturity in June 2025. Additionally, these funds were used to finance the Company’s acquisition of Micro-LAM and to finance share repurchases. The Company repaid $322.9 million under the Revolving Facility during 2025.

Borrowings under the Credit Agreement bear interest, at either an alternate base rate or Term SOFR (or appropriate alternative currency reference rates) plus, in each case, an applicable margin. Such applicable margin is based on the better of the Company’s senior, unsecured, long-term debt rating or the Company’s applicable leverage ratio and can range from 0.00% to 1.275%. Interest is payable (a) in the case of base rate loans, quarterly, and (b) in the case of Term SOFR loans, on the last day of the applicable interest period selected, or every three months from the effective date of such interest period for interest periods exceeding three months. The weighted-average interest rate for borrowings outstanding under the Revolving Facility was 3.55% and 4.46% for the years ended December 31, 2025 and 2024, respectively. The weighted-average interest rate for borrowings outstanding under the Term Facility was 6.54% for the year ended December 31, 2024. There were no borrowings outstanding under the Term Facility during the year ended December 31, 2025.

The Credit Agreement requires payment to the lenders of a facility fee based upon the amount of the lenders’ commitments under the credit facility from time to time, equal to the applicable interest rate times the actual daily amount of the Revolving Facility. Voluntary prepayments of any loans and voluntary reductions of the unutilized portion of the commitments under the credit facility are permissible without penalty, subject to break funding payments and minimum notice and minimum reduction amount requirements.
The Credit Agreement gives the Company the option to enter into a future environmental, social and governance amendment by which pricing may be adjusted pursuant to the Company’s performance measured against certain key performance indicators agreed by the Company and BofA Securities, Inc., as sustainability coordinator.

At December 31, 2025, there was $228.8 million outstanding under the Revolving Facility and $2.6 million of outstanding letters of credit, resulting in a net available borrowing capacity under the Revolving Facility of approximately $568.6 million. Subsequent to December 31, 2025, the Company had net borrowings on the Revolving Facility of $58.2 million.

Senior Notes

At December 31, 2025, the Company has $1.6 billion in senior notes outstanding at various interest rates detailed in the table above (the “Senior Notes”). Interest is payable semi-annually in arrears during the second and fourth quarters of the year for all the Senior Notes except for the 4.950% Senior Notes, which is payable semi-annually in arrears during the first and third quarters of the year. The Senior Notes are unsecured obligations of the Company and rank pari passu in right of payment with all of the Company’s other unsecured, unsubordinated debt. Subject to the terms of the respective indenture, the Company may redeem all or a portion of the Senior Notes at any time prior to maturity at the redemption prices set forth in each indenture governing the respective Senior Notes. The terms of the Senior Notes also require the Company to make an offer to repurchase the respective notes upon a change of control event at a defined price (both of which are defined within each indenture governing the respective Senior Notes).

Covenants

There are two key financial covenants that the Company is required to maintain in connection with the Credit Agreement and the Senior Notes, excluding the 4.950% Senior Notes, the 3.00% Senior Notes and the 2.625% Senior Notes which have no financial covenants. Those two covenants include a minimum interest coverage ratio of 3.0 to 1 and a maximum leverage ratio of 3.50 to 1, which is the ratio of the Company’s consolidated total debt to its consolidated EBITDA, as defined within the Credit Agreement, both of which are tested quarterly and in the case of the leverage ratio, there is an option to increase the ratio to 4.00 for 12 months in connection with certain acquisitions. While there are no financial covenants relating to the 4.950% Senior Notes, the 3.00% Senior Notes and the 2.625% Senior Notes, they are subject to cross-acceleration provisions.

Total borrowings at December 31, 2025 have scheduled maturities as follows:

Maturity of Borrowings
2026$0.7 
2027229.1 
2028100.0 
2029500.0 
2030500.0 
Thereafter500.0 
Total borrowings$1,829.8 
v3.25.4
Fair Value Measurements
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
ASC 820, Fair Value Measurements and Disclosures, defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The standard utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

•Level 1:  Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
•Level 2: Inputs, other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
•Level 3:  Unobservable inputs that reflect the reporting entity’s own assumptions.

The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheets at December 31, 2025 and 2024:

 December 31, 2025
 Level 1Level 2Level 3Total
Assets
Trading securities - mutual funds held in nonqualified SERP(1)
$10.8 $— $— $10.8 
Liabilities
Contingent consideration(2)
$— $— $1.2 $1.2 
 December 31, 2024
 Level 1Level 2Level 3Total
Assets
Trading securities - mutual funds held in nonqualified SERP(1)
$10.6 $— $— $10.6 

(1) The Supplemental Executive Retirement Plan (“SERP”) investment assets are offset by a SERP liability which represents the Company’s obligation to distribute SERP funds to participants. The SERP investment assets and liability are included in Other noncurrent assets and Other noncurrent liabilities, respectively, on the Company’s Consolidated Balance Sheets.

(2) In connection with the acquisition of Micro-LAM, the Company entered into an earnout agreement that may require it to make future cash consideration payments of up to $12.0 million based upon the achievement of certain financial performance targets from January 1, 2026 to December 31, 2027. As of December 31, 2025, $1.2 million of contingent consideration related to the Micro-LAM acquisition is included in Other noncurrent liabilities on the Company’s Consolidated Balance Sheets and was derived using a Monte Carlo simulation model which utilizes inputs including discount rates, volatility rates, and estimated probability of achieving projected revenue and profitability targets. This fair value measurement of contingent consideration is categorized within Level 3 of the fair value hierarchy, as the measurement amount is based primarily on significant inputs that are not observable in the market. The fair value of the contingent consideration is re-measured at each reporting period, and the change in fair value is recognized within Selling, general and administrative expenses in the Company’s Consolidated Statements of Income. There was no change in the fair value measurement of contingent consideration during 2025.

There were no transfers of assets or liabilities between Level 1, Level 2 and Level 3 in 2025 or 2024.

The carrying values of the Company’s other financial instruments (i.e., cash and cash equivalents, accounts receivable, accounts payable and accrued expenses) approximate fair value because of the short-term nature of these instruments.

Certain non-financial assets, primarily property, plant and equipment, goodwill and intangible assets, are not required to be measured at fair value on a recurring basis and are reported at their carrying value. However, these assets are required to be assessed for impairment whenever events or circumstances indicate that their carrying value may not be fully recoverable, and at least annually for goodwill and indefinite-lived intangible assets. See Note 6, “Goodwill and Intangible Assets,” for additional information about these assets.
The following table provides the fair value of the outstanding indebtedness described in Note 7, “Borrowings,” which is based on quoted market prices and current market rates for debt with similar credit risk and maturity, as well as the carrying value. These fair value measurements are classified as Level 2 within the fair value hierarchy since they are determined based upon significant inputs observable in the market, including interest rates on recent financing transactions to entities with a credit rating similar to the Company’s rating.

December 31, 2025December 31, 2024
Fair ValueCarrying AmountFair ValueCarrying Amount
Total Borrowings, less unaccreted debt discount $1,773.9 $1,828.8 $1,855.0 $1,970.1 
v3.25.4
Leases
 12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases Leases
The Company has commitments under operating leases for certain office facilities, warehouses, manufacturing plants, equipment (which includes both office and plant equipment) and vehicles used in its operations. Leases with an initial term of 12 months or less are not recorded on the balance sheet and the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company’s finance leases are immaterial.

Certain leases include one or more options to renew. The exercise of lease renewal options is at the Company’s sole discretion. The Company does not include renewal periods in any of the leases’ terms until the renewal is executed as they are generally not reasonably certain of being exercised. The Company does not have any material purchase options.

Certain of the Company’s lease agreements contain provisions for future rent increases or have rental payments that are adjusted periodically for inflation or based on usage. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The Company does not have any significant leases that have not yet commenced.

Supplemental balance sheet information related to leases as of December 31, 2025 and 2024 was as follows:

Balance Sheet CaptionDecember 31, 2025December 31, 2024
Right-of-Use (“ROU”) Assets:
Building ROU assets - net Other noncurrent assets$109.5 $114.4 
Equipment ROU assets - netOther noncurrent assets10.2 10.8 
Total ROU assets - net$119.7 $125.2 
Lease Liabilities:
Current lease liabilitiesAccrued expenses$27.8 $26.1 
Noncurrent lease liabilitiesOther noncurrent liabilities94.1 101.6 
Total lease liabilities$121.9 $127.7 

The components of lease cost for the years ended December 31, 2025, 2024 and 2023 were as follows:

202520242023
Fixed lease cost(1)
$36.6 $34.7 $33.0 
Variable lease cost4.2 3.1 2.7 
Total lease expense$40.8 $37.8 $35.7 

(1) Includes short-term leases, which are immaterial.
Supplemental cash flow information related to leases for the years ended December 31, 2025, 2024 and 2023 was as follows:

202520242023
Cash paid for amounts included in the measurement of lease liabilities$33.1 $34.6 $33.6 
Right-of-use assets obtained in exchange for new lease liabilities17.4 19.1 29.0 

Other supplemental information related to leases as of December 31, 2025 and 2024 was as follows:

Lease Term and Discount RateDecember 31, 2025December 31, 2024
Weighted-average remaining lease term (years):
Building and equipment5.716.40
Vehicles2.642.69
Weighted-average discount rate:
Building and equipment4.19%4.07%
Vehicles4.47%4.35%

The Company uses its incremental borrowing rate to determine the present value of the lease payments.

Total lease liabilities at December 31, 2025 have scheduled maturities as follows:

Maturity of Lease Liabilities
2026$29.1 
202727.7 
202823.2 
202917.7 
203012.2 
Thereafter27.3 
Total lease payments137.2 
Less: Imputed interest(15.3)
Present value of lease liabilities$121.9 
v3.25.4
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Warranty costs are provided for at the time of sale. The warranty provision is based on historical costs and adjusted for specific known claims. A rollforward of the warranty reserve is as follows:

202520242023
Beginning balance, January 1$13.6 $9.1 $8.1 
Provision for warranties8.2 5.1 5.8 
Claim settlements(13.8)(4.1)(4.7)
Acquisitions and divestitures
6.2 3.6 (0.1)
Other adjustments, including foreign currency translation
0.2 (0.1)— 
Ending balance, December 31$14.4 $13.6 $9.1 
The Company and certain of its subsidiaries are involved in pending and threatened legal, regulatory and other proceedings incidental to the operations of their businesses. These proceedings may pertain to matters such as product liability or contract disputes, and may also involve governmental inquiries, inspections, audits or investigations relating to issues such as tax matters, intellectual property, environmental, health and safety issues, governmental regulations, employment and other matters. Although the results of such legal proceedings cannot be predicted with certainty, the Company believes that the ultimate disposition of these matters will not have a material adverse effect, individually or in the aggregate, on the Company’s business, financial condition, results of operations or cash flows.
v3.25.4
Share Repurchases
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Share Repurchases Share Repurchases
On September 17, 2025, the Company’s Board of Directors authorized the repurchase of an additional $635.0 million of the Company’s common shares. This approval is in addition to the prior repurchase authorization of the Company’s Board of Directors of $500.0 million on March 17, 2020. These authorizations have no expiration date. During 2025, the Company repurchased a total of 1.4 million shares at a cost of $252.4 million (which includes estimated excise taxes of $2.4 million which will be paid in 2026), of which $2.2 million was settled in January 2026. There were no share repurchases during 2024. During 2023, the Company repurchased a total of 0.1 million shares at a cost of $24.2 million. As of December 31, 2025, the amount of share repurchase authorization remaining was $924.7 million, excluding fees, commissions, excise taxes and other expenses related to such common stock repurchases. Subsequent to December 31, 2025, the Company repurchased 0.2 million shares at a cost of $38.1 million.
v3.25.4
Income Taxes
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Pretax income for 2025, 2024 and 2023 was taxed in the following jurisdictions:

202520242023
U.S.$375.5 $377.9 $534.1 
Foreign257.1 261.4 226.2 
Total$632.6 $639.3 $760.3 
The provision (benefit) for income taxes for 2025, 2024 and 2023 was as follows:

202520242023
Current
U.S.$47.4 $69.0 $103.8 
State and local10.9 11.6 13.7 
Foreign79.0 73.5 61.9 
Total current137.3 154.1 179.4 
Deferred
U.S.26.1 (2.6)(11.1)
State and local1.9 (2.1)1.7 
Foreign(15.2)(14.7)(5.3)
Total deferred12.8 (19.4)(14.7)
Total provision for income taxes$150.1 $134.7 $164.7 

Deferred tax assets (liabilities) at December 31, 2025 and 2024 were:

December 31, 2025December 31, 2024
Allowances and accruals$23.7 $21.7 
Employee and retiree benefit plans19.8 19.4 
Inventories17.3 13.9 
Foreign tax credit and other carryforwards30.4 20.8 
Lease liabilities27.8 26.4 
Right of use assets(26.7)(25.1)
Depreciation and amortization(353.8)(311.6)
Taxes on undistributed foreign earnings(17.4)(14.9)
Other0.8 1.0 
Total gross deferred tax liabilities(278.1)(248.4)
Valuation allowance(23.7)(17.3)
Total deferred tax liabilities, net of valuation allowances$(301.8)$(265.7)
 
The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2025 and 2024 were:

December 31, 2025December 31, 2024
Noncurrent deferred tax asset - Other noncurrent assets$1.2 $1.5 
Noncurrent deferred tax liabilities - Deferred income taxes(303.0)(267.2)
Net deferred tax liabilities$(301.8)$(265.7)

The Company had prepaid income taxes, recorded within Other current assets on the Consolidated Balance Sheets, of $20.2 million and $18.3 million as of December 31, 2025 and 2024, respectively.
As further described in Note 1, “Significant Accounting Policies,” the Company has elected to prospectively adopt the guidance in ASU 2023-09, Improvements to Income Tax Disclosures. The following table shows the principal reasons for the difference between the effective income tax rate and the statutory federal income tax rate for the year ended December 31, 2025 in accordance with ASU 2023-09:
2025
U.S. Federal statutory tax rate
$132.8 21.0%
State and local income taxes, net of federal income tax effect(1)
10.1 1.6%
Foreign tax effects11.0 1.7%
Effect of cross-border tax laws2.6 0.4%
Tax credits
Foreign tax credit(2)
(10.4)(1.6%)
Other(3.8)(0.6%)
Changes in valuation allowances(2)
4.5 0.7%
Nontaxable or nondeductible items3.4 0.5%
Changes in unrecognized tax benefits0.4 0.1%
Other adjustments(0.5)(0.1%)
Total provision for income taxes$150.1 23.7%

(1) The states that contribute to the majority (greater than 50%) of the tax effect in this category include California, Florida and Illinois.

(2) During 2025, the Company recorded an additional deferred tax asset for a foreign tax credit carryforward of $4.4 million with a full valuation allowance.

The following table is a reconciliation of the U.S. federal statutory rate and the effective tax rate for the years ended December 31, 2024 and 2023 in accordance with U.S. GAAP prior to the adoption of ASU 2023-09:
20242023
Pretax income$639.3 $760.3 
Provision for income taxes:
Computed amount at statutory rate of 21%$134.2 21.0%$159.7 21.0%
State and local income tax, net of federal tax benefit7.3 1.1%12.6 1.7%
Taxes on non-U.S. earnings, net of foreign tax credits6.3 1.0%10.8 1.4%
Foreign-Derived Intangible Income Deduction(9.7)(1.5%)(11.3)(1.5%)
Share-based payments(0.7)(0.1%)(2.0)(0.3%)
Other(2.7)(0.4%)(5.1)(0.6%)
Total provision for income taxes$134.7 21.1%$164.7 21.7%

The Company has $90.2 million and $73.4 million of permanently reinvested earnings of non-U.S. subsidiaries as of December 31, 2025 and 2024, respectively. No deferred U.S. income taxes have been provided on the $90.2 million of earnings that are considered to be permanently reinvested. The Company does not expect these earnings to incur U.S. taxes when ultimately repatriated other than potentially U.S. federal, state and local taxes on foreign exchange gains or losses recognized on the distribution of such earnings. Such distributions could also be subject to additional foreign withholding and foreign income taxes. The amount of unrecognized deferred income tax liabilities on currently permanently reinvested earnings is estimated to be $13.5 million and $11.0 million as of December 31, 2025 and 2024, respectively.

During the years ended December 31, 2025, 2024 and 2023, the Company repatriated $79.8 million, $483.8 million and $134.1 million of foreign earnings, respectively. These actual distributions resulted in no incremental income tax expense other than tax impacts on foreign exchange gains or losses.

As of December 31, 2025, the Company had an unrecognized tax benefit of $0.3 million, resulting from a gross increase for tax positions of prior years. The Company did not have any significant unrecognized tax benefits in 2024 and 2023. The Company recognizes interest and penalties related to uncertain tax positions within Provision for income taxes in the
Consolidated Statements of Income. As of December 31, 2025, the Company accrued interest and penalties of less than $0.2 million related to uncertain tax positions.

As of December 31, 2025, the total amount of unrecognized tax benefits that would affect the Company's effective tax rate if recognized is $0.3 million. The tax years 2020-2025 remain open to examination by major taxing jurisdictions.

As of December 31, 2025, the Company has deferred tax assets on U.S., non-U.S. and U.S. state net operating loss carryforwards of $2.5 million, $1.0 million and $0.9 million, respectively. The majority of the balance of net operating losses across jurisdictions, most of which relates to acquisitions, is available to be carried forward indefinitely. The deferred tax assets on the non-U.S. net operating losses have a valuation allowance of $0.9 million. There is no valuation allowance on the U.S. and U.S. state net operating loss carryforward as it is more likely than not that the net operating losses will be realized.

As of December 31, 2025, the Company has deferred tax assets on non-U.S. capital loss carryforwards of $3.8 million with a full valuation allowance. The non-U.S. capital loss can be carried forward indefinitely.

As of December 31, 2025, the Company has deferred tax assets on non-U.S. disallowed interest expense carryforwards of $3.5 million. The non-U.S. disallowed interest expense carryforwards are available to be carried forward indefinitely. A valuation allowance of $0.7 million has been recorded to recognize only the portion of the deferred tax asset that is more likely than not to be realized.

As of December 31, 2025, the Company has deferred tax assets on foreign tax credit carryforwards for U.S. federal tax purposes of approximately $17.9 million with a full valuation allowance. The U.S. federal foreign tax credit carryforward will expire between 2029 and 2035.

Disclosed below is a summary of income taxes paid by jurisdiction for the year ended December 31, 2025, in accordance with ASU 2023-09:

2025
Federal$46.8 
State11.1 
Foreign
China
8.5 
Germany23.7 
India6.9 
Netherlands12.7 
All other foreign24.9 
Income taxes paid, net of amounts refunded$134.6 
For the years ended December 31, 2024 and 2023, the Company paid income taxes, net of refunds, of $171.4 million and $199.5 million, respectively.
v3.25.4
Business Segments and Geographic Information
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic Information
IDEX has three operating business segments, which are the same as our reportable business segments: HST, FMT and FSDP. The Company has determined its segments based on how financial information is reviewed by the chief operating decision maker (“CODM”) to analyze financial performance, make decisions and allocate resources.

The Company’s CODM is the Chief Executive Officer. The Company’s CODM evaluates the performance of the segments and allocates resources to them based on Adjusted EBITDA. Segment Adjusted EBITDA includes intersegment revenues as well as charges allocating certain corporate overhead costs. Intersegment sales are contracted with terms equivalent to those of an arm’s-length transaction. Adjusted EBITDA is the Company’s measure of segment performance.

For all segments, the CODM uses Adjusted EBITDA in the annual budgeting and forecasting process. The CODM considers Adjusted EBITDA budget and forecast-to-actual variances when making decisions about the allocation of operating and capital resources to each segment. Adjusted EBITDA is also used in determining the compensation of certain employees.
The HST segment designs, produces and distributes a wide range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, ultra-precision diamond tools, laboratory and commercial equipment and precision photonic solutions, technical ceramics and hermetic sealing products and porous material structures and flow control solutions. HST primarily serves a variety of end markets, including life sciences, industrial, semiconductor, energy, space and defense and food and beverage.

The FMT segment designs, produces and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors and other fluid-handling pump modules and systems and provides flow monitoring and other services. FMT primarily serves the industrial, water, energy, chemical and agriculture markets.

The FSDP segment designs, produces and distributes firefighting pumps, valves and controls, rescue tools, lifting bags and other components and systems, engineered stainless steel banding and clamping devices and precision equipment for dispensing, metering and mixing colorants and paints. FSDP primarily serves the fire suppression, paint dispensing, rescue tools, automotive and aviation and industrial markets.

Financial information for the Company’s reportable business segments is presented below:
For the Year Ended December 31, 2025
HSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,490.7 $1,222.5 $744.3 $3,457.5 $— $3,457.5 
Intersegment sales4.8 1.5 1.0 7.3 (7.3)— 
 Net sales1,495.5 1,224.0 745.3 3,464.8 (7.3)3,457.5 
Adjusted segment cost of sales(1)
(885.5)(622.8)(417.1)(1,925.4)7.3 (1,918.1)
Other segment expenses(2)
(212.2)(194.4)(114.7)(521.3)
Segment Adjusted EBITDA397.8 406.8 213.5 1,018.1 

For the Year Ended December 31, 2024
HSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,294.0 $1,231.8 $743.0 $3,268.8 $— $3,268.8 
Intersegment sales4.1 1.4 1.3 6.8 (6.8)— 
 Net sales1,298.1 1,233.2 744.3 3,275.6 (6.8)3,268.8 
Adjusted segment cost of sales(1)
(769.5)(639.4)(411.9)(1,820.8)6.8 (1,814.0)
Other segment expenses(2)
(181.8)(187.5)(118.2)(487.5)
Segment Adjusted EBITDA346.8 406.3 214.2 967.3 

For the Year Ended December 31, 2023
HSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,313.5 $1,244.2 $716.2 $3,273.9 $— $3,273.9 
Intersegment sales2.9 2.9 2.6 8.4 (8.4)— 
 Net sales1,316.4 1,247.1 718.8 3,282.3 (8.4)3,273.9 
Adjusted segment cost of sales(1)
(783.1)(650.1)(400.6)(1,833.8)8.4 (1,825.4)
Other segment expenses(2)
(173.8)(180.9)(109.6)(464.3)
Segment Adjusted EBITDA359.5 416.1 208.6 984.2 
(1) Adjusted segment cost of sales represents Cost of sales excluding fair value inventory step-up charges. There were step-up charges of $0.6 million, $9.6 million, and $1.6 million recorded during the years ended December 31, 2025, 2024 and 2023, respectively. All step-up charges were recorded within the HST segment.
(2) Other segment expenses consists primarily of selling, general and administrative expenses.

202520242023
ADJUSTED EBITDA
Health & Science Technologies $397.8 $346.8 $359.5 
Fluid & Metering Technologies 406.8 406.3 416.1 
Fire & Safety/Diversified Products213.5 214.2 208.6 
Segment Adjusted EBITDA1,018.1 967.3 984.2 
Corporate and other(1)
(92.2)(93.0)(84.6)
Interest expense - net(64.4)(44.5)(51.7)
Depreciation(75.8)(68.5)(57.2)
Amortization of intangible assets(130.7)(107.1)(94.9)
Fair value inventory step-up charges(0.6)(9.6)(1.6)
Restructuring expenses and asset impairments(20.7)(9.3)(10.9)
Gain on sale of businesses - net— 4.0 84.7 
Loss on sale of assets
(1.1)— — 
Credit loss on note receivable from collaborative partner(2)
— — (7.7)
Income before income taxes$632.6 $639.3 $760.3 

(1) Corporate expenses that can be identified with a segment have been included in determining segment results. The remainder is included in Corporate and other.
(2) Represents a reserve recorded on an investment with a collaborative partner in Other expense (income) – net during 2023. During the fourth quarter of 2023, the Company converted the promissory note receivable from the collaborative partner to equity, resulting in a cost method investment with zero value. See Note 3, “Collaborative Investments,” for further detail.
202520242023
DEPRECIATION
Health & Science Technologies$47.9 $41.2 $33.2 
Fluid & Metering Technologies17.9 17.3 14.1 
Fire & Safety/Diversified Products9.2 9.0 8.9 
Total Segments75.0 67.5 56.2 
Corporate and other0.8 1.0 1.0 
Total depreciation$75.8 $68.5 $57.2 
AMORTIZATION OF INTANGIBLE ASSETS
Health & Science Technologies$103.7 $79.7 $65.8 
Fluid & Metering Technologies21.6 21.1 22.7 
Fire & Safety/Diversified Products5.4 6.3 6.4 
Total amortization$130.7 $107.1 $94.9 
CAPITAL EXPENDITURES
Health & Science Technologies$32.9 $40.1 $55.1 
Fluid & Metering Technologies21.3 14.8 24.2 
Fire & Safety/Diversified Products8.9 10.2 9.7 
Total Segments63.1 65.1 89.0 
Corporate and other0.5 — 0.9 
Total capital expenditures$63.6 $65.1 $89.9 
December 31, 2025December 31, 2024
ASSETS
Health & Science Technologies$4,301.1 $4,142.6 
Fluid & Metering Technologies1,694.4 1,609.4 
Fire & Safety/Diversified Products825.2 794.1 
Total Segments6,820.7 6,546.1 
Corporate and other106.3 199.2 
Total assets$6,927.0 $6,745.3 

Information about the Company’s long-lived assets in different geographical regions as of December 31, 2025 and 2024 is shown below.
December 31, 2025December 31, 2024
LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT
U.S.$273.6 $271.7 
North America, excluding U.S.19.2 20.6 
Netherlands
50.2 51.4 
Europe, excluding Netherlands
83.6 71.6 
Asia41.1 44.7 
Other(1)
0.3 0.4 
Total long-lived assets - net$468.0 $460.4 

(1) Other includes: South America, Middle East, Australia and Africa.
v3.25.4
Restructuring Expenses and Asset Impairments
 12 Months Ended
Dec. 31, 2025
Restructuring Costs and Asset Impairment Charges [Abstract]  
Restructuring Expenses and Asset Impairments Restructuring Expenses and Asset Impairments
Restructuring expenses generally represent expenses incurred by the Company to facilitate long-term sustainable growth through cost reduction actions, consisting of employee reductions, facility rationalization and contract termination costs. These costs include severance costs, exit costs and asset impairments and are included in Restructuring expenses and asset impairments in the Consolidated Statements of Income. Severance costs primarily consist of severance benefits through payroll continuation, COBRA subsidies, outplacement services, conditional separation costs, employer tax liabilities and related legal costs, while exit costs primarily consist of lease exit and contract termination costs.

2025 Initiative

In January 2025, the Company initiated restructuring actions designed with the focus of connecting scalable groups of businesses, which resulted in a reduction of headcount. Additionally, the Company eliminated certain management layers in select areas. These changes are expected to enable the Company to self-fund more growth resources, increase sourcing productivity, improve agility and speed of decision making and position the Company closer to the customer for maximum impact. These actions, which have primarily resulted in recognizing severance costs related to employee reductions, have been substantially completed during 2025.

Pre-tax Restructuring expenses and asset impairments by segment for the 2025 initiative were as follows:
Severance CostsExit CostsAsset ImpairmentsTotal
Health & Science Technologies$11.8 $0.1 $0.6 $12.5 
Fluid & Metering Technologies4.9 — 0.1 5.0 
Fire & Safety/Diversified Products2.4 — — 2.4 
Corporate/Other0.8 — — 0.8 
Total restructuring costs and asset impairments
$19.9 $0.1 $0.7 $20.7 

2024 Initiatives

During the year ended December 31, 2024, the Company incurred severance costs related to employee reductions in conjunction with cost mitigation efforts as a result of market conditions, all of which were substantially completed during 2024.

Pre-tax Restructuring expenses and asset impairments by segment for the 2024 initiative were as follows:
Severance CostsExit CostsAsset ImpairmentsTotal
Health & Science Technologies$5.8 $— $0.1 $5.9 
Fluid & Metering Technologies2.4 — — 2.4 
Fire & Safety/Diversified Products0.5 — — 0.5 
Corporate/Other0.5 — — 0.5 
Total restructuring costs and asset impairments
$9.2 $— $0.1 $9.3 

2023 Initiatives

During the year ended December 31, 2023, the Company incurred severance costs related to employee reductions in conjunction with cost mitigation efforts as a result of market conditions, which were substantially completed during 2023, as well as contract termination costs and asset impairments.
Pre-tax Restructuring expenses and asset impairments by segment for the 2023 initiative were as follows:
Severance CostsExit CostsAsset ImpairmentsTotal
Health & Science Technologies$6.4 $0.2 $— $6.6 
Fluid & Metering Technologies1.5 0.6 0.8 2.9 
Fire & Safety/Diversified Products0.7 0.2 — 0.9 
Corporate/Other0.5 — — 0.5 
Total restructuring costs and asset impairments
$9.1 $1.0 $0.8 $10.9 


Restructuring accruals reflected in Accrued expenses in the Company’s Consolidated Balance Sheets are as follows:
Restructuring
Initiatives
Balance at January 1, 2024$2.1 
Restructuring expenses(1)
9.2 
Payments, utilization and other(10.4)
Balance at December 31, 20240.9 
Restructuring expenses(2)
19.9 
Payments, utilization and other(17.8)
Balance at December 31, 2025$3.0 

(1) Excludes $0.1 million of asset impairments related to property, plant and equipment.
(2) Excludes $0.7 million of asset impairments related to property, plant and equipment and $0.1 million of exit costs.
v3.25.4
Share-Based Compensation
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company maintains a share-based compensation plan for executives, non-employee directors and certain key employees that authorize the granting of restricted stock, performance share units and stock options and other types of awards consistent with the purpose of the plan. A total of 9.9 million shares of the Company’s common stock have been authorized for issuance under the Company’s share-based compensation plan. As of December 31, 2025, 9.4 million shares of the Company’s common stock were available for future issuance.

The Company typically grants equity awards annually at its regularly scheduled first quarter meeting of the Company’s Board of Directors based on the recommendation from the Compensation Committee of the Company’s Board of Directors.

Stock Options

Stock options granted under the Company’s plan are generally non-qualified and are granted with an exercise price equal to the market price of the Company’s common stock on the date of grant. The fair value of each option grant in the periods presented was estimated on the date of the grant using the Black Scholes valuation model. Stock options generally vest ratably over four years, with vesting beginning one year from the date of grant, and generally expire 10 years from the date of grant.
The service period for certain retiree eligible participants is accelerated. The assumptions used in determining the fair value of the stock options granted during December 31, 2025, 2024 and 2023 were as follows:
 Years Ended December 31,
 202520242023
Weighted average fair value of grants$46.74$63.61$59.77
Dividend yield1.41%1.09%1.09%
Volatility23.06%26.66%27.14%
Risk-free interest rate4.28%
4.31%
4.15%
Expected life (in years)4.704.604.50

The assumptions were determined as follows:

•The Company estimated volatility using its historical share price performance over the expected life of the option.
•The Company uses historical data to estimate the expected life of the option based on IDEX’s own exercise and cancellation history adjusted for current vesting schedules.
•The risk-free interest rate is based on the U.S. Treasury yield curve commensurate with the expected life of the option. The Company presents the spot rate used in the Black Scholes valuation model.
•The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the option.

A summary of the Company’s stock option activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
SharesWeighted
Average Exercise Price		Weighted-Average
Remaining
Contractual Term
(years)		Aggregate
Intrinsic
Value
Stock Options
Outstanding at January 1, 2025998,856 $191.96 6.63$24.9 
Granted82,470 196.07 
Exercised(28,408)128.86 
Forfeited(98,717)212.92 
Outstanding at December 31, 2025954,201 $192.03 5.82$8.9 
Vested and expected to vest at December 31, 2025942,815 $191.69 5.79$8.9 
Exercisable at December 31, 2025671,427 $181.50 4.95$8.9 

The intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock as of the end of the period and the grant price. The total intrinsic value of options exercised in 2025, 2024 and 2023 was $1.8 million, $9.6 million and $14.9 million, respectively. In 2025, 2024 and 2023, cash received from options exercised was $3.7 million, $19.4 million and $26.3 million, respectively, while the actual tax benefit realized for the tax deductions from stock options exercised totaled $0.4 million, $2.0 million and $3.1 million, respectively.

As of December 31, 2025, there was $4.5 million of total unrecognized compensation cost related to stock options that is expected to be recognized over a weighted-average period of 1.1 years.

Restricted Stock

Restricted stock awards generally cliff vest after three years for employees and generally cliff vest after one year for non-employee directors. The service period for certain retiree eligible participants is accelerated. Unvested restricted stock granted after the adoption of the 2024 Incentive Award Plan earn dividend equivalents for the award period, which will be paid to participants upon vesting of the underlying awards. Unvested restricted stock granted prior to the adoption of the 2024 Incentive Award Plan earn and are paid dividends on a current basis. The sale of the shares is restricted prior to the date of vesting. The fair value of restricted stock is equal to the market price of the Company’s common stock at the date of the grant. A summary of the Company’s restricted stock activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
Restricted StockSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 2025175,991 $201.27 
Granted106,875 191.13 
Vested(64,072)190.37 
Forfeited(27,972)205.42 
Unvested at December 31, 2025190,822 $198.64 

As of December 31, 2025, there was $14.9 million of total unrecognized compensation cost related to restricted stock that is expected to be recognized over a weighted-average period of 0.9 years.

Cash-Settled Restricted Stock

The Company also maintains a cash-settled share-based compensation plan for certain employees. Cash-settled restricted stock awards generally cliff vest after three years. The service period for certain retiree eligible participants is accelerated. Cash-settled restricted stock awards are recorded at fair value on a quarterly basis using the market price of the Company’s common stock on the last day of the quarter. At December 31, 2025 and 2024, the Company had accrued $3.6 million and $4.0 million, respectively, for cash-settled restricted stock in Accrued expenses in the Consolidated Balance Sheets and had accrued $2.4 million in both periods for cash-settled restricted stock in Other noncurrent liabilities in the Consolidated Balance Sheets. These recurring fair value measurements are classified as Level 1 in the fair value hierarchy. Dividend equivalents are earned throughout the award period and paid upon vesting for certain cash-settled restricted stock awards granted after the adoption of the 2024 Incentive Award Plan. Dividend equivalents are paid on a current basis on certain cash-settled restricted stock awards granted prior to the adoption of the 2024 Incentive Award Plan. A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
Cash-Settled Restricted StockSharesWeighted-Average
Fair Value
Unvested at January 1, 202555,395 $209.29 
Granted32,090 195.10 
Vested(19,131)186.52 
Forfeited(6,062)177.94 
Unvested at December 31, 202562,292 $177.94 

As of December 31, 2025, there was $3.9 million of total unrecognized compensation cost related to cash-settled restricted stock that is expected to be recognized over a weighted-average period of 1.0 year.

Performance Share Units

The Company grants performance share units to selected key employees. Performance share unit awards represent rights to receive shares of the Company’s common stock and will vest between 0% to 250% of the target share unit amount. Performance share units are expected to be made annually and are paid out at the end of a three-year period following the date of grant, based on the Company’s performance, as described below. Performance share units granted in 2025 are earned over a three-year performance period based on an internal income growth metric (a performance condition), weighted 25%, and the total shareholder return of the Company’s common stock in relation to the total shareholder return of companies in the S&P 500 Index (a market condition), weighted 75%. Performance share unit awards granted prior to 2025 are earned solely based on the Company’s total shareholder return ranking in relation to the total shareholder return of companies in the S&P 500 Index over a three-year period following the date of grant. A target payout of 100% of the market condition portion of the award is earned if total shareholder return is equal to the 50th percentile of the peer group. Performance share units earn dividend equivalents for the award period, which will be paid to participants with the award payout at the end of the period based on the actual number of performance share units that are earned. Payments made at the end of the award period will be in the form of stock for performance share units and will be in cash for dividend equivalents.

The fair value of the performance condition portion of the 2025 awards is equal to the market price of the Company’s common stock at the date of the grant, and the amount of expense recognized over the vesting period is subject to adjustment based on the expected attainment of the performance condition. The fair value of the market condition portion of the 2025
awards and all awards granted prior to 2025 is determined using a Monte Carlo simulation model, and the amount of expense recognized over the vesting period is not subject to change based on future market conditions.

The assumptions used in the Monte Carlo simulation model to determine the fair value of the market condition portion of the performance share units granted during December 31, 2025, 2024 and 2023 were as follows:
Years Ended December 31,
 202520242023
Weighted average fair value of grants$232.44$349.59$308.18
Dividend yield—%—%—%
Volatility22.93%22.23%27.00%
Risk-free interest rate4.23%4.45%4.37%
Expected life (in years)2.942.942.94

The assumptions used in the Monte Carlo simulation model were determined as follows:

•The Company estimated volatility using its historical share price performance over the remaining performance period as of the grant date.
•The Company uses a Monte Carlo simulation model that uses an expected life commensurate with the performance period. As a result, the expected life of the performance share units was assumed to be the period from the grant date to the end of the performance period.
•The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant with a term commensurate with the remaining performance period.
•Total shareholder return is determined assuming that dividends are reinvested in the issuing entity over the performance period, which is mathematically equivalent to utilizing a 0% dividend yield.

A summary of the Company’s performance share unit activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
Performance Share UnitsSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 202572,825 $299.87 
Granted43,360 216.98 
Vested(15,530)234.23 
Forfeited(22,450)264.20 
Unvested at December 31, 202578,205 $267.78 

The performance period for the 2022 grants ended as of January 31, 2025. The 2022 grants achieved a 65% payout factor and the Company issued 15,530 shares of the Company’s common stock in February 2025 for awards that vested in 2025. The performance period for the 2023 grants ended as of January 31, 2026. The 2023 grants achieved a 0% payout factor, and as such, the Company did not issue any shares of the Company’s stock for awards that vested in 2026.

As of December 31, 2025, there was $2.4 million of total unrecognized compensation cost related to performance share units that is expected to be recognized over a weighted-average period of 1.0 year.
Summary of Share-Based Compensation Expense

The Company’s policy is to recognize compensation cost on a straight-line basis, assuming forfeitures, over the requisite service period for the entire award. Classification of share-based compensation cost within the Consolidated Statements of Income is consistent with the classification of cash compensation for the same employees. Total compensation cost related to all share-based awards was as follows:

Years Ended December 31,
202520242023
Stock options expense$6.1 $9.8 $9.9 
Restricted stock expense15.2 8.3 5.7 
Cash-settled restricted stock expense3.2 3.4 3.4 
Performance share units expense6.0 7.7 6.0 
Total pre-tax share-based compensation expense(1)
30.5 29.2 25.0 
Income tax benefit(4.1)(3.2)(2.7)
Total share-based compensation expense, net of income taxes$26.4 $26.0 $22.3 

(1) Pre-tax compensation cost is recognized in the Company’s Consolidated Statements of Income depending on the functional area of the underlying employees, as follows:

Years Ended December 31,
202520242023
Cost of sales$1.9 $1.6 $1.4 
Selling, general and administrative expenses29.2 27.6 23.6 
Restructuring expenses and asset impairments(2)
(0.6)— — 
Total pre-tax share-based compensation expense$30.5 $29.2 $25.0 

(2) During the year ended December 31, 2025, a benefit of $0.6 million was recognized in Restructuring expenses and asset impairments in the Company’s Consolidated Statements of Income related to forfeitures of share-based compensation awards resulting from previously announced restructuring actions initiated during the first quarter of 2025.
v3.25.4
Accumulated Other Comprehensive Income (Loss)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The components of Accumulated other comprehensive income (loss) for the years ended December 31, 2025, 2024 and 2023 are as follows:
Cumulative Translation AdjustmentPension and Other Postretirement AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance, January 1, 2023(1)
$(137.1)$10.9 $(126.2)
Other comprehensive income (loss) before reclassification adjustments87.8 (8.2)79.6 
Gain reclassified from Accumulated other comprehensive loss(2)(3)
— (1.5)(1.5)
Tax impact— 2.3 2.3 
Net other comprehensive income (loss)(1)
87.8 (7.4)80.4 
Balance, December 31, 2023(1)
$(49.3)$3.5 $(45.8)
Other comprehensive (loss) income before reclassification adjustments(93.7)4.8 (88.9)
Gain reclassified from Accumulated other comprehensive loss(2)(3)
— (1.0)(1.0)
Loss reclassified related to divestitures(4)
5.5 — 5.5 
Tax impact— (0.7)(0.7)
Net other comprehensive (loss) income(1)
(88.2)3.1 (85.1)
Balance, December 31, 2024(1)
$(137.5)$6.6 $(130.9)
Other comprehensive income before reclassification adjustments
186.3 4.3 190.6 
Gain reclassified from Accumulated other comprehensive loss(2)(3)
— (0.9)(0.9)
Tax impact— (1.2)(1.2)
Net other comprehensive income(1)
186.3 2.2 188.5 
Balance, December 31, 2025(1)
$48.8 $8.8 $57.6 

(1) Amounts are presented net of tax.
(2) Included in the computation of net periodic cost (benefit). See Note 17, “Retirement Benefits.”
(3) Included in Other expense (income) – net in the Consolidated Statements of Income.
(4) In conjunction with the divestiture of Alfa Valvole during the second quarter of 2024, the Company released
associated cumulative foreign currency translation losses and included the release as part of the gain on sale of business.
v3.25.4
Retirement Benefits
 12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Retirement Benefits Retirement Benefits
The Company sponsors several qualified and nonqualified defined benefit and defined contribution pension plans as well as other post-retirement plans for its employees. The Company uses a measurement date of December 31 for its defined benefit pension plans and post-retirement medical plans. The Company employs the measurement date provisions of ASC 715, Compensation-Retirement Benefits, which require the measurement date of plan assets and liabilities to coincide with the sponsor’s year end.
The following table provides a reconciliation of the changes in the benefit obligation and fair value of plan assets over the periods described below:

 Pension BenefitsOther Benefits
 2025202420252024
 U.S.Non-U.S.U.S.Non-U.S.  
CHANGE IN BENEFIT OBLIGATION
Obligation at January 1$8.3 $84.6 $8.9 $88.5 $16.8 $17.2 
Service cost0.1 1.5 0.1 1.5 0.4 0.5 
Interest cost0.4 2.5 0.4 2.6 0.8 0.8 
Benefits paid(0.6)(2.9)(0.8)(2.2)(0.8)(0.8)
Actuarial (gain) loss
0.3 (5.4)(0.3)0.3 0.3 (0.7)
Currency translation— 10.4 — (5.3)0.2 (0.2)
Settlements— (4.8)— (2.5)— — 
Curtailments— (0.4)— — — — 
Acquisition/Divestiture— — — 0.9 — — 
Participant contributions
— 0.9 — 0.9 — — 
Other— — — (0.1)(0.1)— 
Obligation at December 31$8.5 $86.4 $8.3 $84.6 $17.6 $16.8 
CHANGE IN PLAN ASSETS
Fair value of plan assets at January 1$4.1 $45.1 $4.3 $41.7 $— $— 
Actual return on plan assets(0.1)0.9 0.2 6.2 — — 
Employer contributions0.6 3.8 0.4 3.4 0.8 0.8 
Benefits paid(0.6)(2.9)(0.8)(2.2)(0.8)(0.8)
Currency translation— 5.3 — (2.3)— — 
Settlements— (4.8)— (2.5)— — 
Participant contributions
— 0.9 — 0.9 — — 
Other— 0.1 — (0.1)— — 
Fair value of plan assets at December 31$4.0 $48.4 $4.1 $45.1 $— $— 
Funded status at December 31$(4.5)$(38.0)$(4.2)$(39.5)$(17.6)$(16.8)
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS
Other noncurrent assets$— $3.8 $— $2.1 $— $— 
Accrued expenses
(0.8)(2.1)(0.7)(1.8)(1.0)(1.1)
Other noncurrent liabilities(3.7)(39.7)(3.5)(39.8)(16.6)(15.7)
Net asset (liability) at December 31$(4.5)$(38.0)$(4.2)$(39.5)$(17.6)$(16.8)

The pension benefits actuarial gain in 2025 was primarily driven by the increase in discount rates from 2024 to 2025 for the non-U.S. pension schemes, partially offset by lower than expected asset returns.

The other benefits actuarial loss in 2025 was primarily driven by the decrease in discount rates from 2024 to 2025 and losses from the updated health care trend and claim cost assumptions, partially offset by gains from updated participant data for the U.S. plans.

The accumulated benefit obligation for all defined benefit pension plans was $91.6 million and $89.4 million at December 31, 2025 and 2024, respectively.
The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2025 and 2024 were as follows:
 U.S. PlansNon-U.S. PlansOther Benefits
 202520242025202420252024
Discount rate5.09%5.41%3.38%2.91%5.16%5.40%
Rate of compensation increase
N/AN/A2.33%2.38%N/AN/A
Cash balance interest credit rateN/AN/A1.31%1.25%N/AN/A

The pretax amounts recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheets as of December 31, 2025 and 2024 were as follows:
 Pension BenefitsOther Benefits
 2025202420252024
 U.S.Non-U.S.U.S.Non-U.S.  
Prior service cost (credit)$0.1 $(0.2)$0.1 $(0.3)$(0.3)$(0.2)
Net loss (gain)2.6 (6.6)2.3 (1.8)(7.3)(8.4)
Total$2.7 $(6.8)$2.4 $(2.1)$(7.6)$(8.6)

The components of the net periodic cost (benefit) for the plans in 2025, 2024 and 2023 are as follows:
 Pension Benefits
 202520242023
 U.S.Non-U.S.U.S.Non-U.S.U.S.Non-U.S.
Service cost$0.1 $1.5 $0.1 $1.5 $0.1 $1.2 
Interest cost0.4 2.5 0.4 2.6 0.4 2.8 
Expected return on plan assets(0.2)(1.9)(0.3)(1.8)(0.2)(1.6)
Settlement gain recognized
— (0.1)— (0.3)— (0.1)
Curtailment gain recognized
— (0.4)— — — — 
Net amortization0.3 (0.3)0.3 (0.1)0.1 (0.6)
Net periodic cost $0.6 $1.3 $0.5 $1.9 $0.4 $1.7 
 
 Other Benefits
 202520242023
Service cost$0.4 $0.5 $0.4 
Interest cost0.8 0.8 0.8 
Net amortization(0.8)(0.9)(0.9)
Net periodic cost
$0.4 $0.4 $0.3 

The Company recognizes the service cost component in both Cost of sales and Selling, general and administrative expenses in the Consolidated Statements of Income depending on the functional area of the underlying employees. All other components of net periodic cost (benefit) are recorded in Other expense (income) – net in the Consolidated Statements of Income.

The assumptions used in determining the net periodic cost (benefit) were as follows:

 U.S. PlansNon-U.S. Plans
 202520242023202520242023
Discount rate5.41%4.93%5.17%2.91%3.01%3.75%
Expected return on plan assets4.15%5.40%4.65%4.13%4.37%4.17%
Rate of compensation increaseN/AN/AN/A2.38%2.55%2.44%
 Other Benefits
 202520242023
Discount rate5.40%4.90%5.21%
Expected return on plan assetsN/AN/AN/A
Rate of compensation increaseN/AN/AN/A

The pretax change recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheet in 2025 is as follows:
 Pension BenefitsOther
Benefits
 U.S.Non-U.S.
Net gain in current year
$(0.6)$4.4 $(0.3)
Prior service credit
— — 0.1 
Amortization of prior service credit— (0.1)— 
Amortization of net loss (gain) 0.3 (0.2)(0.8)
Settlement gain recognized
— (0.1)— 
Exchange rate effect on amounts in other comprehensive income— 0.7 — 
Total$(0.3)$4.7 $(1.0)

The discount rates for the Company’s plans are derived by matching the plan’s cash flows to a yield curve that provides the equivalent yields on zero-coupon bonds for each maturity. The discount rate selected is the rate that produces the same present value of cash flows.

In selecting the expected rate of return on plan assets, the Company considers the historical returns and expected returns on plan assets. The expected returns are evaluated using asset return class, variance and correlation assumptions based on the plan’s target asset allocation and current market conditions.

Prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10% of the greater of the benefit obligation or the market value of assets are amortized over the average remaining service period of active participants.

A 7.87% weighted average annual rate of increase in the per capita cost of covered health care benefits was assumed for measurement of the pension obligation as of December 31, 2025 and measurement of the following year’s expense. The rate was assumed to decrease gradually each year to a rate of 4.00% for 2050 and remain at that level thereafter.

Costs of defined contribution plans were $17.8 million, $17.4 million and $16.8 million for 2025, 2024 and 2023, respectively.

The Company, through its subsidiaries, participates in a multi-employer pension plan covering approximately 216 participants under U.S. collective bargaining agreements. None of these plans are considered individually significant to the Company as contributions to these plans totaled $1.0 million, $1.0 million, and $0.9 million for 2025, 2024 and 2023, respectively.


 
Plan Assets

The Company’s pension plan weighted average asset allocations at December 31, 2025 and 2024, by asset category, were as follows:
U.S. PlansNon-U.S. Plans
2025202420252024
Equity securities9%9%1%1%
Fixed income securities83%79%29%25%
Cash/Commingled Funds/Other(1)
8%12%70%74%
Total100%100%100%100%

The basis used to measure the defined benefit plans’ assets at fair value at December 31, 2025 and 2024 is summarized as follows:
 Basis of Fair Value Measurement
 Outstanding
Balances		Level 1Level 2Level 3
As of December 31, 2025
Equity
U.S. Large Cap$0.2 $0.2 $— $— 
U.S. Small / Mid Cap— — — — 
International0.8 0.8 — — 
Fixed Income
U.S. Intermediate2.2 — 2.2 — 
U.S. Long Term3.1 — 3.1 — 
U.S. High Yield1.0 — 1.0 — 
International10.8 0.2 10.6 — 
Other Commingled Funds(1)
31.5 — — 31.5 
Cash and Equivalents0.8 0.8 — — 
Other2.0 — 2.0 — 
$52.4 $2.0 $18.9 $31.5 
 
(1)Other commingled funds represent pooled institutional investments in non-U.S. plans.
 Basis of Fair Value Measurement
 Outstanding
Balances		Level 1Level 2Level 3
As of December 31, 2024
Equity
U.S. Large Cap$0.2 $0.2 $— $— 
U.S. Small / Mid Cap— — — — 
International0.8 0.8 — — 
Fixed Income
U.S. Intermediate2.5 — 2.5 — 
U.S. Long Term3.1 — 3.1 — 
U.S. High Yield0.7 — 0.7 — 
International8.2 0.2 8.0 — 
Other Commingled Funds(1)
30.0 — — 30.0 
Cash and Equivalents2.1 2.1 — — 
Other1.7 — 1.7 — 
$49.3 $3.3 $16.0 $30.0 

(1)Other commingled funds represent pooled institutional investments in non-U.S. plans.

Equities that are valued using quoted prices are valued at the published market prices. Equities in a common collective trust or a registered investment company that are valued using significant other observable inputs are valued at the net asset value (“NAV”) provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund minus its liabilities. Fixed income securities that are valued using significant other observable inputs are valued at prices obtained from independent financial service industry-recognized vendors.

Investment Policies and Strategies

The investment objective of the U.S. plan, consistent with prudent standards for preservation of capital and maintenance of liquidity, is to earn the highest possible total rate of return consistent with the plan’s tolerance for risk. The general asset allocation guidelines for plan assets are that “equities” will constitute 10% and “fixed income” obligations, including cash, will constitute 90% of the market value of total fund assets.

The investment objective of the UK plan, consistent with prudent standards for preservation of capital and maintenance of liquidity, is to earn a target return of a reasonable margin above UK Gilts. The general asset allocation guidelines for plan assets are that “fixed income” obligations, including cash, will constitute 100% of the market value of total fund assets.

The term “equities” includes common stock, while the term “fixed income” includes obligations with contractual payments and a specific maturity date. Diversification of assets is employed to ensure that adverse performance of one security or security class does not have an undue detrimental impact on the portfolio as a whole. Diversification is interpreted to include diversification by type, characteristic and number of investments as well as by investment style of designated investment fund managers. No restrictions are placed on the selection of individual investments by the investment fund managers. The total fund performance and the performance of the investment fund managers is reviewed on a regular basis using an appointed professional independent advisor. As of December 31, 2025, there were no shares of the Company’s stock held in plan assets.

Cash Flows

The Company expects to contribute approximately $4.6 million to its defined benefit plans and $1.0 million to its other postretirement benefit plans in 2026. The Company also expects to contribute approximately $19.1 million to its defined contribution plan in 2026 using cash on hand.
Estimated Future Benefit Payments

The future estimated benefit payments for the next five years and the five years thereafter are as follows:
Estimated Future Benefits
2026$7.7 
20277.4 
20287.1 
20297.6 
20307.1 
2031 to 203537.5 
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Risk Management and Strategy.

The Company’s cybersecurity program is designed to be aligned to the Cybersecurity Framework published by the National Institute of Standards and Technology (“NIST CSF”). While we use the NIST CSF as a guide, this does not imply that
we meet any particular standards, specifications or requirements. We conduct regular internal and external assessments of our information security and cybersecurity programs, including periodic external audits for company-wide compliance with our program as well as specific business unit alignment, as required, with U.S. federal acquisition regulations and UK Cyber Essentials certifications. An external penetration test is performed annually against the Company’s network, in addition to our regular internal vulnerability scans.

The Company’s internal Incident Response Policy sets forth specific protocols for cyber or data incident detection, response and recovery. This process includes the assembly of a response team consisting of internal and, as required, external technical and legal experts upon the event of a cyberattack or incident. The Company reviews and updates this process regularly, including by engaging in tabletop exercises to simulate cybersecurity and data breach incidents. The Company maintains global cybersecurity insurance coverage that is reviewed annually for adequacy against operations and information systems.

The Company has implemented a number of measures to mitigate cybersecurity risk in its operations, including annual cybersecurity awareness training for employees, regular internal phishing exercises, technical security controls, maintenance of certain backup and protective systems, physical and system securities measures, and data security protocols. Once fully integrated, all of our businesses have access to a “cyber risk dashboard” that monitors various risk indicators. The cyber risk dashboard is monitored by our business units. The Company’s internal auditors periodically review and audit various processes and controls throughout the organization related to cybersecurity readiness.

The Company also has certain processes in place to manage cyber risks associated with third-party service providers which include various technical as well as contractual measures.
For more information on cybersecurity risks and how they affect our business, operating results and financial condition, please refer to Item 1A., “Risk Factors – The Company’s Business Operations May Be Materially Adversely Affected by Information Systems Interruptions or Intrusion, Including those Arising From Cybersecurity Attacks or Incidents or Violations of Laws Regulating Privacy and Data Security.” Based on our analysis at this time, we have not identified any risks from a cybersecurity threat or incident that we believe has or is reasonably likely to materially affect the Company.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
The Company’s internal Incident Response Policy sets forth specific protocols for cyber or data incident detection, response and recovery. This process includes the assembly of a response team consisting of internal and, as required, external technical and legal experts upon the event of a cyberattack or incident. The Company reviews and updates this process regularly, including by engaging in tabletop exercises to simulate cybersecurity and data breach incidents. The Company maintains global cybersecurity insurance coverage that is reviewed annually for adequacy against operations and information systems.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] The Company’s Board of Directors and the Audit Committee oversee management’s efforts to address cybersecurity and information security risks. Senior management provides the Company’s Board of Directors updates on the Company’s cybersecurity program at least once a year, including as part of the Company’s enterprise risk management assessment, and, beginning in 2026, the Audit Committee reviews the cybersecurity program at least three times a year and on an as-needed basis. Such reviews, among other things, include the results of internal and/or external assessments, a review of cybersecurity governance at the management level, and a review of the Company’s cybersecurity program and progress toward various initiatives.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] The Chief Information Officer (“CIO”), who reports to the Chief Financial Officer, along with members of the corporate and business unit information technology teams, are generally responsible for developing and managing the Company’s cybersecurity programs.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
The Company also maintains an Executive Cybersecurity Steering Committee (the “Cybersecurity Committee”), made up of key members of senior leadership, to oversee and monitor progress of various cybersecurity initiatives throughout the organization. The Cybersecurity Committee meets quarterly. In addition, the Company asks each business unit to designate an employee as the local Information Security Officer responsible for monitoring the business unit’s cyber risk dashboard and coordinating with local leadership to respond to identified risks accordingly. Each local Information Security Officer completes an annual certification process and receives regular updates with respect to the Company’s cybersecurity program.

The Chief Information Officer (“CIO”), who reports to the Chief Financial Officer, along with members of the corporate and business unit information technology teams, are generally responsible for developing and managing the Company’s cybersecurity programs. Our CIO has over 20 years of experience in various information technology and information security roles, and our information security team is comprised of employees with broad knowledge of cybersecurity issues gained through experience and through training and certifications and includes our Director of Information Security, who has over 20 years of experience leading and managing cybersecurity programs. These individuals, along with other internal and external personnel as needed, monitor the prevention, detection, mitigation and remediation of cybersecurity incidents, and applicable personnel are informed of known cybersecurity incidents to form the appropriate incident response team and respond accordingly.
Cybersecurity Risk Role of Management [Text Block]
The Company also maintains an Executive Cybersecurity Steering Committee (the “Cybersecurity Committee”), made up of key members of senior leadership, to oversee and monitor progress of various cybersecurity initiatives throughout the organization. The Cybersecurity Committee meets quarterly. In addition, the Company asks each business unit to designate an employee as the local Information Security Officer responsible for monitoring the business unit’s cyber risk dashboard and coordinating with local leadership to respond to identified risks accordingly. Each local Information Security Officer completes an annual certification process and receives regular updates with respect to the Company’s cybersecurity program.

The Chief Information Officer (“CIO”), who reports to the Chief Financial Officer, along with members of the corporate and business unit information technology teams, are generally responsible for developing and managing the Company’s cybersecurity programs. Our CIO has over 20 years of experience in various information technology and information security roles, and our information security team is comprised of employees with broad knowledge of cybersecurity issues gained through experience and through training and certifications and includes our Director of Information Security, who has over 20 years of experience leading and managing cybersecurity programs. These individuals, along with other internal and external personnel as needed, monitor the prevention, detection, mitigation and remediation of cybersecurity incidents, and applicable personnel are informed of known cybersecurity incidents to form the appropriate incident response team and respond accordingly.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] The Chief Information Officer (“CIO”), who reports to the Chief Financial Officer, along with members of the corporate and business unit information technology teams, are generally responsible for developing and managing the Company’s cybersecurity programs.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our CIO has over 20 years of experience in various information technology and information security roles, and our information security team is comprised of employees with broad knowledge of cybersecurity issues gained through experience and through training and certifications and includes our Director of Information Security, who has over 20 years of experience leading and managing cybersecurity programs.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
The Company also maintains an Executive Cybersecurity Steering Committee (the “Cybersecurity Committee”), made up of key members of senior leadership, to oversee and monitor progress of various cybersecurity initiatives throughout the organization. The Cybersecurity Committee meets quarterly. In addition, the Company asks each business unit to designate an employee as the local Information Security Officer responsible for monitoring the business unit’s cyber risk dashboard and coordinating with local leadership to respond to identified risks accordingly. Each local Information Security Officer completes an annual certification process and receives regular updates with respect to the Company’s cybersecurity program.

The Chief Information Officer (“CIO”), who reports to the Chief Financial Officer, along with members of the corporate and business unit information technology teams, are generally responsible for developing and managing the Company’s cybersecurity programs. Our CIO has over 20 years of experience in various information technology and information security roles, and our information security team is comprised of employees with broad knowledge of cybersecurity issues gained through experience and through training and certifications and includes our Director of Information Security, who has over 20 years of experience leading and managing cybersecurity programs. These individuals, along with other internal and external personnel as needed, monitor the prevention, detection, mitigation and remediation of cybersecurity incidents, and applicable personnel are informed of known cybersecurity incidents to form the appropriate incident response team and respond accordingly.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Consolidation and Basis of Presentation
Consolidation and Basis of Presentation

The accompanying Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for credit losses, inventory valuation, recoverability of long-lived assets, valuation of goodwill and intangible assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions.
Revenue Recognition
Revenue Recognition

The Company accounts for a contract with a customer when it has approval from both parties, the rights and payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company determines the appropriate revenue recognition by analyzing the terms and conditions of the contract. Revenue, or Net sales, is recognized when control of the products or services is transferred to a customer at an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring the products or providing the services. Control is transferred to customers when performance obligations within a contract are satisfied. A performance obligation is a promise to transfer a distinct product or service to a customer.

The majority of the Company’s contracts have a single performance obligation which represents, in most cases, the product being sold to the customer. Some contracts include multiple performance obligations such as a product and related installation, extended warranty, engineering, software and/or maintenance services.

For contracts that require complex design, manufacturing and installation activities, certain performance obligations may not be separately identifiable and, therefore, not distinct. As a result, the entire contract is accounted for as a single performance obligation. For contracts that include distinct products or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct products or services. For product sales, each product sold to a customer generally represents a distinct performance obligation. For contracts with multiple performance obligations, the Company allocates the total transaction price to each performance obligation in an amount based on the relative standalone selling prices of the promised products or services underlying each performance obligation. When available, the observable standalone sales are used in the allocation of the total transaction price, but in certain cases, the Company may be required to estimate the standalone selling price using the expected cost plus margin approach, under which it forecasts the expected costs of satisfying a performance obligation and then adds an appropriate margin for the distinct product or service.

The Company’s performance obligations are satisfied at either a point in time or over time as work progresses. For performance obligations satisfied at a point in time, revenue is recognized when control transfers to the customer, typically upon shipment. For performance obligations in which the Company transfers control of a product or service over time, revenue
is recognized over time as work is performed. Typically, this results when the Company performs services over time or the Company creates a product with no alternative use and has an enforceable right to payment for its performance to date.

When accounting for over-time contracts, the Company generally uses a cost input measure to determine the extent of progress towards completion of the performance obligation. The Company believes this measure of progress best depicts the transfer of control to the customer which occurs as the Company incurs costs on its contracts. Incurred cost represents work performed, which corresponds with the transfer of control to the customer. Contract costs include labor, material and overhead. Revenue is recognized based on the relationship between actual costs incurred to date for each contract and the total estimated costs for such contract at completion of the performance obligation.

As a significant change in one or more of these estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its estimates regularly. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised. Such revisions to costs and income are recognized in the period in which the revisions are determined as a cumulative catch-up adjustment. The impact of the adjustment on profit recorded to date on a contract is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance are recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, the Company recognizes provisions for estimated losses on incomplete contracts in the period in which such losses are determined.

The Company records allowances for discounts and product returns at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties (primarily assurance-type) and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company.

Contract Assets and Liabilities

The timing of billings and cash collections can result in customer receivables, billings in excess of revenue recognized, advance payments or deposits. Customer receivables include both amounts billed and currently due from customers as well as unbilled amounts (contract assets) and are included in Receivables - net on the Consolidated Balance Sheets. Amounts are billed in accordance with contractual terms or as work progresses. Unbilled amounts arise when the timing of billing differs from the timing of revenue recognized, such as when contract provisions require specific milestones to be met before a customer can be billed. Unbilled amounts primarily relate to performance obligations satisfied over time when the cost-to-cost method is utilized and the revenue recognized exceeds the amount billed to the customer as there is not yet a right to invoice in accordance with contractual terms. Unbilled amounts are recorded as a contract asset when the revenue associated with the contract is recognized prior to billing and derecognized when billed in accordance with the terms of the contract.

Contract liabilities include advance payments, deposits and billings in excess of revenue recognized and are included in deferred revenue which is classified as current or noncurrent based on the timing of when the Company expects to recognize the revenue. The current portion is included in Accrued expenses and the noncurrent portion is included in Other noncurrent liabilities on the Consolidated Balance Sheets. Advance payments, deposits and billings in excess of revenue represent contract liabilities and are recorded when customers remit contractual cash payments in advance of satisfaction of performance obligations under contractual arrangements, including those with performance obligations satisfied over time. The Company generally receives advance payments from customers related to maintenance services which are recognized ratably over the service term. The Company also receives deposits from customers on certain orders which the Company recognizes as revenue at a point in time. Contract liabilities are derecognized when revenue is recognized.
Shipping and Handling Costs
Shipping and Handling Costs

Shipping and handling costs are included in Cost of sales and are recognized as a period expense during the period in which they are incurred.
Advertising Costs
Advertising Costs

Advertising costs of $16.3 million, $16.9 million and $15.9 million for 2025, 2024 and 2023, respectively, are expensed as incurred within Selling, general and administrative expenses.
Cash and Cash Equivalents
Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with an original maturity of 3 months or less to be cash and cash equivalents.
Marketable Securities
Marketable Securities
From time to time, the Company may hold investments in marketable securities, which are recorded in Other current assets in the Consolidated Balance Sheets. These investments are recorded at fair value, with gains and losses, dividends and interest income included in Other expense (income) – net in the Consolidated Statements of Income.
Accounts Receivable and Allowance for Credit Losses
Accounts Receivable and Allowance for Credit Losses

Accounts receivable are recorded at face amount less an allowance for credit losses including bad debts as well as other estimated returns and allowances. The allowance for bad debt is an estimate based on historical collection experience, current and future economic and market conditions and a review of the current status of each customer’s trade accounts receivable. Management evaluates the aging of the accounts receivable balances and the financial condition of its customers and all other forward-looking information that is reasonably available to estimate the amount of accounts receivable that may not be collected in the future and records the appropriate provision. Reserves for returns and other allowances and adjustments, which are provided for in the same period the related sales are recorded and reduce net sales, are estimated using historical experience as well as specific customer circumstances when known.
Inventories
Inventories

The Company states inventories at the lower of cost or net realizable value. Cost, which includes material, labor and overhead, is determined on a first in, first out basis. The Company makes adjustments to reduce the cost of inventory to its net realizable value, if required, for estimated excess, obsolete, zero usage or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
A long-lived asset is reviewed for impairment if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below its carrying value, as measured by comparing its net book value to the projected undiscounted future cash flows generated by its use. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. A long-lived asset impairment exists when the carrying value of the asset group exceeds its fair value. The amount and timing of the impairment charge for an asset group requires the estimation of future cash flows, which are then discounted to determine the fair value of the asset group. An impaired asset group is recorded at its estimated fair value.
Goodwill and Indefinite-Lived Intangible Assets
Goodwill and Indefinite-Lived Intangible Assets
The Company reviews the carrying value of goodwill and indefinite-lived intangible assets annually, or more frequently if events occur or circumstances change that would indicate an asset may be impaired. The Company evaluates the recoverability of these assets as of October 31 based on the estimated fair value of each reporting unit and the indefinite-lived intangible assets.
Borrowing Expenses
Borrowing Expenses

Expenses incurred in securing and issuing debt are capitalized and amortized over the life of the related borrowing and the related amortization is included in Interest expense - net in the Consolidated Statements of Income. Debt issuance costs related to senior notes and term loans are included as a reduction of the carrying amount of the related borrowing. Debt issuance costs related to securing the Company’s Revolving Facility are included in Other noncurrent assets in the Consolidated Balance Sheets.
Earnings per Common Share
Earnings per Common Share

Diluted earnings per common share (“EPS”) attributable to IDEX is computed by dividing Net income attributable to IDEX by the weighted average number of common shares outstanding (basic) plus common stock equivalents outstanding (diluted) during the year. Common stock equivalents consist of restricted stock, performance share units and stock options, which have been included in the calculation of weighted average common shares outstanding using the treasury stock method.

Outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has both participating and non-participating securities. Dividend rights for restricted stock awards issued under the IDEX Corporation 2024 Incentive Award Plan (the “2024 Incentive Award Plan”) are subject to the same vesting requirements as the underlying restricted stock awards, and therefore these awards are considered non-participating securities. Dividend rights for restricted stock awards issued prior to the adoption of the 2024 Incentive Award Plan are non-forfeitable and are not subject to the same vesting requirements as the underlying restricted stock awards. As such, these awards have been determined to be participating securities. Accordingly, Diluted EPS attributable to IDEX was computed using the two-class method.
Share-Based Compensation
Share-Based Compensation
The Company expenses the fair value of the awards granted under its share-based compensation plan. That cost is recognized in the Consolidated Financial Statements over the requisite service period of the grants.
Depreciation and Amortization
Depreciation and Amortization

Property and equipment are stated at historical cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over each asset’s estimated useful life. Property and equipment are generally depreciated over the following estimated useful lives:

Land improvements
8 to 12 years
Buildings and improvements
8 to 30 years
Machinery, equipment and other
3 to 12 years
Office and transportation equipment
2 to 10 years
Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are generally as follows:

Trade names
15 to 20 years
Customer relationships
5 to 20 years
Technology
5 to 20 years
Software5 years
Research and Development Expenditures
Research and Development Expenditures

Costs associated with engineering activities, including research and development, are expensed in the period incurred and are included in Cost of sales.
Foreign Currency Translation and Transaction
Foreign Currency Translation and Transaction
The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date and the income statement amounts have been translated using the average monthly exchange rates for the year. Translation adjustments from year to year have been reported in Accumulated other comprehensive income (loss) in the Consolidated Balance Sheets. Foreign currency transaction gains and losses from transactions denominated in a currency other than the functional currency of the subsidiary involved are reported within Other expense (income) – net in the Consolidated Statements of Income.
Income Taxes
Income Taxes
Income tax expense includes U.S., state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and tax bases of existing assets and liabilities and for loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company recognizes the tax benefit of uncertain income tax positions only if those positions are more likely than not to be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.
Concentration of Credit Risk
Concentration of Credit Risk

The Company is not dependent on a single customer as its largest customer accounted for less than 3% of net sales for all years presented.
Recently Adopted Accounting Standards and Recently Issued Accounting Standards
Recently Adopted Accounting Standards
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to disclose standard categories in the tax rate reconciliation, additional information for reconciling items that meet a quantitative threshold and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied prospectively, but may be applied retrospectively to all prior periods presented in the financial statements. The Company adopted this standard on a prospective basis during the year ended December 31, 2025. The adoption of this standard did not have a material impact on the Company’s Consolidated Financial Statements, but resulted in incremental income tax disclosures.
Recently Issued Accounting Standards

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires public entities to disclose, within the footnotes to the financial statements, disaggregated information about certain income statement expense captions, including disclosure of amounts for purchases of inventory, employee compensation, depreciation and intangible asset amortization, included in each relevant expense caption. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU should be applied prospectively, but may be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company’s financial statement disclosures and expects the standard will increase disclosures in the Company’s annual and interim reporting when adopted.

In December 2025, the FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities, which establishes authoritative guidance on the accounting for government grants to business entities. ASU 2025-10 is effective for annual and interim periods beginning after December 15, 2028. Adoption of this ASU may be applied using a modified prospective, modified retrospective or retrospective approach. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company’s financial statement disclosures, but does not expect the impact to be material.
v3.25.4
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Basic Weighted Average Shares Reconciles to Diluted Weighted Average Shares
Basic weighted average common shares outstanding reconciles to diluted weighted average common shares outstanding as follows:
202520242023
Basic weighted average common shares outstanding75.3 75.7 75.6 
Dilutive effect of restricted stock, performance share units and stock options— 0.2 0.3 
Diluted weighted average common shares outstanding75.3 75.9 75.9 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Share-based payment awards that were not included in the computation of Diluted EPS attributable to IDEX because the effect of their inclusion would have been antidilutive were as follows:

202520242023
Antidilutive shares not included in Diluted EPS attributable to IDEX0.8 0.4 0.2 
Schedule of Property and Equipment at Cost, Depreciation and Amortization Estimated Useful Lives
Property and equipment are stated at historical cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over each asset’s estimated useful life. Property and equipment are generally depreciated over the following estimated useful lives:

Land improvements
8 to 12 years
Buildings and improvements
8 to 30 years
Machinery, equipment and other
3 to 12 years
Office and transportation equipment
2 to 10 years
Schedule of Identifiable Intangible Assets, Useful Lives
Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are generally as follows:

Trade names
15 to 20 years
Customer relationships
5 to 20 years
Technology
5 to 20 years
Software5 years
v3.25.4
Acquisitions and Divestitures (Tables)
 12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Business Combination, Recognized Asset Acquired and Liability Assumed
As of December 31, 2025, the preliminary allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$7.5 
Property, plant and equipment8.1 
Goodwill37.0
Intangible assets44.8 
Other noncurrent assets2.9 
Total assets acquired100.3 
Current liabilities(6.2)
Deferred income taxes(9.9)
Other noncurrent liabilities(2.6)
Net assets acquired(1)
$81.6 

(1) During the fourth quarter of 2025, the Company finalized the purchase price of Micro-LAM, resulting in a reduction to the purchase price of $0.3 million.
The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$82.3 
Property, plant and equipment51.5 
Goodwill488.6
Intangible assets412.8
Other noncurrent assets15.0
Total assets acquired1,050.2 
Current liabilities(50.7)
Deferred income taxes(4.6)
Other noncurrent liabilities(12.9)
Net assets acquired(1)
$982.0 

(1) During the first quarter of 2025, the Company finalized the purchase price of Mott, resulting in a reduction to the purchase price of $4.2 million. Funds were received by the Company in the first quarter of 2025.
The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$10.6 
Property, plant and equipment19.4 
Goodwill54.2
Intangible assets44.1
Other noncurrent assets5.4
Total assets acquired133.7
Current liabilities(1.2)
Deferred income taxes(17.8)
Other noncurrent liabilities(4.9)
Net assets acquired
$109.8 
The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows:

Total
Current assets, net of cash acquired$16.7 
Property, plant and equipment12.1 
Goodwill104.3 
Intangible assets92.3 
Other noncurrent assets3.0 
Total assets acquired228.4 
Current liabilities(5.5)
Deferred income taxes(19.8)
Other noncurrent liabilities(2.7)
Net assets acquired(1)
$200.4 
(1) During the first quarter of 2024, the Company finalized the purchase price of STC, resulting in a reduction to the purchase price of $1.6 million.
Schedule of Finite-Lived Intangible Assets Acquired
The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$5.3 15
Customer relationships21.1 11
Technology18.4 12
Acquired intangible assets$44.8 
The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$42.0 15
Customer relationships269.0 14
Technology101.8 13
Acquired intangible assets$412.8 
The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$5.2 15
Customer relationships27.8 12
Technology11.1 11
Acquired intangible assets$44.1 
The acquired intangible assets and weighted average amortization periods are as follows:

Total
Weighted Average Life (in years)
Trade names$9.3 15
Customer relationships63.0 15
Technology20.0 11
Acquired intangible assets$92.3 
Schedule of Business Acquisitions-Related cost and the Fair value Inventory A summary of the acquisition costs and the fair value inventory step-up charges recorded in the years ended December 31, 2025, 2024 and 2023 are presented in the following table:
202520242023
Acquisition costs$4.6 $10.4 $7.3 
Fair value inventory step-up charges0.6 9.6 1.6 
v3.25.4
Balance Sheet Components (Tables)
 12 Months Ended
Dec. 31, 2025
Additional Financial Information Disclosure [Abstract]  
Schedule of Balance Sheet Components
 December 31,
 20252024
RECEIVABLES - NET
Customers$511.9 $461.0 
Other19.2 14.7 
Total531.1 475.7 
Less: allowance for credit losses
9.4 9.8 
Receivables - net$521.7 $465.9 
INVENTORIES - NET
Raw materials and components parts$316.1 $285.5 
Work in process47.7 34.4 
Finished goods115.6 109.8 
Inventories - net$479.4 $429.7 
PROPERTY, PLANT AND EQUIPMENT - NET
Land and improvements$31.6 $30.0 
Buildings and improvements287.5 268.9 
Machinery, equipment and other657.3 607.9 
Office and transportation equipment107.9 108.6 
Construction in progress38.0 34.9 
Total1,122.3 1,050.3 
Less: accumulated depreciation and amortization
654.3 589.9 
Property, plant and equipment - net$468.0 $460.4 
ACCRUED EXPENSES
Payroll and related items$112.2 $105.0 
Management incentive compensation19.1 14.6 
Income taxes payable14.0 10.1 
Warranty14.4 13.6 
Deferred revenue45.8 50.7 
Lease liability27.8 26.1 
Restructuring3.0 0.9 
Accrued interest11.7 12.7 
Other49.0 45.0 
Accrued expenses$297.0 $278.7 
v3.25.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Reporting Unit
Revenue by reporting unit for the years ended December 31, 2025, 2024 and 2023 was as follows:
For the Year Ended December 31,
202520242023
Scientific Fluidics & Optics$859.3 $706.1 $681.5 
Performance Pneumatic Technologies259.2 237.4 250.0 
Sealing Solutions249.6 232.4 242.3 
Material Processing Technologies127.4 122.2 120.7 
Micropump(1)
— — 21.9 
Intersegment elimination(4.8)(4.1)(2.9)
Health & Science Technologies1,490.7 1,294.0 1,313.5 
Pumps426.6 408.3 402.9 
Water351.8 347.8 345.8 
Energy205.2 207.6 209.3 
Agriculture143.3 146.4 159.6 
Valves97.1 123.1 129.5 
Intersegment elimination(1.5)(1.4)(2.9)
Fluid & Metering Technologies1,222.5 1,231.8 1,244.2 
Fire & Safety478.4 467.2 431.9 
Dispensing147.2 161.3 167.5 
BAND-IT119.7 115.8 119.4 
Intersegment elimination(1.0)(1.3)(2.6)
Fire & Safety/Diversified Products744.3 743.0 716.2 
Net sales
$3,457.5 $3,268.8 $3,273.9 

(1) Revenue from Micropump (sold on August 3, 2023) has been included in the Company’s Consolidated Statements of Income through the date of disposition. See Note 2, “Acquisitions and Divestitures,” for further detail.
Schedule of External Net Sales Disaggregated by Geography
Revenue by geographical region for the years ended December 31, 2025, 2024 and 2023 was as follows:

For the Year Ended December 31, 2025
HSTFMTFSDPIDEX
U.S.$695.7 $693.3 $371.8 $1,760.8 
North America, excluding U.S.24.7 73.0 32.0 129.7 
Europe448.4 202.6 195.2 846.2 
Asia292.3 158.1 112.6 563.0 
Other(1)
34.4 97.0 33.7 165.1 
Intersegment elimination(4.8)(1.5)(1.0)(7.3)
Net sales
$1,490.7 $1,222.5 $744.3 $3,457.5 

For the Year Ended December 31, 2024
HSTFMTFSDPIDEX
U.S.$573.7 $693.1 $354.9 $1,621.7 
North America, excluding U.S.29.9 68.3 34.2 132.4 
Europe408.0 210.1 178.4 796.5 
Asia261.4 169.7 139.9 571.0 
Other(1)
25.1 92.0 36.9 154.0 
Intersegment elimination(4.1)(1.4)(1.3)(6.8)
Net sales
$1,294.0 $1,231.8 $743.0 $3,268.8 

For the Year Ended December 31, 2023
HSTFMTFSDPIDEX
U.S.$575.5 $695.7 $371.9 $1,643.1 
North America, excluding U.S.22.6 70.3 33.4 126.3 
Europe439.9 213.8 166.7 820.4 
Asia249.4 177.6 108.5 535.5 
Other(1)
29.0 89.7 38.3 157.0 
Intersegment elimination(2.9)(2.9)(2.6)(8.4)
Net sales
$1,313.5 $1,244.2 $716.2 $3,273.9 

(1) Other includes: South America, Middle East, Australia and Africa.
Schedule of Contract with Customer, Asset and Liability
The composition of customer receivables was as follows:
December 31, 2025December 31, 2024
Billed receivables$477.1 $443.2 
Unbilled receivables34.8 17.8 
Total customer receivables$511.9 $461.0 
Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The composition of deferred revenue was as follows:

December 31, 2025December 31, 2024
Deferred revenue - current$45.8 $50.7 
Deferred revenue - noncurrent22.0 13.2 
Total deferred revenue$67.8 $63.9 
v3.25.4
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in the Carrying Amount of Goodwill
The changes in the carrying amount of goodwill for 2025 and 2024, by reportable business segment, were as follows:

HSTFMTFSDPTotal
Goodwill$1,834.5 $805.7 $398.7 $3,038.9 
Accumulated goodwill impairment losses(149.8)(20.7)(30.1)(200.6)
Balance at January 1, 20241,684.7 785.0 368.6 2,838.3 
Foreign currency translation(43.4)(8.9)(8.1)(60.4)
Acquisitions483.6 — — 483.6 
Measurement period adjustments1.8 — — 1.8 
Divestitures— (11.6)— (11.6)
Balance at December 31, 20242,126.7 764.5 360.5 3,251.7 
Foreign currency translation88.0 16.5 16.3 120.8 
Acquisitions37.0 — — 37.0 
Measurement period adjustments5.0 — — 5.0 
Balance at December 31, 2025$2,256.7 $781.0 $376.8 $3,414.5 
Schedule of Gross Carrying Value and Accumulated Amortization For Each Major Class of Intangible Asset
The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2025 and 2024:

 At December 31, 2025At December 31, 2024
 Gross
Carrying
Amount		Accumulated
Amortization		NetGross
Carrying
Amount		Accumulated
Amortization		Net
Amortized intangible assets:
Trade names209.7 (71.4)138.3 201.4 (60.0)141.4 
Customer relationships1,148.4 (380.9)767.5 1,078.8 (278.7)800.1 
Technology(1)
344.3 (102.3)242.0 327.9 (87.1)240.8 
Software 16.0 (7.3)8.7 15.2 (3.6)11.6 
Total amortized intangible assets1,718.4 (561.9)1,156.5 1,623.3 (429.4)1,193.9 
Indefinite-lived intangible assets:
Banjo trade name62.1 — 62.1 62.1 — 62.1 
Akron Brass trade name28.8 — 28.8 28.8 — 28.8 
Total intangible assets$1,809.3 $(561.9)$1,247.4 $1,714.2 $(429.4)$1,284.8 

(1) In the third quarter of 2025, the Company revised its classification of intangible assets to combine patents and unpatented technology into a single category. This change was made to better reflect the integrated nature of the Company’s intellectual property portfolio. The gross carrying amount and accumulated amortization for patents as of December 31, 2024 of $2.5 million and $2.0 million, respectively, have been reclassified to conform to the current period presentation. The change had no impact on total intangible assets or amortization expense.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Based on the intangible asset balances as of December 31, 2025, expected amortization expense for the years 2026 through 2030 is as follows:
Estimated Amortization
2026$133.5 
2027128.7 
2028125.9 
2029115.7 
2030106.5 
v3.25.4
Borrowings (Tables)
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Borrowings
Borrowings at December 31, 2025 and 2024 consisted of the following:
December 31, 2025December 31, 2024
3.37% Senior Notes, due June 2025 (the “3.37% Senior Notes”)
$— $100.0 
5.13% Senior Notes, due June 2028 (the “5.13% Senior Notes”)
100.0 100.0 
4.950% Senior Notes, due September 2029 (the “4.950% Senior Notes”)
500.0 500.0 
3.00% Senior Notes, due May 2030 (the “3.00% Senior Notes”)
500.0 500.0 
2.625% Senior Notes, due June 2031 (the “2.625% Senior Notes”)
500.0 500.0 
$800.0 million Revolving Facility, due November 2027 (the “Revolving Facility”)
228.8 269.8 
Other borrowings1.0 1.5 
Total borrowings1,829.8 1,971.3 
Less: current portion0.7 100.7 
Less: unamortized debt issuance costs and discount on debt9.0 11.1 
Long-term borrowings$1,820.1 $1,859.5 
Schedule of Maturities of Borrowings
Total borrowings at December 31, 2025 have scheduled maturities as follows:

Maturity of Borrowings
2026$0.7 
2027229.1 
2028100.0 
2029500.0 
2030500.0 
Thereafter500.0 
Total borrowings$1,829.8 
v3.25.4
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Company's Financial Assets (Liabilities) at Fair Value on Recurring Basis
The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheets at December 31, 2025 and 2024:

 December 31, 2025
 Level 1Level 2Level 3Total
Assets
Trading securities - mutual funds held in nonqualified SERP(1)
$10.8 $— $— $10.8 
Liabilities
Contingent consideration(2)
$— $— $1.2 $1.2 
 December 31, 2024
 Level 1Level 2Level 3Total
Assets
Trading securities - mutual funds held in nonqualified SERP(1)
$10.6 $— $— $10.6 

(1) The Supplemental Executive Retirement Plan (“SERP”) investment assets are offset by a SERP liability which represents the Company’s obligation to distribute SERP funds to participants. The SERP investment assets and liability are included in Other noncurrent assets and Other noncurrent liabilities, respectively, on the Company’s Consolidated Balance Sheets.

(2) In connection with the acquisition of Micro-LAM, the Company entered into an earnout agreement that may require it to make future cash consideration payments of up to $12.0 million based upon the achievement of certain financial performance targets from January 1, 2026 to December 31, 2027. As of December 31, 2025, $1.2 million of contingent consideration related to the Micro-LAM acquisition is included in Other noncurrent liabilities on the Company’s Consolidated Balance Sheets and was derived using a Monte Carlo simulation model which utilizes inputs including discount rates, volatility rates, and estimated probability of achieving projected revenue and profitability targets. This fair value measurement of contingent consideration is categorized within Level 3 of the fair value hierarchy, as the measurement amount is based primarily on significant inputs that are not observable in the market. The fair value of the contingent consideration is re-measured at each reporting period, and the change in fair value is recognized within Selling, general and administrative expenses in the Company’s Consolidated Statements of Income. There was no change in the fair value measurement of contingent consideration during 2025.
Schedule of Fair Value, by Balance Sheet Grouping
The following table provides the fair value of the outstanding indebtedness described in Note 7, “Borrowings,” which is based on quoted market prices and current market rates for debt with similar credit risk and maturity, as well as the carrying value. These fair value measurements are classified as Level 2 within the fair value hierarchy since they are determined based upon significant inputs observable in the market, including interest rates on recent financing transactions to entities with a credit rating similar to the Company’s rating.

December 31, 2025December 31, 2024
Fair ValueCarrying AmountFair ValueCarrying Amount
Total Borrowings, less unaccreted debt discount $1,773.9 $1,828.8 $1,855.0 $1,970.1 
v3.25.4
Leases (Tables)
 12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Schedule of Lease Cost
Supplemental balance sheet information related to leases as of December 31, 2025 and 2024 was as follows:

Balance Sheet CaptionDecember 31, 2025December 31, 2024
Right-of-Use (“ROU”) Assets:
Building ROU assets - net Other noncurrent assets$109.5 $114.4 
Equipment ROU assets - netOther noncurrent assets10.2 10.8 
Total ROU assets - net$119.7 $125.2 
Lease Liabilities:
Current lease liabilitiesAccrued expenses$27.8 $26.1 
Noncurrent lease liabilitiesOther noncurrent liabilities94.1 101.6 
Total lease liabilities$121.9 $127.7 

The components of lease cost for the years ended December 31, 2025, 2024 and 2023 were as follows:

202520242023
Fixed lease cost(1)
$36.6 $34.7 $33.0 
Variable lease cost4.2 3.1 2.7 
Total lease expense$40.8 $37.8 $35.7 

(1) Includes short-term leases, which are immaterial.
Schedule of Cash Flow Supplemental Disclosures
Supplemental cash flow information related to leases for the years ended December 31, 2025, 2024 and 2023 was as follows:

202520242023
Cash paid for amounts included in the measurement of lease liabilities$33.1 $34.6 $33.6 
Right-of-use assets obtained in exchange for new lease liabilities17.4 19.1 29.0 

Other supplemental information related to leases as of December 31, 2025 and 2024 was as follows:

Lease Term and Discount RateDecember 31, 2025December 31, 2024
Weighted-average remaining lease term (years):
Building and equipment5.716.40
Vehicles2.642.69
Weighted-average discount rate:
Building and equipment4.19%4.07%
Vehicles4.47%4.35%
Disclosed below is a summary of income taxes paid by jurisdiction for the year ended December 31, 2025, in accordance with ASU 2023-09:

2025
Federal$46.8 
State11.1 
Foreign
China
8.5 
Germany23.7 
India6.9 
Netherlands12.7 
All other foreign24.9 
Income taxes paid, net of amounts refunded$134.6 
Schedule of Maturity of Operating Lease Liability
Total lease liabilities at December 31, 2025 have scheduled maturities as follows:

Maturity of Lease Liabilities
2026$29.1 
202727.7 
202823.2 
202917.7 
203012.2 
Thereafter27.3 
Total lease payments137.2 
Less: Imputed interest(15.3)
Present value of lease liabilities$121.9 
v3.25.4
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Roll Forward of the Warranty Reserve A rollforward of the warranty reserve is as follows:
202520242023
Beginning balance, January 1$13.6 $9.1 $8.1 
Provision for warranties8.2 5.1 5.8 
Claim settlements(13.8)(4.1)(4.7)
Acquisitions and divestitures
6.2 3.6 (0.1)
Other adjustments, including foreign currency translation
0.2 (0.1)— 
Ending balance, December 31$14.4 $13.6 $9.1 
v3.25.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income Before Income Tax
Pretax income for 2025, 2024 and 2023 was taxed in the following jurisdictions:

202520242023
U.S.$375.5 $377.9 $534.1 
Foreign257.1 261.4 226.2 
Total$632.6 $639.3 $760.3 
Schedule of Provision Benefit for Income Taxes
The provision (benefit) for income taxes for 2025, 2024 and 2023 was as follows:

202520242023
Current
U.S.$47.4 $69.0 $103.8 
State and local10.9 11.6 13.7 
Foreign79.0 73.5 61.9 
Total current137.3 154.1 179.4 
Deferred
U.S.26.1 (2.6)(11.1)
State and local1.9 (2.1)1.7 
Foreign(15.2)(14.7)(5.3)
Total deferred12.8 (19.4)(14.7)
Total provision for income taxes$150.1 $134.7 $164.7 
Schedule of Deferred Tax Assets and Liabilities
Deferred tax assets (liabilities) at December 31, 2025 and 2024 were:

December 31, 2025December 31, 2024
Allowances and accruals$23.7 $21.7 
Employee and retiree benefit plans19.8 19.4 
Inventories17.3 13.9 
Foreign tax credit and other carryforwards30.4 20.8 
Lease liabilities27.8 26.4 
Right of use assets(26.7)(25.1)
Depreciation and amortization(353.8)(311.6)
Taxes on undistributed foreign earnings(17.4)(14.9)
Other0.8 1.0 
Total gross deferred tax liabilities(278.1)(248.4)
Valuation allowance(23.7)(17.3)
Total deferred tax liabilities, net of valuation allowances$(301.8)$(265.7)
Schedule of Deferred Tax Assets (Liabilities) Recognized In Balance Sheets
The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2025 and 2024 were:

December 31, 2025December 31, 2024
Noncurrent deferred tax asset - Other noncurrent assets$1.2 $1.5 
Noncurrent deferred tax liabilities - Deferred income taxes(303.0)(267.2)
Net deferred tax liabilities$(301.8)$(265.7)
Schedule of Effective Income Tax Rate Reconciliation The following table shows the principal reasons for the difference between the effective income tax rate and the statutory federal income tax rate for the year ended December 31, 2025 in accordance with ASU 2023-09:
2025
U.S. Federal statutory tax rate
$132.8 21.0%
State and local income taxes, net of federal income tax effect(1)
10.1 1.6%
Foreign tax effects11.0 1.7%
Effect of cross-border tax laws2.6 0.4%
Tax credits
Foreign tax credit(2)
(10.4)(1.6%)
Other(3.8)(0.6%)
Changes in valuation allowances(2)
4.5 0.7%
Nontaxable or nondeductible items3.4 0.5%
Changes in unrecognized tax benefits0.4 0.1%
Other adjustments(0.5)(0.1%)
Total provision for income taxes$150.1 23.7%

(1) The states that contribute to the majority (greater than 50%) of the tax effect in this category include California, Florida and Illinois.

(2) During 2025, the Company recorded an additional deferred tax asset for a foreign tax credit carryforward of $4.4 million with a full valuation allowance.

The following table is a reconciliation of the U.S. federal statutory rate and the effective tax rate for the years ended December 31, 2024 and 2023 in accordance with U.S. GAAP prior to the adoption of ASU 2023-09:
20242023
Pretax income$639.3 $760.3 
Provision for income taxes:
Computed amount at statutory rate of 21%$134.2 21.0%$159.7 21.0%
State and local income tax, net of federal tax benefit7.3 1.1%12.6 1.7%
Taxes on non-U.S. earnings, net of foreign tax credits6.3 1.0%10.8 1.4%
Foreign-Derived Intangible Income Deduction(9.7)(1.5%)(11.3)(1.5%)
Share-based payments(0.7)(0.1%)(2.0)(0.3%)
Other(2.7)(0.4%)(5.1)(0.6%)
Total provision for income taxes$134.7 21.1%$164.7 21.7%
Schedule of Cash Flow Supplemental Disclosures
Supplemental cash flow information related to leases for the years ended December 31, 2025, 2024 and 2023 was as follows:

202520242023
Cash paid for amounts included in the measurement of lease liabilities$33.1 $34.6 $33.6 
Right-of-use assets obtained in exchange for new lease liabilities17.4 19.1 29.0 

Other supplemental information related to leases as of December 31, 2025 and 2024 was as follows:

Lease Term and Discount RateDecember 31, 2025December 31, 2024
Weighted-average remaining lease term (years):
Building and equipment5.716.40
Vehicles2.642.69
Weighted-average discount rate:
Building and equipment4.19%4.07%
Vehicles4.47%4.35%
Disclosed below is a summary of income taxes paid by jurisdiction for the year ended December 31, 2025, in accordance with ASU 2023-09:

2025
Federal$46.8 
State11.1 
Foreign
China
8.5 
Germany23.7 
India6.9 
Netherlands12.7 
All other foreign24.9 
Income taxes paid, net of amounts refunded$134.6 
v3.25.4
Business Segments and Geographic Information (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Information on Company's Business Segments
Financial information for the Company’s reportable business segments is presented below:
For the Year Ended December 31, 2025
HSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,490.7 $1,222.5 $744.3 $3,457.5 $— $3,457.5 
Intersegment sales4.8 1.5 1.0 7.3 (7.3)— 
 Net sales1,495.5 1,224.0 745.3 3,464.8 (7.3)3,457.5 
Adjusted segment cost of sales(1)
(885.5)(622.8)(417.1)(1,925.4)7.3 (1,918.1)
Other segment expenses(2)
(212.2)(194.4)(114.7)(521.3)
Segment Adjusted EBITDA397.8 406.8 213.5 1,018.1 

For the Year Ended December 31, 2024
HSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,294.0 $1,231.8 $743.0 $3,268.8 $— $3,268.8 
Intersegment sales4.1 1.4 1.3 6.8 (6.8)— 
 Net sales1,298.1 1,233.2 744.3 3,275.6 (6.8)3,268.8 
Adjusted segment cost of sales(1)
(769.5)(639.4)(411.9)(1,820.8)6.8 (1,814.0)
Other segment expenses(2)
(181.8)(187.5)(118.2)(487.5)
Segment Adjusted EBITDA346.8 406.3 214.2 967.3 

For the Year Ended December 31, 2023
HSTFMTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,313.5 $1,244.2 $716.2 $3,273.9 $— $3,273.9 
Intersegment sales2.9 2.9 2.6 8.4 (8.4)— 
 Net sales1,316.4 1,247.1 718.8 3,282.3 (8.4)3,273.9 
Adjusted segment cost of sales(1)
(783.1)(650.1)(400.6)(1,833.8)8.4 (1,825.4)
Other segment expenses(2)
(173.8)(180.9)(109.6)(464.3)
Segment Adjusted EBITDA359.5 416.1 208.6 984.2 
(1) Adjusted segment cost of sales represents Cost of sales excluding fair value inventory step-up charges. There were step-up charges of $0.6 million, $9.6 million, and $1.6 million recorded during the years ended December 31, 2025, 2024 and 2023, respectively. All step-up charges were recorded within the HST segment.
(2) Other segment expenses consists primarily of selling, general and administrative expenses.

202520242023
ADJUSTED EBITDA
Health & Science Technologies $397.8 $346.8 $359.5 
Fluid & Metering Technologies 406.8 406.3 416.1 
Fire & Safety/Diversified Products213.5 214.2 208.6 
Segment Adjusted EBITDA1,018.1 967.3 984.2 
Corporate and other(1)
(92.2)(93.0)(84.6)
Interest expense - net(64.4)(44.5)(51.7)
Depreciation(75.8)(68.5)(57.2)
Amortization of intangible assets(130.7)(107.1)(94.9)
Fair value inventory step-up charges(0.6)(9.6)(1.6)
Restructuring expenses and asset impairments(20.7)(9.3)(10.9)
Gain on sale of businesses - net— 4.0 84.7 
Loss on sale of assets
(1.1)— — 
Credit loss on note receivable from collaborative partner(2)
— — (7.7)
Income before income taxes$632.6 $639.3 $760.3 

(1) Corporate expenses that can be identified with a segment have been included in determining segment results. The remainder is included in Corporate and other.
(2) Represents a reserve recorded on an investment with a collaborative partner in Other expense (income) – net during 2023. During the fourth quarter of 2023, the Company converted the promissory note receivable from the collaborative partner to equity, resulting in a cost method investment with zero value. See Note 3, “Collaborative Investments,” for further detail.
202520242023
DEPRECIATION
Health & Science Technologies$47.9 $41.2 $33.2 
Fluid & Metering Technologies17.9 17.3 14.1 
Fire & Safety/Diversified Products9.2 9.0 8.9 
Total Segments75.0 67.5 56.2 
Corporate and other0.8 1.0 1.0 
Total depreciation$75.8 $68.5 $57.2 
AMORTIZATION OF INTANGIBLE ASSETS
Health & Science Technologies$103.7 $79.7 $65.8 
Fluid & Metering Technologies21.6 21.1 22.7 
Fire & Safety/Diversified Products5.4 6.3 6.4 
Total amortization$130.7 $107.1 $94.9 
CAPITAL EXPENDITURES
Health & Science Technologies$32.9 $40.1 $55.1 
Fluid & Metering Technologies21.3 14.8 24.2 
Fire & Safety/Diversified Products8.9 10.2 9.7 
Total Segments63.1 65.1 89.0 
Corporate and other0.5 — 0.9 
Total capital expenditures$63.6 $65.1 $89.9 
December 31, 2025December 31, 2024
ASSETS
Health & Science Technologies$4,301.1 $4,142.6 
Fluid & Metering Technologies1,694.4 1,609.4 
Fire & Safety/Diversified Products825.2 794.1 
Total Segments6,820.7 6,546.1 
Corporate and other106.3 199.2 
Total assets$6,927.0 $6,745.3 
Schedule of Sales From External Customers and Long-Lived Assets
Information about the Company’s long-lived assets in different geographical regions as of December 31, 2025 and 2024 is shown below.
December 31, 2025December 31, 2024
LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT
U.S.$273.6 $271.7 
North America, excluding U.S.19.2 20.6 
Netherlands
50.2 51.4 
Europe, excluding Netherlands
83.6 71.6 
Asia41.1 44.7 
Other(1)
0.3 0.4 
Total long-lived assets - net$468.0 $460.4 

(1) Other includes: South America, Middle East, Australia and Africa.
v3.25.4
Restructuring Expenses and Asset Impairments (Tables)
 12 Months Ended
Dec. 31, 2025
Restructuring Costs and Asset Impairment Charges [Abstract]  
Schedule of Restructuring Costs
Pre-tax Restructuring expenses and asset impairments by segment for the 2025 initiative were as follows:
Severance CostsExit CostsAsset ImpairmentsTotal
Health & Science Technologies$11.8 $0.1 $0.6 $12.5 
Fluid & Metering Technologies4.9 — 0.1 5.0 
Fire & Safety/Diversified Products2.4 — — 2.4 
Corporate/Other0.8 — — 0.8 
Total restructuring costs and asset impairments
$19.9 $0.1 $0.7 $20.7 
Pre-tax Restructuring expenses and asset impairments by segment for the 2024 initiative were as follows:
Severance CostsExit CostsAsset ImpairmentsTotal
Health & Science Technologies$5.8 $— $0.1 $5.9 
Fluid & Metering Technologies2.4 — — 2.4 
Fire & Safety/Diversified Products0.5 — — 0.5 
Corporate/Other0.5 — — 0.5 
Total restructuring costs and asset impairments
$9.2 $— $0.1 $9.3 
Pre-tax Restructuring expenses and asset impairments by segment for the 2023 initiative were as follows:
Severance CostsExit CostsAsset ImpairmentsTotal
Health & Science Technologies$6.4 $0.2 $— $6.6 
Fluid & Metering Technologies1.5 0.6 0.8 2.9 
Fire & Safety/Diversified Products0.7 0.2 — 0.9 
Corporate/Other0.5 — — 0.5 
Total restructuring costs and asset impairments
$9.1 $1.0 $0.8 $10.9 
Schedule of Restructuring Accruals Expenses
Restructuring accruals reflected in Accrued expenses in the Company’s Consolidated Balance Sheets are as follows:
Restructuring
Initiatives
Balance at January 1, 2024$2.1 
Restructuring expenses(1)
9.2 
Payments, utilization and other(10.4)
Balance at December 31, 20240.9 
Restructuring expenses(2)
19.9 
Payments, utilization and other(17.8)
Balance at December 31, 2025$3.0 

(1) Excludes $0.1 million of asset impairments related to property, plant and equipment.
(2) Excludes $0.7 million of asset impairments related to property, plant and equipment and $0.1 million of exit costs.
v3.25.4
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Option Fair Values and Assumptions The assumptions used in determining the fair value of the stock options granted during December 31, 2025, 2024 and 2023 were as follows:
 Years Ended December 31,
 202520242023
Weighted average fair value of grants$46.74$63.61$59.77
Dividend yield1.41%1.09%1.09%
Volatility23.06%26.66%27.14%
Risk-free interest rate4.28%
4.31%
4.15%
Expected life (in years)4.704.604.50
Schedule of Stock Option Activity
A summary of the Company’s stock option activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
SharesWeighted
Average Exercise Price		Weighted-Average
Remaining
Contractual Term
(years)		Aggregate
Intrinsic
Value
Stock Options
Outstanding at January 1, 2025998,856 $191.96 6.63$24.9 
Granted82,470 196.07 
Exercised(28,408)128.86 
Forfeited(98,717)212.92 
Outstanding at December 31, 2025954,201 $192.03 5.82$8.9 
Vested and expected to vest at December 31, 2025942,815 $191.69 5.79$8.9 
Exercisable at December 31, 2025671,427 $181.50 4.95$8.9 
Schedule of Restricted Stock Activity A summary of the Company’s restricted stock activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
Restricted StockSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 2025175,991 $201.27 
Granted106,875 191.13 
Vested(64,072)190.37 
Forfeited(27,972)205.42 
Unvested at December 31, 2025190,822 $198.64 
Schedule of Unvested Cash-settled Restricted Stock Activity A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
Cash-Settled Restricted StockSharesWeighted-Average
Fair Value
Unvested at January 1, 202555,395 $209.29 
Granted32,090 195.10 
Vested(19,131)186.52 
Forfeited(6,062)177.94 
Unvested at December 31, 202562,292 $177.94 
Schedule of Weighted Average Performance Share Units Fair Values and Assumptions
The assumptions used in the Monte Carlo simulation model to determine the fair value of the market condition portion of the performance share units granted during December 31, 2025, 2024 and 2023 were as follows:
Years Ended December 31,
 202520242023
Weighted average fair value of grants$232.44$349.59$308.18
Dividend yield—%—%—%
Volatility22.93%22.23%27.00%
Risk-free interest rate4.23%4.45%4.37%
Expected life (in years)2.942.942.94
Schedule of Performance Shares Units Activity
A summary of the Company’s performance share unit activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:
Performance Share UnitsSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 202572,825 $299.87 
Granted43,360 216.98 
Vested(15,530)234.23 
Forfeited(22,450)264.20 
Unvested at December 31, 202578,205 $267.78 
Schedule of Pre-Tax Compensation Cost Total compensation cost related to all share-based awards was as follows:
Years Ended December 31,
202520242023
Stock options expense$6.1 $9.8 $9.9 
Restricted stock expense15.2 8.3 5.7 
Cash-settled restricted stock expense3.2 3.4 3.4 
Performance share units expense6.0 7.7 6.0 
Total pre-tax share-based compensation expense(1)
30.5 29.2 25.0 
Income tax benefit(4.1)(3.2)(2.7)
Total share-based compensation expense, net of income taxes$26.4 $26.0 $22.3 

(1) Pre-tax compensation cost is recognized in the Company’s Consolidated Statements of Income depending on the functional area of the underlying employees, as follows:

Years Ended December 31,
202520242023
Cost of sales$1.9 $1.6 $1.4 
Selling, general and administrative expenses29.2 27.6 23.6 
Restructuring expenses and asset impairments(2)
(0.6)— — 
Total pre-tax share-based compensation expense$30.5 $29.2 $25.0 

(2) During the year ended December 31, 2025, a benefit of $0.6 million was recognized in Restructuring expenses and asset impairments in the Company’s Consolidated Statements of Income related to forfeitures of share-based compensation awards resulting from previously announced restructuring actions initiated during the first quarter of 2025.
v3.25.4
Accumulated Other Comprehensive Income (Loss) (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The components of Accumulated other comprehensive income (loss) for the years ended December 31, 2025, 2024 and 2023 are as follows:
Cumulative Translation AdjustmentPension and Other Postretirement AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance, January 1, 2023(1)
$(137.1)$10.9 $(126.2)
Other comprehensive income (loss) before reclassification adjustments87.8 (8.2)79.6 
Gain reclassified from Accumulated other comprehensive loss(2)(3)
— (1.5)(1.5)
Tax impact— 2.3 2.3 
Net other comprehensive income (loss)(1)
87.8 (7.4)80.4 
Balance, December 31, 2023(1)
$(49.3)$3.5 $(45.8)
Other comprehensive (loss) income before reclassification adjustments(93.7)4.8 (88.9)
Gain reclassified from Accumulated other comprehensive loss(2)(3)
— (1.0)(1.0)
Loss reclassified related to divestitures(4)
5.5 — 5.5 
Tax impact— (0.7)(0.7)
Net other comprehensive (loss) income(1)
(88.2)3.1 (85.1)
Balance, December 31, 2024(1)
$(137.5)$6.6 $(130.9)
Other comprehensive income before reclassification adjustments
186.3 4.3 190.6 
Gain reclassified from Accumulated other comprehensive loss(2)(3)
— (0.9)(0.9)
Tax impact— (1.2)(1.2)
Net other comprehensive income(1)
186.3 2.2 188.5 
Balance, December 31, 2025(1)
$48.8 $8.8 $57.6 

(1) Amounts are presented net of tax.
(2) Included in the computation of net periodic cost (benefit). See Note 17, “Retirement Benefits.”
(3) Included in Other expense (income) – net in the Consolidated Statements of Income.
(4) In conjunction with the divestiture of Alfa Valvole during the second quarter of 2024, the Company released
associated cumulative foreign currency translation losses and included the release as part of the gain on sale of business.
v3.25.4
Retirement Benefits (Tables)
 12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets
The following table provides a reconciliation of the changes in the benefit obligation and fair value of plan assets over the periods described below:

 Pension BenefitsOther Benefits
 2025202420252024
 U.S.Non-U.S.U.S.Non-U.S.  
CHANGE IN BENEFIT OBLIGATION
Obligation at January 1$8.3 $84.6 $8.9 $88.5 $16.8 $17.2 
Service cost0.1 1.5 0.1 1.5 0.4 0.5 
Interest cost0.4 2.5 0.4 2.6 0.8 0.8 
Benefits paid(0.6)(2.9)(0.8)(2.2)(0.8)(0.8)
Actuarial (gain) loss
0.3 (5.4)(0.3)0.3 0.3 (0.7)
Currency translation— 10.4 — (5.3)0.2 (0.2)
Settlements— (4.8)— (2.5)— — 
Curtailments— (0.4)— — — — 
Acquisition/Divestiture— — — 0.9 — — 
Participant contributions
— 0.9 — 0.9 — — 
Other— — — (0.1)(0.1)— 
Obligation at December 31$8.5 $86.4 $8.3 $84.6 $17.6 $16.8 
CHANGE IN PLAN ASSETS
Fair value of plan assets at January 1$4.1 $45.1 $4.3 $41.7 $— $— 
Actual return on plan assets(0.1)0.9 0.2 6.2 — — 
Employer contributions0.6 3.8 0.4 3.4 0.8 0.8 
Benefits paid(0.6)(2.9)(0.8)(2.2)(0.8)(0.8)
Currency translation— 5.3 — (2.3)— — 
Settlements— (4.8)— (2.5)— — 
Participant contributions
— 0.9 — 0.9 — — 
Other— 0.1 — (0.1)— — 
Fair value of plan assets at December 31$4.0 $48.4 $4.1 $45.1 $— $— 
Funded status at December 31$(4.5)$(38.0)$(4.2)$(39.5)$(17.6)$(16.8)
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS
Other noncurrent assets$— $3.8 $— $2.1 $— $— 
Accrued expenses
(0.8)(2.1)(0.7)(1.8)(1.0)(1.1)
Other noncurrent liabilities(3.7)(39.7)(3.5)(39.8)(16.6)(15.7)
Net asset (liability) at December 31$(4.5)$(38.0)$(4.2)$(39.5)$(17.6)$(16.8)
Schedule of Weighted Average Assumptions Used in Measurement of Benefit Obligation
The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2025 and 2024 were as follows:
 U.S. PlansNon-U.S. PlansOther Benefits
 202520242025202420252024
Discount rate5.09%5.41%3.38%2.91%5.16%5.40%
Rate of compensation increase
N/AN/A2.33%2.38%N/AN/A
Cash balance interest credit rateN/AN/A1.31%1.25%N/AN/A
The assumptions used in determining the net periodic cost (benefit) were as follows:

 U.S. PlansNon-U.S. Plans
 202520242023202520242023
Discount rate5.41%4.93%5.17%2.91%3.01%3.75%
Expected return on plan assets4.15%5.40%4.65%4.13%4.37%4.17%
Rate of compensation increaseN/AN/AN/A2.38%2.55%2.44%
 Other Benefits
 202520242023
Discount rate5.40%4.90%5.21%
Expected return on plan assetsN/AN/AN/A
Rate of compensation increaseN/AN/AN/A
Schedule of Pretax Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
The pretax amounts recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheets as of December 31, 2025 and 2024 were as follows:
 Pension BenefitsOther Benefits
 2025202420252024
 U.S.Non-U.S.U.S.Non-U.S.  
Prior service cost (credit)$0.1 $(0.2)$0.1 $(0.3)$(0.3)$(0.2)
Net loss (gain)2.6 (6.6)2.3 (1.8)(7.3)(8.4)
Total$2.7 $(6.8)$2.4 $(2.1)$(7.6)$(8.6)
The pretax change recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheet in 2025 is as follows:
 Pension BenefitsOther
Benefits
 U.S.Non-U.S.
Net gain in current year
$(0.6)$4.4 $(0.3)
Prior service credit
— — 0.1 
Amortization of prior service credit— (0.1)— 
Amortization of net loss (gain) 0.3 (0.2)(0.8)
Settlement gain recognized
— (0.1)— 
Exchange rate effect on amounts in other comprehensive income— 0.7 — 
Total$(0.3)$4.7 $(1.0)
Schedule of Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans
The components of the net periodic cost (benefit) for the plans in 2025, 2024 and 2023 are as follows:
 Pension Benefits
 202520242023
 U.S.Non-U.S.U.S.Non-U.S.U.S.Non-U.S.
Service cost$0.1 $1.5 $0.1 $1.5 $0.1 $1.2 
Interest cost0.4 2.5 0.4 2.6 0.4 2.8 
Expected return on plan assets(0.2)(1.9)(0.3)(1.8)(0.2)(1.6)
Settlement gain recognized
— (0.1)— (0.3)— (0.1)
Curtailment gain recognized
— (0.4)— — — — 
Net amortization0.3 (0.3)0.3 (0.1)0.1 (0.6)
Net periodic cost $0.6 $1.3 $0.5 $1.9 $0.4 $1.7 
 
 Other Benefits
 202520242023
Service cost$0.4 $0.5 $0.4 
Interest cost0.8 0.8 0.8 
Net amortization(0.8)(0.9)(0.9)
Net periodic cost
$0.4 $0.4 $0.3 
Schedule of Basis Used to Measure Defined Benefit Plans' Assets at Fair Value
The Company’s pension plan weighted average asset allocations at December 31, 2025 and 2024, by asset category, were as follows:
U.S. PlansNon-U.S. Plans
2025202420252024
Equity securities9%9%1%1%
Fixed income securities83%79%29%25%
Cash/Commingled Funds/Other(1)
8%12%70%74%
Total100%100%100%100%

The basis used to measure the defined benefit plans’ assets at fair value at December 31, 2025 and 2024 is summarized as follows:
 Basis of Fair Value Measurement
 Outstanding
Balances		Level 1Level 2Level 3
As of December 31, 2025
Equity
U.S. Large Cap$0.2 $0.2 $— $— 
U.S. Small / Mid Cap— — — — 
International0.8 0.8 — — 
Fixed Income
U.S. Intermediate2.2 — 2.2 — 
U.S. Long Term3.1 — 3.1 — 
U.S. High Yield1.0 — 1.0 — 
International10.8 0.2 10.6 — 
Other Commingled Funds(1)
31.5 — — 31.5 
Cash and Equivalents0.8 0.8 — — 
Other2.0 — 2.0 — 
$52.4 $2.0 $18.9 $31.5 
 
(1)Other commingled funds represent pooled institutional investments in non-U.S. plans.
 Basis of Fair Value Measurement
 Outstanding
Balances		Level 1Level 2Level 3
As of December 31, 2024
Equity
U.S. Large Cap$0.2 $0.2 $— $— 
U.S. Small / Mid Cap— — — — 
International0.8 0.8 — — 
Fixed Income
U.S. Intermediate2.5 — 2.5 — 
U.S. Long Term3.1 — 3.1 — 
U.S. High Yield0.7 — 0.7 — 
International8.2 0.2 8.0 — 
Other Commingled Funds(1)
30.0 — — 30.0 
Cash and Equivalents2.1 2.1 — — 
Other1.7 — 1.7 — 
$49.3 $3.3 $16.0 $30.0 

(1)Other commingled funds represent pooled institutional investments in non-U.S. plans.
Schedule of Expected Benefit Payments
The future estimated benefit payments for the next five years and the five years thereafter are as follows:
Estimated Future Benefits
2026$7.7 
20277.4 
20287.1 
20297.6 
20307.1 
2031 to 203537.5 
v3.25.4
Significant Accounting Policies - Business (Details)
 12 Months Ended
Dec. 31, 2025
segment
Accounting Policies [Abstract]  
Number of reportable segments 3
v3.25.4
Significant Accounting Policies - Advertising Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Advertising costs $ 16.3 $ 16.9 $ 15.9
v3.25.4
Significant Accounting Policies - Schedule of Basic Weighted Average Shares Reconciles to Diluted Weighted Average Shares Outstanding (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Basic weighted average common shares outstanding (in shares) 75.3 75.7 75.6
Dilutive effect of restricted stock, performance share units and stock options (in shares) 0.0 0.2 0.3
Diluted weighted average common shares outstanding (in shares) 75.3 75.9 75.9
v3.25.4
Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Antidilutive shares not included in Diluted EPS attributable to IDEX (in shares) 0.8 0.4 0.2
v3.25.4
Significant Accounting Policies - Schedule of Property and Equipment at Cost, Depreciation and Amortization Estimated Useful Lives (Details)
Dec. 31, 2025
Land improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 8 years
Land improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 12 years
Buildings and improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 8 years
Buildings and improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 30 years
Machinery, equipment and other | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 3 years
Machinery, equipment and other | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 12 years
Office and transportation equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 2 years
Office and transportation equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life 10 years
v3.25.4
Significant Accounting Policies - Schedule of Identifiable Intangible Assets, Useful Lives (Details)
Dec. 31, 2025
Trade names | Minimum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 15 years
Trade names | Maximum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 20 years
Customer relationships | Minimum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 5 years
Customer relationships | Maximum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 20 years
Technology | Minimum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 5 years
Technology | Maximum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 20 years
Software  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 5 years
v3.25.4
Significant Accounting Policies - Research and Development Expenditures (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Engineering expense $ 122.3 $ 111.2 $ 107.5
Research and development expense $ 70.0 $ 67.4 $ 68.4
v3.25.4
Significant Accounting Policies - Foreign Currency (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Foreign currency transaction (gain) loss $ 5.6 $ (1.0) $ 7.3
v3.25.4
Significant Accounting Policies - Concentration of Credit Risk (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer | Customer Concentration Risk | Largest Customer      
Concentration Risk [Line Items]      
Percentage of concentration risk (less than) 3.00% 3.00% 3.00%
v3.25.4
Acquisitions and Divestitures - Acquisitions (Details) - USD ($)
 12 Months Ended
Jul. 29, 2025
Sep. 05, 2024
Dec. 14, 2023
May 19, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Aug. 21, 2024
Business Combination [Line Items]                
Business combination, measurement period         1 year      
Goodwill         $ 3,414,500,000 $ 3,251,700,000 $ 2,838,300,000  
Borrowings under revolving credit facilities         $ 252,000,000.0 $ 279,300,000 $ 0  
Senior Notes | 4.950% Senior Notes, due September 2029 (the “4.950% Senior Notes”)                
Business Combination [Line Items]                
Interest rate on senior notes   4.95%     4.95%     4.95%
Micro-LAM, Inc                
Business Combination [Line Items]                
Aggregate purchase price, cash paid $ 80,400,000              
Cash acquired 300,000              
Contingent consideration, range of outcomes, maximum, amount $ 12,000,000.0       $ 12,000,000.0      
Contingent consideration, period 2 years              
Consideration transferred $ 81,600,000              
Fair value of the potential earnout as of the acquisition date $ 1,200,000              
Goodwill         37,000,000.0      
Intangible assets         44,800,000      
Mott Corporation                
Business Combination [Line Items]                
Aggregate purchase price, cash paid   $ 982,000,000.0            
Cash acquired   3,100,000            
Goodwill   488,600,000            
Intangible assets   412,800,000            
Goodwill expected to be deductible for tax purposes   439,000,000.0            
Mott Corporation | Senior Notes | 4.950% Senior Notes, due September 2029 (the “4.950% Senior Notes”)                
Business Combination [Line Items]                
Proceeds from issuance of debt   495,000,000.0            
Mott Corporation | Revolving Facility | Line of Credit                
Business Combination [Line Items]                
Borrowings under revolving credit facilities   279,300,000     $ 252,000,000.0      
Mott Corporation | Cash On Hand                
Business Combination [Line Items]                
Aggregate purchase price, cash paid   $ 207,700,000            
Iridian                
Business Combination [Line Items]                
Aggregate purchase price, cash paid       $ 109,800,000        
Goodwill       54,200,000        
Intangible assets       $ 44,100,000        
STC                
Business Combination [Line Items]                
Aggregate purchase price, cash paid     $ 200,400,000          
Goodwill     104,300,000          
Intangible assets     92,300,000          
Goodwill expected to be deductible for tax purposes     $ 0          
v3.25.4
Acquisitions and Divestitures - Schedule of Allocation of Acquisition Costs to Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Sep. 05, 2024
Dec. 31, 2023
Dec. 14, 2023
May 19, 2023
Business Combination [Line Items]                
Goodwill $ 3,414.5     $ 3,251.7   $ 2,838.3    
Micro-LAM, Inc                
Business Combination [Line Items]                
Current assets, net of cash acquired 7.5              
Property, plant and equipment 8.1              
Goodwill 37.0              
Intangible assets 44.8              
Other noncurrent assets 2.9              
Total assets acquired 100.3              
Current liabilities (6.2)              
Deferred income taxes (9.9)              
Other noncurrent liabilities (2.6)              
Net assets acquired 81.6              
Adjustment to purchase price $ (0.3)              
Mott Corporation                
Business Combination [Line Items]                
Current assets, net of cash acquired         $ 82.3      
Property, plant and equipment         51.5      
Goodwill         488.6      
Intangible assets         412.8      
Other noncurrent assets         15.0      
Total assets acquired         1,050.2      
Current liabilities         (50.7)      
Deferred income taxes         (4.6)      
Other noncurrent liabilities         (12.9)      
Net assets acquired         $ 982.0      
Adjustment to purchase price   $ 4.2            
Iridian                
Business Combination [Line Items]                
Current assets, net of cash acquired               $ 10.6
Property, plant and equipment               19.4
Goodwill               54.2
Intangible assets               44.1
Other noncurrent assets               5.4
Total assets acquired               133.7
Current liabilities               (1.2)
Deferred income taxes               (17.8)
Other noncurrent liabilities               (4.9)
Net assets acquired               $ 109.8
STC                
Business Combination [Line Items]                
Current assets, net of cash acquired             $ 16.7  
Property, plant and equipment             12.1  
Goodwill             104.3  
Intangible assets             92.3  
Other noncurrent assets             3.0  
Total assets acquired             228.4  
Current liabilities             (5.5)  
Deferred income taxes             (19.8)  
Other noncurrent liabilities             (2.7)  
Net assets acquired             $ 200.4  
Adjustment to purchase price     $ 1.6          
v3.25.4
Acquisitions and Divestitures - Schedule of Acquired Intangible Assets and Weighted Average Amortization Periods (Details) - USD ($)
$ in Millions
Jul. 29, 2025
Sep. 05, 2024
Dec. 14, 2023
May 19, 2023
Micro-LAM, Inc        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total $ 44.8      
Micro-LAM, Inc | Trade names        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total $ 5.3      
Weighted Average Life (in years) 15 years      
Micro-LAM, Inc | Customer relationships        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total $ 21.1      
Weighted Average Life (in years) 11 years      
Micro-LAM, Inc | Technology        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total $ 18.4      
Weighted Average Life (in years) 12 years      
Mott Corporation        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total   $ 412.8    
Mott Corporation | Trade names        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total   $ 42.0    
Weighted Average Life (in years)   15 years    
Mott Corporation | Customer relationships        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total   $ 269.0    
Weighted Average Life (in years)   14 years    
Mott Corporation | Technology        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total   $ 101.8    
Weighted Average Life (in years)   13 years    
Iridian        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total       $ 44.1
Iridian | Trade names        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total       $ 5.2
Weighted Average Life (in years)       15 years
Iridian | Customer relationships        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total       $ 27.8
Weighted Average Life (in years)       12 years
Iridian | Technology        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total       $ 11.1
Weighted Average Life (in years)       11 years
STC        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total     $ 92.3  
STC | Trade names        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total     $ 9.3  
Weighted Average Life (in years)     15 years  
STC | Customer relationships        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total     $ 63.0  
Weighted Average Life (in years)     15 years  
STC | Technology        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Total     $ 20.0  
Weighted Average Life (in years)     11 years  
v3.25.4
Acquisitions and Divestitures - Schedule of Business Acquisitions-Related cost and the Fair value Inventory (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]      
Fair value inventory step-up charges $ 0.6 $ 9.6 $ 1.6
Selling, General and Administrative Expenses      
Business Combination [Line Items]      
Acquisition costs $ 4.6 $ 10.4 $ 7.3
v3.25.4
Acquisitions and Divestitures - Divestitures (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 03, 2024
Dec. 29, 2023
Aug. 03, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Gain (loss) on sale of business       $ 0 $ 4,000 $ 84,700
Provision for income taxes       $ (150,100) $ (134,700) (164,700)
Disposed of by Sale | Alfa Valvole Srl            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from sale of businesses, net of cash remitted $ 45,100          
Gain (loss) on sale of business 4,000          
Foreign currency translation adjustment, net of tax $ 5,500          
Disposed of by Sale | Novotema            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from sale of businesses, net of cash remitted   $ 8,300        
Gain (loss) on sale of business   $ (9,100)        
Disposed of by Sale | Micropump            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from sale of businesses, net of cash remitted     $ 110,300      
Gain (loss) on sale of business     $ 93,800      
Provision for income taxes           $ (22,700)
v3.25.4
Collaborative Investments (Details) - USD ($)
$ in Millions
 12 Months Ended 24 Months Ended
May 12, 2020
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Dec. 31, 2022
Net Investment Income [Line Items]            
Contribution to joint venture $ 0.7          
Note receivable from collaborative partner         $ 7.2 $ 7.2
Credit loss on note receivable from collaborative partner   $ 0.0 $ 0.0 $ 7.7    
Convertible Promissory Note            
Net Investment Income [Line Items]            
Credit loss on note receivable from collaborative partner   $ 7.7        
Elastomer Seals Joint Venture Partner            
Net Investment Income [Line Items]            
Contribution to joint venture $ 0.6          
Elastomer Seals Joint Venture            
Net Investment Income [Line Items]            
Ownership percentage by parent 55.00%          
Ownership percentage by noncontrolling owners 45.00%          
v3.25.4
Balance Sheet Components - Balance Sheet Components (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
RECEIVABLES - NET    
Customers $ 511.9 $ 461.0
Other 19.2 14.7
Total 531.1 475.7
Less: allowance for credit losses 9.4 9.8
Receivables - net 521.7 465.9
INVENTORIES - NET    
Raw materials and components parts 316.1 285.5
Work in process 47.7 34.4
Finished goods 115.6 109.8
Inventories - net 479.4 429.7
PROPERTY, PLANT AND EQUIPMENT - NET    
Land and improvements 31.6 30.0
Buildings and improvements 287.5 268.9
Machinery, equipment and other 657.3 607.9
Office and transportation equipment 107.9 108.6
Construction in progress 38.0 34.9
Total 1,122.3 1,050.3
Less: accumulated depreciation and amortization 654.3 589.9
Property, plant and equipment - net 468.0 460.4
ACCRUED EXPENSES    
Payroll and related items 112.2 105.0
Management incentive compensation 19.1 14.6
Income taxes payable 14.0 10.1
Warranty 14.4 13.6
Deferred revenue 45.8 50.7
Lease liability 27.8 26.1
Restructuring 3.0 0.9
Accrued interest 11.7 12.7
Other 49.0 45.0
Accrued expenses $ 297.0 $ 278.7
v3.25.4
Revenue - Schedule of Revenue by Reporting Unit (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Net sales $ 3,457.5 $ 3,268.8 $ 3,273.9
Operating Segments | HST      
Disaggregation of Revenue [Line Items]      
Net sales 1,490.7 1,294.0 1,313.5
Operating Segments | HST | Scientific Fluidics & Optics      
Disaggregation of Revenue [Line Items]      
Net sales 859.3 706.1 681.5
Operating Segments | HST | Performance Pneumatic Technologies      
Disaggregation of Revenue [Line Items]      
Net sales 259.2 237.4 250.0
Operating Segments | HST | Sealing Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 249.6 232.4 242.3
Operating Segments | HST | Material Processing Technologies      
Disaggregation of Revenue [Line Items]      
Net sales 127.4 122.2 120.7
Operating Segments | HST | Micropump      
Disaggregation of Revenue [Line Items]      
Net sales 0.0 0.0 21.9
Operating Segments | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 1,222.5 1,231.8 1,244.2
Operating Segments | FMT | Pumps      
Disaggregation of Revenue [Line Items]      
Net sales 426.6 408.3 402.9
Operating Segments | FMT | Water      
Disaggregation of Revenue [Line Items]      
Net sales 351.8 347.8 345.8
Operating Segments | FMT | Energy      
Disaggregation of Revenue [Line Items]      
Net sales 205.2 207.6 209.3
Operating Segments | FMT | Agriculture      
Disaggregation of Revenue [Line Items]      
Net sales 143.3 146.4 159.6
Operating Segments | FMT | Valves      
Disaggregation of Revenue [Line Items]      
Net sales 97.1 123.1 129.5
Operating Segments | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 744.3 743.0 716.2
Operating Segments | FSDP | Fire & Safety      
Disaggregation of Revenue [Line Items]      
Net sales 478.4 467.2 431.9
Operating Segments | FSDP | Dispensing      
Disaggregation of Revenue [Line Items]      
Net sales 147.2 161.3 167.5
Operating Segments | FSDP | BAND-IT      
Disaggregation of Revenue [Line Items]      
Net sales 119.7 115.8 119.4
Intersegment elimination      
Disaggregation of Revenue [Line Items]      
Net sales (7.3) (6.8) (8.4)
Intersegment elimination | HST      
Disaggregation of Revenue [Line Items]      
Net sales (4.8) (4.1) (2.9)
Intersegment elimination | FMT      
Disaggregation of Revenue [Line Items]      
Net sales (1.5) (1.4) (2.9)
Intersegment elimination | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales $ (1.0) $ (1.3) $ (2.6)
v3.25.4
Revenue - Schedule of External Net Sales Disaggregated by Geography (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Net sales $ 3,457.5 $ 3,268.8 $ 3,273.9
U.S.      
Disaggregation of Revenue [Line Items]      
Net sales 1,760.8 1,621.7 1,643.1
North America, excluding U.S.      
Disaggregation of Revenue [Line Items]      
Net sales 129.7 132.4 126.3
Europe      
Disaggregation of Revenue [Line Items]      
Net sales 846.2 796.5 820.4
Asia      
Disaggregation of Revenue [Line Items]      
Net sales 563.0 571.0 535.5
Other      
Disaggregation of Revenue [Line Items]      
Net sales 165.1 154.0 157.0
Operating Segments | HST      
Disaggregation of Revenue [Line Items]      
Net sales 1,490.7 1,294.0 1,313.5
Operating Segments | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 1,222.5 1,231.8 1,244.2
Operating Segments | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 744.3 743.0 716.2
Operating Segments | U.S. | HST      
Disaggregation of Revenue [Line Items]      
Net sales 695.7 573.7 575.5
Operating Segments | U.S. | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 693.3 693.1 695.7
Operating Segments | U.S. | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 371.8 354.9 371.9
Operating Segments | North America, excluding U.S. | HST      
Disaggregation of Revenue [Line Items]      
Net sales 24.7 29.9 22.6
Operating Segments | North America, excluding U.S. | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 73.0 68.3 70.3
Operating Segments | North America, excluding U.S. | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 32.0 34.2 33.4
Operating Segments | Europe | HST      
Disaggregation of Revenue [Line Items]      
Net sales 448.4 408.0 439.9
Operating Segments | Europe | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 202.6 210.1 213.8
Operating Segments | Europe | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 195.2 178.4 166.7
Operating Segments | Asia | HST      
Disaggregation of Revenue [Line Items]      
Net sales 292.3 261.4 249.4
Operating Segments | Asia | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 158.1 169.7 177.6
Operating Segments | Asia | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 112.6 139.9 108.5
Operating Segments | Other | HST      
Disaggregation of Revenue [Line Items]      
Net sales 34.4 25.1 29.0
Operating Segments | Other | FMT      
Disaggregation of Revenue [Line Items]      
Net sales 97.0 92.0 89.7
Operating Segments | Other | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales 33.7 36.9 38.3
Intersegment elimination      
Disaggregation of Revenue [Line Items]      
Net sales (7.3) (6.8) (8.4)
Intersegment elimination | HST      
Disaggregation of Revenue [Line Items]      
Net sales (4.8) (4.1) (2.9)
Intersegment elimination | FMT      
Disaggregation of Revenue [Line Items]      
Net sales (1.5) (1.4) (2.9)
Intersegment elimination | FSDP      
Disaggregation of Revenue [Line Items]      
Net sales $ (1.0) $ (1.3) $ (2.6)
v3.25.4
Revenue - Narrative (Details) - Revenue from Contract with Customer - Product Concentration Risk
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Transferred at Point in Time      
Disaggregation of Revenue [Line Items]      
Revenue from products and services transferred to customers 95.00% 95.00% 95.00%
Transferred over Time      
Disaggregation of Revenue [Line Items]      
Revenue from products and services transferred to customers 5.00% 5.00% 5.00%
v3.25.4
Revenue - Schedule of Contract with Customer, Asset and Liability (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unbilled receivables $ 34.8 $ 17.8
Total customer receivables 511.9 461.0
Billed receivables    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total customer receivables $ 477.1 $ 443.2
v3.25.4
Revenue - Schedule of New Accounting Pronouncements and Changes in Accounting Principles (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]    
Deferred revenue - current $ 45.8 $ 50.7
Deferred revenue - noncurrent 22.0 13.2
Total deferred revenue $ 67.8 $ 63.9
v3.25.4
Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Line Items]      
Goodwill     $ 3,038.9
Accumulated goodwill impairment losses     (200.6)
Goodwill      
Beginning Balance $ 3,251.7 $ 2,838.3  
Foreign currency translation 120.8 (60.4)  
Acquisitions 37.0 483.6  
Measurement period adjustments 5.0 1.8  
Divestitures   (11.6)  
Ending Balance 3,414.5 3,251.7  
HST      
Goodwill and Intangible Assets Disclosure [Line Items]      
Goodwill     1,834.5
Accumulated goodwill impairment losses     (149.8)
Goodwill      
Beginning Balance 2,126.7 1,684.7  
Foreign currency translation 88.0 (43.4)  
Acquisitions 37.0 483.6  
Measurement period adjustments 5.0 1.8  
Divestitures   0.0  
Ending Balance 2,256.7 2,126.7  
FMT      
Goodwill and Intangible Assets Disclosure [Line Items]      
Goodwill     805.7
Accumulated goodwill impairment losses     (20.7)
Goodwill      
Beginning Balance 764.5 785.0  
Foreign currency translation 16.5 (8.9)  
Acquisitions 0.0 0.0  
Measurement period adjustments 0.0 0.0  
Divestitures   (11.6)  
Ending Balance 781.0 764.5  
FSDP      
Goodwill and Intangible Assets Disclosure [Line Items]      
Goodwill     398.7
Accumulated goodwill impairment losses     $ (30.1)
Goodwill      
Beginning Balance 360.5 368.6  
Foreign currency translation 16.3 (8.1)  
Acquisitions 0.0 0.0  
Measurement period adjustments 0.0 0.0  
Divestitures   0.0  
Ending Balance $ 376.8 $ 360.5  
v3.25.4
Goodwill and Intangible Assets - Schedule of Gross Carrying Value and Accumulated Amortization for Each Major Class of Intangible Asset (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Goodwill And Intangible Assets [Line Items]    
Amortized intangible assets - Gross Carrying Amount $ 1,718.4 $ 1,623.3
Amortized intangible assets - accumulated amortization (561.9) (429.4)
Intangible assets - Gross Carrying Amount 1,809.3 1,714.2
Amortized intangible assets - Net 1,156.5 1,193.9
Intangible assets - Net 1,247.4 1,284.8
Banjo trade name    
Goodwill And Intangible Assets [Line Items]    
Indefinite lived intangible assets 62.1 62.1
Akron Brass trade name    
Goodwill And Intangible Assets [Line Items]    
Indefinite lived intangible assets 28.8 28.8
Trade names    
Goodwill And Intangible Assets [Line Items]    
Amortized intangible assets - Gross Carrying Amount 209.7 201.4
Amortized intangible assets - accumulated amortization (71.4) (60.0)
Amortized intangible assets - Net 138.3 141.4
Customer relationships    
Goodwill And Intangible Assets [Line Items]    
Amortized intangible assets - Gross Carrying Amount 1,148.4 1,078.8
Amortized intangible assets - accumulated amortization (380.9) (278.7)
Amortized intangible assets - Net 767.5 800.1
Technology    
Goodwill And Intangible Assets [Line Items]    
Amortized intangible assets - Gross Carrying Amount 344.3 327.9
Amortized intangible assets - accumulated amortization (102.3) (87.1)
Amortized intangible assets - Net 242.0 240.8
Software    
Goodwill And Intangible Assets [Line Items]    
Amortized intangible assets - Gross Carrying Amount 16.0 15.2
Amortized intangible assets - accumulated amortization (7.3) (3.6)
Amortized intangible assets - Net $ 8.7 11.6
Patents    
Goodwill And Intangible Assets [Line Items]    
Amortized intangible assets - Gross Carrying Amount   2.5
Amortized intangible assets - accumulated amortization   $ (2.0)
v3.25.4
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization of intangible assets $ 130.7 $ 107.1 $ 94.9
v3.25.4
Goodwill and Intangible Assets - Schedule of Finite Lived Intangible Assets Future Amortization Expense (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2026 $ 133.5
2027 128.7
2028 125.9
2029 115.7
2030 $ 106.5
v3.25.4
Borrowings - Schedule of Borrowings (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Sep. 05, 2024
Aug. 21, 2024
Nov. 01, 2022
Debt Instrument [Line Items]          
Total borrowings $ 1,829,800,000 $ 1,971,300,000      
Long-Term debt, gross 1,829,800,000        
Other borrowings 1,000,000.0 1,500,000      
Less: current portion 700,000 100,700,000      
Less: unamortized debt issuance costs and discount on debt 9,000,000.0 11,100,000      
Long-term borrowings 1,820,100,000 1,859,500,000      
Line of Credit | Revolving Facility          
Debt Instrument [Line Items]          
Borrowing capacity 800,000,000.0       $ 800,000,000
Long-Term debt, gross $ 228,800,000 269,800,000      
3.37% Senior Notes, due June 2025 (the “3.37% Senior Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Stated interest rate 3.37%        
Total borrowings $ 0 100,000,000.0      
5.13% Senior Notes, due June 2028 (the “5.13% Senior Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Stated interest rate 5.13%        
Total borrowings $ 100,000,000.0 100,000,000.0      
4.950% Senior Notes, due September 2029 (the “4.950% Senior Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Stated interest rate 4.95%   4.95% 4.95%  
Total borrowings $ 500,000,000.0 500,000,000.0      
3.00% Senior Notes, due May 2030 (the “3.00% Senior Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Stated interest rate 3.00%        
Total borrowings $ 500,000,000.0 500,000,000.0      
2.625% Senior Notes, due June 2031 (the “2.625% Senior Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Stated interest rate 2.625%        
Total borrowings $ 500,000,000.0 $ 500,000,000.0      
v3.25.4
Borrowings - Narrative (Details)
 2 Months Ended 12 Months Ended
Nov. 01, 2022
USD ($)
Feb. 19, 2026
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Sep. 05, 2024
Aug. 21, 2024
May 31, 2019
USD ($)
Debt Instrument [Line Items]                
Borrowings under revolving credit facilities     $ 252,000,000.0 $ 279,300,000 $ 0      
Payments under revolving credit facilities     322,900,000 $ 69,100,000 $ 0      
Balance outstanding     $ 1,829,800,000          
For 12 Months in Connection with Certain Acquisitions                
Debt Instrument [Line Items]                
Leverage ratio required     4.00          
Line of Credit                
Debt Instrument [Line Items]                
Revolving facility, extension term 1 year              
Senior Notes | 3.37% Senior Notes, due June 2025 (the “3.37% Senior Notes”)                
Debt Instrument [Line Items]                
Interest rate on senior notes     3.37%          
Senior Notes | 4.950% Senior Notes, due September 2029 (the “4.950% Senior Notes”)                
Debt Instrument [Line Items]                
Interest rate on senior notes     4.95%     4.95% 4.95%  
Senior Notes | 3.00% Senior Notes, due May 2030 (the “3.00% Senior Notes”)                
Debt Instrument [Line Items]                
Interest rate on senior notes     3.00%          
Senior Notes | 2.625% Senior Notes, due June 2031 (the “2.625% Senior Notes”)                
Debt Instrument [Line Items]                
Interest rate on senior notes     2.625%          
Revolving Facility | Minimum                
Debt Instrument [Line Items]                
Interest coverage ratio     3.0          
Revolving Facility | Maximum                
Debt Instrument [Line Items]                
Leverage ratio required     3.50          
Revolving Facility | Line of Credit                
Debt Instrument [Line Items]                
Borrowing capacity $ 800,000,000   $ 800,000,000.0          
Aggregate lending commitments               $ 400,000,000
Payments under revolving credit facilities     $ 322,900,000          
Weighted average interest rate     3.55% 4.46%        
Balance outstanding     $ 228,800,000 $ 269,800,000        
Outstanding letters of credit     2,600,000          
Revolving facility, amount available to borrow     $ 568,600,000          
Revolving Facility | Line of Credit | Minimum                
Debt Instrument [Line Items]                
Leverage ratio required     0.0000          
Revolving Facility | Line of Credit | Maximum                
Debt Instrument [Line Items]                
Leverage ratio required     0.01275          
Revolving Facility | Line of Credit | Subsequent Event                
Debt Instrument [Line Items]                
Net borrowings   $ 58,200,000            
Term Facility | Line of Credit                
Debt Instrument [Line Items]                
Borrowing capacity 200,000,000              
Line of Credit | Letters of Credit                
Debt Instrument [Line Items]                
Borrowing capacity 100,000,000              
Line of Credit | Swing line Loans                
Debt Instrument [Line Items]                
Borrowing capacity $ 50,000,000              
Line of Credit | Senior Notes                
Debt Instrument [Line Items]                
Balance outstanding     $ 1,600,000,000          
Secured Debt | Line of Credit                
Debt Instrument [Line Items]                
Weighted average interest rate       6.54%        
v3.25.4
Borrowings - Schedule of Maturities of Borrowings (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Debt Disclosure [Abstract]  
2026 $ 0.7
2027 229.1
2028 100.0
2029 500.0
2030 500.0
Thereafter 500.0
Total borrowings $ 1,829.8
v3.25.4
Fair Value Measurements - Schedule of Company Financial Assets and Liabilities at Fair Value on Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Jul. 29, 2025
Dec. 31, 2024
Liabilities      
Contingent consideration $ 1.2    
Micro-LAM, Inc      
Liabilities      
Business combination, potential earnout of maximum 12.0 $ 12.0  
Mutual Funds Held in Nonqualified SERP      
ASSETS      
Trading securities - mutual funds held in nonqualified SERP 10.8   $ 10.6
Level 1      
Liabilities      
Contingent consideration 0.0    
Level 1 | Mutual Funds Held in Nonqualified SERP      
ASSETS      
Trading securities - mutual funds held in nonqualified SERP 10.8   10.6
Level 2      
Liabilities      
Contingent consideration 0.0    
Level 2 | Mutual Funds Held in Nonqualified SERP      
ASSETS      
Trading securities - mutual funds held in nonqualified SERP 0.0   0.0
Level 3      
Liabilities      
Contingent consideration 1.2    
Level 3 | Mutual Funds Held in Nonqualified SERP      
ASSETS      
Trading securities - mutual funds held in nonqualified SERP $ 0.0   $ 0.0
v3.25.4
Fair Value Measurements - Schedule of Fair Value of Debt Outstanding (Details) - Level 2 - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total Borrowings, less unaccreted debt discount $ 1,773.9 $ 1,855.0
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total Borrowings, less unaccreted debt discount $ 1,828.8 $ 1,970.1
v3.25.4
Leases - Narrative (Details)
Dec. 31, 2025
option
Leases [Abstract]  
Options for renewal 1
v3.25.4
Leases - Schedule of Balance Sheet Composition (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Right-of-Use (“ROU”) Assets:    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other noncurrent assets Other noncurrent assets
Operating lease, right-of-use asset $ 119.7 $ 125.2
Lease Liabilities:    
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses Accrued expenses
Current lease liabilities $ 27.8 $ 26.1
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Other noncurrent liabilities Other noncurrent liabilities
Noncurrent lease liabilities $ 94.1 $ 101.6
Total lease liabilities 121.9 127.7
Building    
Right-of-Use (“ROU”) Assets:    
Operating lease, right-of-use asset 109.5 114.4
Equipment    
Right-of-Use (“ROU”) Assets:    
Operating lease, right-of-use asset $ 10.2 $ 10.8
v3.25.4
Leases - Schedule of Lease, Cost (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]      
Fixed lease cost $ 36.6 $ 34.7 $ 33.0
Variable lease cost 4.2 3.1 2.7
Total lease expense $ 40.8 $ 37.8 $ 35.7
v3.25.4
Leases - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Lessee, Lease, Description [Line Items]      
Cash paid for amounts included in the measurement of lease liabilities $ 33.1 $ 34.6 $ 33.6
Right-of-use assets obtained in exchange for new lease liabilities $ 17.4 $ 19.1 $ 29.0
Building and equipment      
Weighted-average remaining lease term (years):      
Operating lease - building and equipment, vehicles 5 years 8 months 15 days 6 years 4 months 24 days  
Weighted-average discount rate:      
Operating lease, weighted-average discount rate - building and equipment, vehicles 4.19% 4.07%  
Vehicles      
Weighted-average remaining lease term (years):      
Operating lease - building and equipment, vehicles 2 years 7 months 20 days 2 years 8 months 8 days  
Weighted-average discount rate:      
Operating lease, weighted-average discount rate - building and equipment, vehicles 4.47% 4.35%  
v3.25.4
Leases - Schedule of Operating Lease, Liability, Maturity (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Leases [Abstract]    
2026 $ 29.1  
2027 27.7  
2028 23.2  
2029 17.7  
2030 12.2  
Thereafter 27.3  
Total lease payments 137.2  
Less: Imputed interest (15.3)  
Present value of lease liabilities $ 121.9 $ 127.7
v3.25.4
Commitments and Contingencies (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]      
Beginning balance, January 1 $ 13.6 $ 9.1 $ 8.1
Provision for warranties 8.2 5.1 5.8
Claim settlements (13.8) (4.1) (4.7)
Acquisitions 6.2 3.6  
Divestitures     (0.1)
Other adjustments, including foreign currency translation 0.2 (0.1) 0.0
Ending balance, December 31 $ 14.4 $ 13.6 $ 9.1
v3.25.4
Share Repurchases (Details) - USD ($)
 1 Months Ended 2 Months Ended 12 Months Ended
Sep. 17, 2025
Mar. 17, 2020
Jan. 31, 2026
Feb. 19, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share Repurchase Program [Line Items]              
Increase in share repurchase authorized amount $ 635,000,000.0 $ 500,000,000.0          
Repurchases of common stock (in shares)         1,400,000 0 100,000
Repurchase of common stock         $ 252,400,000   $ 24,200,000
Excise tax         2,400,000    
Remaining authorized repurchase amount         $ 924,700,000    
Subsequent Event              
Share Repurchase Program [Line Items]              
Repurchases of common stock (in shares)       200,000      
Repurchase of common stock     $ 2,200,000 $ 38,100,000      
v3.25.4
Income Taxes - Schedule Of Income Before Income Tax (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
U.S. $ 375.5 $ 377.9 $ 534.1
Foreign 257.1 261.4 226.2
Income before income taxes $ 632.6 $ 639.3 $ 760.3
v3.25.4
Income Taxes - Schedule of Provision Benefit for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current      
U.S. $ 47,400 $ 69,000 $ 103,800
State and local 10,900 11,600 13,700
Foreign 79,000 73,500 61,900
Total current 137,300 154,100 179,400
Deferred      
U.S. 26,100 (2,600) (11,100)
State and local 1,900 (2,100) 1,700
Foreign (15,200) (14,700) (5,300)
Total deferred 12,800 (19,400) (14,700)
Total provision for income taxes $ 150,100 $ 134,700 $ 164,700
v3.25.4
Income Taxes - Schedule of Deferred Tax Assets Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Allowances and accruals $ 23.7 $ 21.7
Employee and retiree benefit plans 19.8 19.4
Inventories 17.3 13.9
Foreign tax credit and other carryforwards 30.4 20.8
Lease liabilities 27.8 26.4
Right of use assets (26.7) (25.1)
Depreciation and amortization (353.8) (311.6)
Taxes on undistributed foreign earnings (17.4) (14.9)
Other 0.8 1.0
Total gross deferred tax liabilities (278.1) (248.4)
Valuation allowance (23.7) (17.3)
Total deferred tax liabilities, net of valuation allowances $ (301.8) $ (265.7)
v3.25.4
Income Taxes - Schedule of Deferred Tax Assets and Liabilities Recognized in Company's Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Noncurrent deferred tax asset - Other noncurrent assets $ 1.2 $ 1.5
Noncurrent deferred tax liabilities - Deferred income taxes (303.0) (267.2)
Net deferred tax liabilities $ (301.8) $ (265.7)
v3.25.4
Income Taxes - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Line Items]      
Permanently reinvested earnings of non-U.S. subsidiaries $ 90,200,000 $ 73,400,000  
Unrecognized deferred income tax liabilities on currently permanently reinvested earnings 13,500,000 11,000,000.0  
Foreign earnings repatriated 79,800,000 483,800,000 $ 134,100,000
Incremental income tax expense (benefit) 0 0 0
Unrecognized tax benefits 300,000 0 $ 0
Accrued interest and penalties 200,000    
Impact effective tax rate 300,000    
Net operating loss carryforwards, domestic 2,500,000    
Net operating loss carryforwards, foreign 1,000,000.0    
Net operating loss carryforwards, state and local 900,000    
Deferred tax assets, valuation allowance 23,700,000 17,300,000  
Foreign tax credit and other carryforwards 30,400,000 20,800,000  
Foreign tax credit carryover for U.S. federal purposes 17,900,000    
Foreign      
Income Tax Disclosure [Line Items]      
Deferred tax assets, valuation allowance 900,000    
Foreign tax credit and other carryforwards 3,800,000    
Deferred tax asset, interest expense carryforwards 3,500,000    
Foreign | More Likely Than Not to be Realized      
Income Tax Disclosure [Line Items]      
Deferred tax assets, valuation allowance 700,000    
Other Current Assets      
Income Tax Disclosure [Line Items]      
Prepaid taxes $ 20,200,000 $ 18,300,000  
v3.25.4
Income Taxes - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Amount      
Pretax income $ 632,600 $ 639,300 $ 760,300
U.S. Federal statutory tax rate 132,800 134,200 159,700
State and local income tax, net of federal tax benefit 10,100 7,300 12,600
Foreign tax effects 11,000 6,300 10,800
Effect of cross-border tax laws 2,600    
Effect of cross-border tax laws      
Effective Income Tax Rate Reconciliation, FDII, Amount   (9,700) (11,300)
Tax credits      
Foreign tax credit (10,400)    
Other (3,800)    
Changes in valuation allowance 4,500    
Nontaxable or nondeductible items 3,400    
Other adjustments (500)    
Share-based payments 400 (700) (2,000)
Other   (2,700) (5,100)
Total provision for income taxes $ 150,100 $ 134,700 $ 164,700
Percent      
U.S. Federal statutory tax rate 21.00% 21.00% 21.00%
State and local income tax, net of federal tax benefit 1.60% 1.10% 1.70%
Foreign tax effects 1.70% 1.00% 1.40%
Effect of cross-border tax laws 0.40%    
Effect of cross-border tax laws      
Effective Income Tax Rate Reconciliation, FDII, Percent   (1.50%) (1.50%)
Tax credits      
Foreign tax credit (1.60%)    
Other (0.60%)    
Changes in valuation allowance 0.70%    
Nontaxable or nondeductible items 0.50%    
Other adjustments (0.10%)    
Share-based payments (0.10%) (0.10%) (0.30%)
Other   (0.40%) (0.60%)
Total provision for income taxes 23.70% 21.10% 21.70%
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign tax credit carryover for U.S. federal purposes $ 17,900    
Full Valuation Allowance      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign tax credit carryover for U.S. federal purposes $ 4,400    
v3.25.4
Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Effective Income Tax Rate Reconciliation [Line Items]      
Federal $ 46.8    
State 11.1    
Total cash paid for taxes (net of refunds) 134.6 $ 171.4 $ 199.5
China      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign 8.5    
Germany      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign 23.7    
India      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign 6.9    
Netherlands      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign 12.7    
All other foreign      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign $ 24.9    
v3.25.4
Business Segments and Geographic Information - Narrative (Details)
 12 Months Ended
Dec. 31, 2025
segment
Segment Reporting [Abstract]  
Number of reportable business segments 3
Number of operating business segments 3
v3.25.4
Business Segments and Geographic Information - Schedule of Information on Company's Business Segments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Revenues $ 3,457.5 $ 3,268.8 $ 3,273.9
Adjusted segment cost of sales (1,918.7) (1,823.6) (1,827.0)
Adjusted segment cost of sales (1,918.1) (1,814.0) (1,825.4)
Fair value inventory step-up charges 0.6 9.6 1.6
Interest expense - net (64.4) (44.5) (51.7)
Depreciation (75.8) (68.5) (57.2)
Amortization of intangible assets (130.7) (107.1) (94.9)
Fair value inventory step-up charges (0.6) (9.6) (1.6)
Restructuring expenses and asset impairments (20.7) (9.3) (10.9)
Gain on sale of businesses - net 0.0 4.0 84.7
Loss on sale of assets (1.1) 0.0 0.0
Credit loss on note receivable from collaborative partner 0.0 0.0 (7.7)
Income before income taxes 632.6 639.3 760.3
Total capital expenditures 63.6 65.1 89.9
Total assets 6,927.0 6,745.3  
HST      
Segment Reporting Information [Line Items]      
Revenues 1,490.7 1,294.0 1,313.5
FMT      
Segment Reporting Information [Line Items]      
Revenues 1,222.5 1,231.8 1,244.2
FSDP      
Segment Reporting Information [Line Items]      
Revenues 744.3 743.0 716.2
Operating Segments      
Segment Reporting Information [Line Items]      
Revenues 3,464.8 3,275.6 3,282.3
Adjusted segment cost of sales (1,925.4) (1,820.8) (1,833.8)
Other segment expenses (521.3) (487.5) (464.3)
Segment Adjusted EBITDA 1,018.1 967.3 984.2
Depreciation (75.0) (67.5) (56.2)
Total capital expenditures 63.1 65.1 89.0
Total assets 6,820.7 6,546.1  
Operating Segments | HST      
Segment Reporting Information [Line Items]      
Revenues 1,495.5 1,298.1 1,316.4
Adjusted segment cost of sales (885.5) (769.5) (783.1)
Other segment expenses (212.2) (181.8) (173.8)
Segment Adjusted EBITDA 397.8 346.8 359.5
Depreciation (47.9) (41.2) (33.2)
Amortization of intangible assets (103.7) (79.7) (65.8)
Total capital expenditures 32.9 40.1 55.1
Total assets 4,301.1 4,142.6  
Operating Segments | FMT      
Segment Reporting Information [Line Items]      
Revenues 1,224.0 1,233.2 1,247.1
Adjusted segment cost of sales (622.8) (639.4) (650.1)
Other segment expenses (194.4) (187.5) (180.9)
Segment Adjusted EBITDA 406.8 406.3 416.1
Depreciation (17.9) (17.3) (14.1)
Amortization of intangible assets (21.6) (21.1) (22.7)
Total capital expenditures 21.3 14.8 24.2
Total assets 1,694.4 1,609.4  
Operating Segments | FSDP      
Segment Reporting Information [Line Items]      
Revenues 745.3 744.3 718.8
Adjusted segment cost of sales (417.1) (411.9) (400.6)
Other segment expenses (114.7) (118.2) (109.6)
Segment Adjusted EBITDA 213.5 214.2 208.6
Depreciation (9.2) (9.0) (8.9)
Amortization of intangible assets (5.4) (6.3) (6.4)
Total capital expenditures 8.9 10.2 9.7
Total assets 825.2 794.1  
Intersegment elimination      
Segment Reporting Information [Line Items]      
Revenues (7.3) (6.8) (8.4)
Adjusted segment cost of sales 7.3 6.8 8.4
Intersegment elimination | HST      
Segment Reporting Information [Line Items]      
Revenues (4.8) (4.1) (2.9)
Intersegment elimination | FMT      
Segment Reporting Information [Line Items]      
Revenues (1.5) (1.4) (2.9)
Intersegment elimination | FSDP      
Segment Reporting Information [Line Items]      
Revenues (1.0) (1.3) (2.6)
Corporate/Other      
Segment Reporting Information [Line Items]      
Segment Adjusted EBITDA (92.2) (93.0) (84.6)
Depreciation (0.8) (1.0) (1.0)
Amortization of intangible assets (130.7) (107.1) (94.9)
Total capital expenditures 0.5 0.0 $ 0.9
Total assets $ 106.3 $ 199.2  
v3.25.4
Business Segments and Geographic Information - Schedule of Sales from External Customers and Long Lived Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net $ 468.0 $ 460.4
U.S.    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net 273.6 271.7
North America, excluding U.S.    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net 19.2 20.6
Netherlands    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net 50.2 51.4
Europe, excluding Netherlands    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net 83.6 71.6
Asia    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net 41.1 44.7
Other    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total long-lived assets - net $ 0.3 $ 0.4
v3.25.4
Restructuring Expenses and Asset Impairments - Schedule of Pre-Tax Restructuring Expenses by Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]      
Asset Impairments $ 0.7 $ 0.1 $ 0.8
Total restructuring costs and asset impairments 20.7 9.3 10.9
Severance Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 19.9 9.2 9.1
Exit Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 0.1 0.0 1.0
Operating Segments | HST      
Restructuring Cost and Reserve [Line Items]      
Asset Impairments 0.6 0.1 0.0
Total restructuring costs and asset impairments 12.5 5.9 6.6
Operating Segments | HST | Severance Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 11.8 5.8 6.4
Operating Segments | HST | Exit Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 0.1 0.0 0.2
Operating Segments | FMT      
Restructuring Cost and Reserve [Line Items]      
Asset Impairments 0.1 0.0 0.8
Total restructuring costs and asset impairments 5.0 2.4 2.9
Operating Segments | FMT | Severance Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 4.9 2.4 1.5
Operating Segments | FMT | Exit Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 0.0 0.0 0.6
Operating Segments | FSDP      
Restructuring Cost and Reserve [Line Items]      
Asset Impairments 0.0 0.0 0.0
Total restructuring costs and asset impairments 2.4 0.5 0.9
Operating Segments | FSDP | Severance Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 2.4 0.5 0.7
Operating Segments | FSDP | Exit Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 0.0 0.0 0.2
Corporate/Other      
Restructuring Cost and Reserve [Line Items]      
Asset Impairments 0.0 0.0 0.0
Total restructuring costs and asset impairments 0.8 0.5 0.5
Corporate/Other | Severance Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs 0.8 0.5 0.5
Corporate/Other | Exit Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs $ 0.0 $ 0.0 $ 0.0
v3.25.4
Restructuring Expenses and Asset Impairments - Schedule of Restructuring Accruals Expenses (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Reserve [Roll Forward]      
Beginning balance $ 0.9 $ 2.1  
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Restructuring expenses and asset impairments Restructuring expenses and asset impairments  
Restructuring expenses $ 19.9 $ 9.2  
Payments, utilization and other (17.8) (10.4)  
Ending balance 3.0 0.9 $ 2.1
Restructuring Cost and Reserve [Line Items]      
Asset Impairments 0.7 0.1 0.8
Exit Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring costs $ 0.1 $ 0.0 $ 1.0
v3.25.4
Share-Based Compensation - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Jan. 31, 2026
Feb. 28, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized (in shares)     9,900,000    
Number of shares available for future issuance (in shares)     9,400,000    
Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option exercisable life     10 years    
Total intrinsic value of options exercised     $ 1.8 $ 9.6 $ 14.9
Proceeds from stock options exercised     3.7 19.4 26.3
Tax benefit realized for the tax deductions from stock options exercised     0.4 $ 2.0 $ 3.1
Total unrecognized compensation cost     $ 4.5    
Weighted-average period of total unrecognized compensation cost, in years     1 year 1 month 6 days    
Dividend yield     1.41% 1.09% 1.09%
Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total unrecognized compensation cost     $ 14.9    
Weighted-average period of total unrecognized compensation cost, in years     10 months 24 days    
Cash-settled Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     3 years    
Total unrecognized compensation cost     $ 3.9    
Weighted-average period of total unrecognized compensation cost, in years     1 year    
Cash-settled Restricted Stock | Accrued Liabilities          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share based compensation, accrued expenses     $ 3.6 $ 4.0  
Cash-settled Restricted Stock | Other Noncurrent Liabilities          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share based compensation, accrued expenses     2.4 $ 2.4  
Performance Shares Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total unrecognized compensation cost     $ 2.4    
Weighted-average period of total unrecognized compensation cost, in years     1 year    
Award requisite service period     3 years    
Performance condition     25.00%    
Market condition     75.00%    
Dividend yield     0.00% 0.00% 0.00%
Payout percent   65.00%      
Net issuance shares of common stock(in shares)   15,530      
Performance Shares Units | Subsequent Event          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Payout percent 0.00%        
Net issuance shares of common stock(in shares) 0        
Performance Shares Units | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Target award     0.00%    
Performance Shares Units | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Target award     250.00%    
Target payout     100.00%    
Employees | Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Employees and Non-employee Directors | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     3 years    
Non-employee Directors | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     1 year    
v3.25.4
Share-Based Compensation - Schedule of Weighted Average Option Fair Values and Assumptions (Details) - Stock Option - $ / shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average fair value of grants (in dollars per share) $ 46.74 $ 63.61 $ 59.77
Dividend yield 1.41% 1.09% 1.09%
Volatility 23.06% 26.66% 27.14%
Risk-free interest rate 4.28% 4.31% 4.15%
Expected life (in years) 4 years 8 months 12 days 4 years 7 months 6 days 4 years 6 months
v3.25.4
Share-Based Compensation - Schedule of Stock Options Activity (Details) - Stock Option - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Shares    
Beginning balance (in shares) 998,856  
Granted (in shares) 82,470  
Exercised (in shares) (28,408)  
Forfeited (in shares) (98,717)  
Ending balance (in shares) 954,201 998,856
Vested and expected to vest (in shares) 942,815  
Exercisable (in shares) 671,427  
Weighted Average Price    
Beginning balance (in dollars per share) $ 191.96  
Granted (in dollars per share) 196.07  
Exercised (in dollars per share) 128.86  
Forfeited (in dollars per share) 212.92  
Ending balance (in dollars per share) 192.03 $ 191.96
Vested and expected to vest (in dollars per share) 191.69  
Exercisable (in dollars per share) $ 181.50  
Weighted-Average Remaining Contractual Term    
Weighted-Average Remaining Contractual Term (years) 5 years 9 months 25 days 6 years 7 months 17 days
Weighted-average remaining contractual term, vested and expected to vest 5 years 9 months 14 days  
Weighted-average remaining contractual term, exercisable 4 years 11 months 12 days  
Aggregate Intrinsic Value    
Stock options outstanding, aggregate intrinsic value $ 8,900,000 $ 24,900,000
Aggregate intrinsic value, vested and expected to vest 8,900,000  
Aggregate intrinsic value, exercisable $ 8,900,000  
v3.25.4
Share-Based Compensation - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock
 12 Months Ended
Dec. 31, 2025
$ / shares
shares
Shares  
Unvested, beginning balance (in shares) | shares 175,991
Granted (in shares) | shares 106,875
Vested (in shares) | shares (64,072)
Forfeited (in shares) | shares (27,972)
Unvested, ending balance (in shares) | shares 190,822
Weighted-Average Grant Date Fair Value  
Unvested, beginning balance (in dollars per share) | $ / shares $ 201.27
Granted (in dollars per share) | $ / shares 191.13
Vested (in dollars per share) | $ / shares 190.37
Forfeited (in dollars per share) | $ / shares 205.42
Unvested, ending balance (in dollars per share) | $ / shares $ 198.64
v3.25.4
Share-Based Compensation - Schedule of Cash-settled Restricted Stock Activity (Details) - Cash-settled Restricted Stock
 12 Months Ended
Dec. 31, 2025
$ / shares
shares
Shares  
Unvested, beginning balance (in shares) | shares 55,395
Granted (in shares) | shares 32,090
Vested (in shares) | shares (19,131)
Forfeited (in shares) | shares (6,062)
Unvested, ending balance (in shares) | shares 62,292
Weighted-Average Grant Date Fair Value  
Unvested, beginning balance (in dollars per share) | $ / shares $ 209.29
Granted (in dollars per share) | $ / shares 195.10
Vested (in dollars per share) | $ / shares 186.52
Forfeited (in dollars per share) | $ / shares 177.94
Unvested, ending balance (in dollars per share) | $ / shares $ 177.94
v3.25.4
Share-Based Compensation - Schedule of Weighted Average Performance Share Units Fair Values and Assumptions (Details) - Performance Shares Units - $ / shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average fair value of grants (in dollars per share) $ 232.44 $ 349.59 $ 308.18
Dividend yield 0.00% 0.00% 0.00%
Volatility 22.93% 22.23% 27.00%
Risk-free interest rate 4.23% 4.45% 4.37%
Expected life (in years) 2 years 11 months 8 days 2 years 11 months 8 days 2 years 11 months 8 days
v3.25.4
Share-Based Compensation - Schedule of Performance Share Unit Activity (Details) - Performance Shares Units
 12 Months Ended
Dec. 31, 2025
$ / shares
shares
Shares  
Unvested, beginning balance (in shares) | shares 72,825
Granted (in shares) | shares 43,360
Vested (in shares) | shares (15,530)
Forfeited (in shares) | shares (22,450)
Unvested, ending balance (in shares) | shares 78,205
Weighted-Average Grant Date Fair Value  
Unvested, beginning balance (in dollars per share) | $ / shares $ 299.87
Granted (in dollars per share) | $ / shares 216.98
Vested (in dollars per share) | $ / shares 234.23
Forfeited (in dollars per share) | $ / shares 264.20
Unvested, ending balance (in dollars per share) | $ / shares $ 267.78
v3.25.4
Share-Based Compensation - Schedule of Pre-Tax Compensation Cost (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense $ 30.5 $ 29.2 $ 25.0
Income tax benefit (4.1) (3.2) (2.7)
Restructuring expenses and asset impairments (0.6) 0.0 0.0
Total share-based compensation expense, net of income taxes 26.4 26.0 22.3
Cost of Sales      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense 1.9 1.6 1.4
Selling, General and Administrative Expenses      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense 29.2 27.6 23.6
Stock options expense      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense 6.1 9.8 9.9
Restricted stock expense      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense 15.2 8.3 5.7
Cash-settled restricted stock expense      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense 3.2 3.4 3.4
Performance share units expense      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total pre-tax share-based compensation expense $ 6.0 $ 7.7 $ 6.0
v3.25.4
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance $ 3,794.1 $ 3,541.2 $ 3,039.6
Other comprehensive income (loss), net of tax 188.5 (85.1) 80.4
Ending balance 4,026.2 3,794.1 3,541.2
Accumulated Other Comprehensive Loss      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (130.9) (45.8) (126.2)
Other comprehensive income (loss) before reclassification adjustments 190.6 (88.9) 79.6
Gain (loss) reclassified from Accumulated other comprehensive loss (0.9) (1.0) (1.5)
Loss reclassified related to divestitures   5.5  
Tax impact (1.2) (0.7) 2.3
Other comprehensive income (loss), net of tax 188.5 (85.1) 80.4
Ending balance 57.6 (130.9) (45.8)
Cumulative Translation Adjustment      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (137.5) (49.3) (137.1)
Other comprehensive income (loss) before reclassification adjustments 186.3 (93.7) 87.8
Gain (loss) reclassified from Accumulated other comprehensive loss 0.0 0.0 0.0
Loss reclassified related to divestitures   5.5  
Tax impact 0.0 0.0 0.0
Other comprehensive income (loss), net of tax 186.3 (88.2) 87.8
Ending balance 48.8 (137.5) (49.3)
Pension and Other Postretirement Adjustments      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance 6.6 3.5 10.9
Other comprehensive income (loss) before reclassification adjustments 4.3 4.8 (8.2)
Gain (loss) reclassified from Accumulated other comprehensive loss (0.9) (1.0) (1.5)
Loss reclassified related to divestitures   0.0  
Tax impact (1.2) (0.7) 2.3
Other comprehensive income (loss), net of tax 2.2 3.1 (7.4)
Ending balance $ 8.8 $ 6.6 $ 3.5
v3.25.4
Retirement Benefits - Schedule of Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CHANGE IN PLAN ASSETS      
Fair value of plan assets at January 1 $ 49.3    
Fair value of plan assets at December 31 52.4 $ 49.3  
Pension Benefits      
CHANGE IN BENEFIT OBLIGATION      
Other 0.0    
Pension Benefits | U.S.      
CHANGE IN BENEFIT OBLIGATION      
Obligation at January 1 8.3 8.9  
Service cost 0.1 0.1 $ 0.1
Interest cost 0.4 0.4 0.4
Benefits paid (0.6) (0.8)  
Actuarial (gain) loss 0.3 (0.3)  
Currency translation 0.0 0.0  
Settlements 0.0 0.0  
Curtailments 0.0 0.0  
Acquisition/Divestiture 0.0 0.0  
Participant contributions 0.0 0.0  
Other   0.0  
Obligation at December 31 8.5 8.3 8.9
CHANGE IN PLAN ASSETS      
Fair value of plan assets at January 1 4.1 4.3  
Actual return on plan assets (0.1) 0.2  
Employer contributions 0.6 0.4  
Benefits paid (0.6) (0.8)  
Currency translation 0.0 0.0  
Settlements 0.0 0.0  
Participant contributions 0.0 0.0  
Other 0.0 0.0  
Fair value of plan assets at December 31 4.0 4.1 4.3
Funded status at December 31 (4.5) (4.2)  
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS      
Other noncurrent assets 0.0 0.0  
Accrued expenses (0.8) (0.7)  
Other noncurrent liabilities (3.7) (3.5)  
Net asset (liability) at December 31 (4.5) (4.2)  
Pension Benefits | Non-U.S.      
CHANGE IN BENEFIT OBLIGATION      
Obligation at January 1 84.6 88.5  
Service cost 1.5 1.5 1.2
Interest cost 2.5 2.6 2.8
Benefits paid (2.9) (2.2)  
Actuarial (gain) loss (5.4) 0.3  
Currency translation 10.4 (5.3)  
Settlements (4.8) (2.5)  
Curtailments (0.4) 0.0  
Acquisition/Divestiture 0.0 0.9  
Participant contributions 0.9 0.9  
Other 0.0 (0.1)  
Obligation at December 31 86.4 84.6 88.5
CHANGE IN PLAN ASSETS      
Fair value of plan assets at January 1 45.1 41.7  
Actual return on plan assets 0.9 6.2  
Employer contributions 3.8 3.4  
Benefits paid (2.9) (2.2)  
Currency translation 5.3 (2.3)  
Settlements (4.8) (2.5)  
Participant contributions 0.9 0.9  
Other 0.1 (0.1)  
Fair value of plan assets at December 31 48.4 45.1 41.7
Funded status at December 31 (38.0) (39.5)  
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS      
Other noncurrent assets 3.8 2.1  
Accrued expenses (2.1) (1.8)  
Other noncurrent liabilities (39.7) (39.8)  
Net asset (liability) at December 31 (38.0) (39.5)  
Other Benefits      
CHANGE IN BENEFIT OBLIGATION      
Obligation at January 1 16.8 17.2  
Service cost 0.4 0.5 0.4
Interest cost 0.8 0.8 0.8
Benefits paid (0.8) (0.8)  
Actuarial (gain) loss 0.3 (0.7)  
Currency translation 0.2 (0.2)  
Settlements 0.0 0.0  
Curtailments 0.0 0.0  
Acquisition/Divestiture 0.0 0.0  
Participant contributions 0.0 0.0  
Other (0.1) 0.0  
Obligation at December 31 17.6 16.8 17.2
CHANGE IN PLAN ASSETS      
Fair value of plan assets at January 1 0.0 0.0  
Actual return on plan assets 0.0 0.0  
Employer contributions 0.8 0.8  
Benefits paid (0.8) (0.8)  
Currency translation 0.0 0.0  
Settlements 0.0 0.0  
Participant contributions 0.0 0.0  
Other 0.0 0.0  
Fair value of plan assets at December 31 0.0 0.0 $ 0.0
Funded status at December 31 (17.6) (16.8)  
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS      
Other noncurrent assets 0.0 0.0  
Accrued expenses (1.0) (1.1)  
Other noncurrent liabilities (16.6) (15.7)  
Net asset (liability) at December 31 $ (17.6) $ (16.8)  
v3.25.4
Retirement Benefits - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
employee
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Defined Benefit Plan Disclosure [Line Items]      
Accumulated benefit obligation for all defined benefit pension plans $ 91.6 $ 89.4  
Percentage of excess gains and losses over benefit obligation or market value of assets amortized 10.00%    
Weighted average annual rate of increase in the per capita cost of covered health care benefits assumed 7.87%    
Assumed decrease of weighted average health care cost trend rate 4.00%    
Year that reaches assumed decrease of weighted average health care cost trend rate 2050    
Costs of defined contribution plans $ 17.8 17.4 $ 16.8
Number of participants covering under multi employer pension plan | employee 216    
Costs of bargaining unit-sponsored multi-employer plans and defined contribution plans $ 1.0 1.0 $ 0.9
Stock held in plan assets (in shares) | shares 0    
Defined Contribution Plan      
Defined Benefit Plan Disclosure [Line Items]      
Defined contribution plan, expected contribution for next fiscal year $ 19.1    
Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, expected contribution for next fiscal year 4.6    
Other Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Actuarial loss (gain) (0.3) 0.7  
Defined benefit plan, expected contribution for next fiscal year 1.0    
U.S. | Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Actuarial loss (gain) (0.3) 0.3  
Non-U.S. | Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Actuarial loss (gain) $ 5.4 $ (0.3)  
Equity securities | U.S.      
Defined Benefit Plan Disclosure [Line Items]      
Target allocation of fund assets in equities 10.00%    
Equity securities | UK      
Defined Benefit Plan Disclosure [Line Items]      
Target allocation of fund assets in equities 100.00%    
Fixed income securities | U.S. | Minimum      
Defined Benefit Plan Disclosure [Line Items]      
Target allocation of fund assets in equities 90.00%    
v3.25.4
Retirement Benefits - Schedule of Weighted Average Assumptions Used in the Measurement of Benefit Obligation (Details)
Dec. 31, 2025
Dec. 31, 2024
Pension Benefits | U.S. Plans    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Discount rate 5.09% 5.41%
Pension Benefits | Non-U.S. Plans    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Discount rate 3.38% 2.91%
Rate of compensation increase 2.33% 2.38%
Cash balance interest credit rate 1.31% 1.25%
Other Benefits    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Discount rate 5.16% 5.40%
v3.25.4
Retirement Benefits - Schedule of Amounts in Accumulated Other Comprehensive Income Loss Expected to be Recognized as Components of Net Periodic Benefit Cost (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Pension Benefits | U.S.    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Prior service cost (credit) $ 0.1 $ 0.1
Net loss (gain) 2.6 2.3
Total 2.7 2.4
Pension Benefits | Non-U.S.    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Prior service cost (credit) (0.2) (0.3)
Net loss (gain) (6.6) (1.8)
Total (6.8) (2.1)
Other Benefits    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Prior service cost (credit) (0.3) (0.2)
Net loss (gain) (7.3) (8.4)
Total $ (7.6) $ (8.6)
v3.25.4
Retirement Benefits - Schedule of Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pension Benefits | U.S. Plans      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Service cost $ 0.1 $ 0.1 $ 0.1
Interest cost 0.4 0.4 0.4
Expected return on plan assets (0.2) (0.3) (0.2)
Settlement gain recognized 0.0 0.0 0.0
Curtailment gain recognized 0.0 0.0 0.0
Net amortization 0.3 0.3 0.1
Net periodic cost 0.6 0.5 0.4
Pension Benefits | Non-U.S. Plans      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Service cost 1.5 1.5 1.2
Interest cost 2.5 2.6 2.8
Expected return on plan assets (1.9) (1.8) (1.6)
Settlement gain recognized (0.1) (0.3) (0.1)
Curtailment gain recognized (0.4) 0.0 0.0
Net amortization (0.3) (0.1) (0.6)
Net periodic cost 1.3 1.9 1.7
Other Benefits      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Service cost 0.4 0.5 0.4
Interest cost 0.8 0.8 0.8
Net amortization (0.8) (0.9) (0.9)
Net periodic cost $ 0.4 $ 0.4 $ 0.3
v3.25.4
Retirement Benefits - Schedule of Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost of Plans (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pension Benefits | U.S. Plans      
Defined Benefit Plan Disclosure [Line Items]      
Discount rate 5.41% 4.93% 5.17%
Expected return on plan assets 4.15% 5.40% 4.65%
Pension Benefits | Non-U.S. Plans      
Defined Benefit Plan Disclosure [Line Items]      
Discount rate 2.91% 3.01% 3.75%
Expected return on plan assets 4.13% 4.37% 4.17%
Rate of compensation increase 2.38% 2.55% 2.44%
Other Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Discount rate 5.40% 4.90% 5.21%
v3.25.4
Retirement Benefits - Schedule of Pretax Amounts Recognized in Accumulated Other Comprehensive Income Loss (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
Pension Benefits | U.S. Plans  
Defined Benefit Plan Disclosure [Line Items]  
Net gain in current year $ (0.6)
Prior service credit 0.0
Amortization of prior service credit 0.0
Amortization of net loss (gain) 0.3
Settlement gain recognized 0.0
Exchange rate effect on amounts in other comprehensive income 0.0
Total (0.3)
Pension Benefits | Non-U.S. Plans  
Defined Benefit Plan Disclosure [Line Items]  
Net gain in current year 4.4
Prior service credit 0.0
Amortization of prior service credit (0.1)
Amortization of net loss (gain) (0.2)
Settlement gain recognized (0.1)
Exchange rate effect on amounts in other comprehensive income 0.7
Total 4.7
Other Benefits  
Defined Benefit Plan Disclosure [Line Items]  
Net gain in current year (0.3)
Prior service credit 0.1
Amortization of prior service credit 0.0
Amortization of net loss (gain) (0.8)
Settlement gain recognized 0.0
Exchange rate effect on amounts in other comprehensive income 0.0
Total $ (1.0)
v3.25.4
Retirement Benefits - Schedule of Pension Plan Weighted Average Asset Allocations (Details) - Pension Benefits
Dec. 31, 2025
Dec. 31, 2024
U.S. Plans    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 100.00% 100.00%
U.S. Plans | Equity securities    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 9.00% 9.00%
U.S. Plans | Fixed income securities    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 83.00% 79.00%
U.S. Plans | Cash/Commingled Funds/Other    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 8.00% 12.00%
Non-U.S. Plans    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 100.00% 100.00%
Non-U.S. Plans | Equity securities    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 1.00% 1.00%
Non-U.S. Plans | Fixed income securities    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 29.00% 25.00%
Non-U.S. Plans | Cash/Commingled Funds/Other    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Total 70.00% 74.00%
v3.25.4
Retirement Benefits - Schedule of Basis Used to Measure Defined Benefit Plans Assets at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets $ 52.4 $ 49.3
Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 2.0 3.3
Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 18.9 16.0
Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 31.5 30.0
U.S. Large Cap    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.2 0.2
U.S. Large Cap | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.2 0.2
U.S. Large Cap | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Large Cap | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Small / Mid Cap    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Small / Mid Cap | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Small / Mid Cap | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Small / Mid Cap | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
International    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.8 0.8
International | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.8 0.8
International | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
International | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Intermediate    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 2.2 2.5
U.S. Intermediate | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Intermediate | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 2.2 2.5
U.S. Intermediate | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Long Term    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 3.1 3.1
U.S. Long Term | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. Long Term | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 3.1 3.1
U.S. Long Term | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. High Yield    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 1.0 0.7
U.S. High Yield | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
U.S. High Yield | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 1.0 0.7
U.S. High Yield | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
International    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 10.8 8.2
International | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.2 0.2
International | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 10.6 8.0
International | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
Other Commingled Funds    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 31.5 30.0
Other Commingled Funds | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
Other Commingled Funds | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
Other Commingled Funds | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 31.5 30.0
Cash and Equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.8 2.1
Cash and Equivalents | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.8 2.1
Cash and Equivalents | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
Cash and Equivalents | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
Other    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 2.0 1.7
Other | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 0.0 0.0
Other | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets 2.0 1.7
Other | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, fair value of plan assets $ 0.0 $ 0.0
v3.25.4
Retirement Benefits- Schedule of Compensation Related Costs, Retirement Benefits (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Estimated Future Benefit Payments  
2026 $ 7.7
2027 7.4
2028 7.1
2029 7.6
2030 7.1
2031 to 2035 $ 37.5